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 Ongoing advances in the field of regenerative medicine towards the development 
of tissue-engineered (TE) replacements of donor organs for transplantation have been 
accompanied by advances in the design of suitable biomaterials for use in combination 
products. These biomaterials may be used either as scaffolds with incorporated biological 
components such as autologous, allogeneic or xenogeneic cell, protein or DNA sources 
which finally progress into healthy, functional tissue, or as carriers in vaccine delivery 
applications (Langer 1993; Atala 2004; Kulig 2004; Tseng 2005). In addition to 
optimizing the surface and bulk properties of these biomaterials to meet their specific 
applications, several groups have focused on overcoming the non-specific host 
inflammatory response generated against the biomaterials, which impedes implant 
functionality during its in vivo lifetime (Llull 1999; Lavik 2004). Besides eliciting a non-
specific host inflammatory response, the biomaterial may also augment the specific host 
adaptive immune response against the biological component in the combination product 
(Babensee 1998a), thereby functioning as an adjuvant. Although biomaterials having 
strong adjuvant potentials would be useful as vaccine carriers where the biomaterial-
mediated enhancement of host immune responses is advantageous, in contrast, the 
opposite effect is required for TE applications, where a minimal host response is 
necessary for successful implant performance, vascularity and integration with host 
tissues. Therefore, it is important to investigate the abilities of biomaterials to potentiate 
diverse adjuvant effects, so that biomaterials having controlled and consistent adjuvant 
effects may be used for varied applications.  
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 The aim of this thesis research was to examine host immune and inflammatory 
responses to biomaterials, focusing on the roles of biomaterials in supporting dendritic 
cell (Tabares 2006) maturation. Since DCs „bridge‟ innate and adaptive immunity and 
DC maturation results in adaptive immunity or tolerance, the hypothesis underlying this 
work is that DC maturation upon biomaterial contact in vitro would be representative of 
the adjuvant effects of the biomaterial in vivo, since adjuvants function by inducing DC 
maturation. Co-delivery of poly (lactic-co-glycolic acid) (PLGA) boosted antibody levels 
specific against the antigen introduced in vivo (Ertl 1996; Walker 1998; Raghuvanshi 
2001; Matzelle 2004). Furthermore, PLGA triggered DC maturation in vitro (Yoshida 
2004). Not all biomaterials support DC maturation; contact with agarose elicited lower 
DC maturation as compared to PLGA exposure in vitro (Yoshida 2006a) and biomaterial 
form (microparticles or film) may regulate differential DC responses as well (Bennewitz 
2005). It was hypothesized that differential biomaterial surface properties such as 
chemistry, charge and hydrophobicity/hydrophilicity would regulate the adsorption of 
distinct DC ligands, that would therefore sustain unique bi-directional interactions with 
DCs and DC receptors, ultimately resulting in varied DC responses and maturation. 
 Following preliminary characterizations of model self-assembled monolayers 
(SAM) endgroups presenting different chemistries, characterization of the profiles of 
carbohydrates ligands of DC Pattern Recognition Receptors (PRRs) namely C-type 
Lectin Receptors (CLRs) associated with adsorbed human serum or plasma proteins were 
performed using enzyme linked lectin assays (ELLAs).  The differential carbohydrate 
profiles observed on different chemistries indicated that distinct „biomaterial associated 
molecular patterns‟ may exist on biomaterials, analogous to the conserved pathogen 
 xv 
associated molecular patterns (PAMPs) that are recognized by DCs and stimulate DC 
maturation. Specifically, the NH2 SAM endgroups were associated with highest complex 
mannose, the CH3 SAM with least sialylated groups, and COOH SAM with higher α-
galactose than CH3 or OH SAMs. These presented carbohydrates may perform individual 
pro- or anti- inflammatory roles in the context of biomaterials, which remain to be 
elucidated.  
As an initial step towards further characterizing the serum or plasma protein 
sources of glycosylations, the adsorbed proteins eluted from different SAM endgroups 
were identified by immunoblotting as part of collaboration with Dr. John Brash and Rena 
Cornelius, from McMaster University, Canada. Lower band intensity of pro-
inflammatory protein fibrinogen was detected in eluates from CH3 SAM endgroups 
compared to other SAM endgroups following pre-adsorption with filtered plasma, as well 
as lower amounts of fibrinogen adsorbed to CH3 SAM compared to COOH or NH2 SAM 
from radiolabeling assays. Also, lower band intensity of adhesive protein vitronectin or 
anti-inflammatory albumin were also measured in eluates from CH3 SAM endgroups 
while no bands could be detected for complement-3 or vitronectin and faint bands for 
albumin in eluates from OH SAM endgroups. On the other hand, pre-incubation with 
filtered serum resulted in absence of bands corresponding to Factor XI, Factor XII, pre-
kallikrein or α1-anti-trypsin in CH3 SAM eluates compared to other SAM endgroups, 
implying differential profiles of adsorbed serum or plasma proteins on different SAM 
chemistries. Although these differences in protein adsorption may be regulated by surface 
chemistry and hence imply that CH3 SAM endgroups were least inflammatory due to 
least presence of pro-inflammatory proteins, the possibility of non-uniform protein 
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elution from the different endgroups cannot be ignored, and was assessed by radioactive 
labeling of fibrinogen to measure protein adsorption and elution from different SAM 
endgroups. Furthermore, types of incubating medias were important in determining the 
profiles of adsorbed proteins: filtered versus unfiltered; serum versus plasma. To 
circumvent the technical difficulty of handling all proteins in serum or plasma 
simultaneously, future directions include focusing in on a panel of upto five glycosylated 
serum or plasma proteins that are commonly adsorbed onto biomaterials, clearly 
distinguishable and with known fragmentation profiles on gels, to investigate the profiles 
and protein sources of detected carbohydrates that are eluted from different SAM 
endgroups.  
The differential effects of different SAM chemistries on DC responses were 
examined by evaluating DC maturation following plating of cultures that were 
characterized as CD4+ DCs, CD3+/CD4+ T lymphocytes and CD19+/CD24+ B 
lymphocytes. These studies demonstrated that DCs cultured on CH3 SAM endgroups 
displayed rounded morphologies, similar to immature DCs (iDCs) and exhibited lower 
allostimulatory abilities. These results implied that while OH, COOH or NH2 SAM 
endgroups were modest stimulators of DCs and triggered higher expression of maturation 
markers as compared to iDCs, CH3 SAM endgroups triggered lowest DC maturation. In 
contrast, measurement of levels of pro-inflammatory cytokines tumor necrosis factor-α 
(TNF- α) or interleukin-6 (IL-6) in DC supernatants, indicated that highest levels of both 
cytokines were present in supernatants on CH3 SAM endgroups, that were hitherto 
thought to be least maturing to DCs. This inconsistency was further investigated in the 
study presented herein, where it was revealed that DCs on CH3 SAM expressed highest 
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levels of anti-inflammatory apoptosis-inducing HLA-DQ and were also undergoing 
highest apoptosis, possibly initiated by high levels of TNF- α. This is significant as 
phagocytosis of apoptotic DCs has potent immunosuppressive effects (Skoberne 2005b; 
Wallet 2005a; Chen 2006b). Furthermore, both DCs and autologous T lymphocytes on 
CH3 SAM significantly upregulated expression of cytotoxic T lymphocyte associated 
antigen receptor-4 (CTLA-4), responsible for T cell inhibition and anergic effects 
(Walunus 1998; Oosterwegel 1999; Orabona 2006), compared to other SAM endgroups. 
Taken together, these results imply possible tolerogenic mechanisms that may have been 
responsible for lower DC maturation on CH3 SAM. For these studies, loosely adherent 
DCs alone were examined for all treatments, since the expression profiles for maturation 
markers following biomaterial exposure were similar to adherent DCs with the exception 
of CD80 expression which was upregulated in the adherent DCs, presumably as a result 
of DC stimulation during the detachment procedure.  
 Collectively, these results demonstrate that carbohydrate constituents of 
„biomaterial associated molecular patterns‟ presented on biomaterial surfaces may vary 
based on surface properties. In addition, these results establish the differential DC 
maturation effects of different SAM chemistries and elucidate the mechanisms 
responsible for their varied abilities to support DC maturation. Finally, the assays 
developed in this research and the mechanisms examined here may be transferred from 
model systems to natural or polymeric biomaterials that have been employed in 
combination products, with the ultimate goal of matching biomaterials that facilitate 





 Following the genomics and proteomics eras, the field of glycomics involving the 
analysis of glycan structure and function and the decoding of the „glycome‟ or the 
comprehensive set of glycosylated moieties associated with cells, tissues or organs has 
recently gained prominence (Turnbull 2007). To further this field, several sophisticated 
tools have emerged including mass spectrometry (MS) (Chalabi 2006; Comelli 2006) 
and/or high performance liquid chromatography (HPLC) techniques (Tabares 2006) that 
are specially optimized for performing glycan studies. Other novel strategies include the 
development of glycan or glycan-binding protein arrays (Feizi 2004; Palma 2006), glycan 
libraries, the generation of synthetic glycoconjugates (Gama 2006; Turnbull 2006), 
glycan-binding lectin microarrays (Kuno 2005) as well as the establishment of large-scale 
databases for the successful amalgamation of varied data types (Goldberg 2005; Turnbull 
2006). Glycans constitute the major type of post-translational modification of proteins 
and invest proteins with immense structural and functional diversity. Additionally, as 
glycans are present in intracellular regions of most tissues and organs as well as on cell 
exteriors (Varki 1999; Shriver 2004), they play significant roles in controlling 
angiogenesis (Liu 2002a), tissue-repair (Shriver 2002), development (Ioffe 1994; 
Perrimon 2000) and even immunity (Baum 2002; Crocker 2002). Hence an improved 
understanding of carbohydrate forms and functions would provide a huge impetus 
towards launching carbohydrate-based biomedical applications. The identification of 
glycosylated markers would aid in the diagnosis of diseases including liver sclerosis, 
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cancer (Smorenburg 2001; Liu 2002b; Wahrenbrock 2003), schizophrenia or in 
inflammation (Turnbull 2007). Furthermore, purified recombinant engineered glycoforms 
may have therapeutic uses in biological drugs (Turnbull 2007). 
 However, the field of glycomics faces tremendous technical challenges due to the 
intrinsic complexity and diversity of glycan structures (Raman 2005). Although, 
considerable progress has been made, there remains an immense potential for further 
advances. A similar lacking is also reflected in the field of biomaterials science and in the 
study of fundamental biomaterial inflammatory responses, where the roles of 
carbohydrates have not been previously considered. The thesis presented herein 
represents initial attempts to characterize and elucidate the role of a novel class of 
biomolecules, the carbohydrates, that are present either in the local milieu or associated 
with adsorbed proteins on biomaterial surfaces, in mediating inflammatory cell 
interactions with the biomaterials.  
Glycans regulate multiple biochemical pathways and coordinate multicellular 
biological responses (Iozzo 2001; Shriver 2004). Likewise, glycans may be critical in 
mediating host immune/inflammatory responses to biomaterials. Glycosylated moieties 
may be associated with adsorbed proteins on biomaterial surfaces and influence cellular 
responses to biomaterials, but these interactions have not been sufficiently examined thus 
far. An understanding of the glycan-based interactions between carbohydrates presented 
by adsorbed proteins on implant surfaces with the glycoproteins present in solution and 
with glycosylations on the surfaces of immune cells recruited to sites of implantation or 
tissue damage, may elicit a superior level of comprehension of the mechanisms 
underlying host responses against tissue-engineered (TE) devices used in regenerative 
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medicine. Specifically, the generation of TE devices composed of a biomaterial scaffold 
within which biological components such as autologous, allogeneic or xenogeneic cells, 
proteins or DNA are incorporated (Langer 1993; Atala 2004; Kulig 2004; Tseng 2005), 
has evolved in an attempt to resolve the scarcity of healthy donor organs that are 
available for transplantation in the treatment of organ failure. The ultimate goal would be 
to successfully integrate these devices with host tissue and achieve complete implant 
functionality. Among the tremendous challenges in meeting this objective, overcoming 
the host inflammatory and immune responses that severely restrict device usage remains 
significant (Babensee 1998a; Llull 1999; Lavik 2004). With combination products such 
as these, in addition to the non-specific inflammatory response mounted against the 
biomaterial component, a specific immune response may also be mounted against the 
biological component facilitated by the biomaterial (Babensee 1998a). Biomaterial 
adjuvancy and underlying mechanisms, from the cellular perspective, are still unknown. 
Understanding this relationship will provide design guidelines for biomaterials for a 
multitude of applications where a broad spectrum of adjuvant potentials are desired, such 
as in TE where minimal biomaterial adjuvancy is optimal or in biomaterial vaccine 
delivery systems where a high adjuvant effect that would enhance the host response is 
desired for enhanced vaccine potency. The adjuvant effect of biomaterials has been 
observed both in vivo and in vitro and has been demonstrated to be mediated by critical 
antigen presenting cells (APCs) such as dendritic cells (DCs) that mature upon adjuvant 
stimulation to present peptide antigen to adaptive immune cells and form the pivotal link 
between innate and adaptive immunity. In the innate immune response, DCs recognize 
conserved pathogen associated molecular patterns (PAMPs) on pathogen surfaces using 
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pattern recognition receptors (PRRs). Since DCs typically recognize and respond to 
complex carbohydrates and lipid patterns in pathogens, the objective here, is to 
characterize the presence of carbohydrates in the adsorbed protein layer, as possible 
mediators of DC interactions with biomaterials in support of DC maturation. 
Furthermore, the emphasis is on investigating a new family of bio-moieties which can 
mediate inflammatory cell/biomaterial interactions and which have hitherto not been 
investigated.   
The objective of this thesis research is to elucidate the ‘biomaterial-
associated molecular patterns’ in the adsorbed proteins on biomaterials of defined 
and different chemistries and correlate their influence on resultant DC responses. In 
particular, the presence of ligands of calcium-dependant C-type lectin receptors (CLRs), 
a carbohydrate-binding family of DC PRRs associated with adsorbed proteins on 
biomaterials and the roles of these carbohydrates in mediating DC maturation will be 
investigated. It was hypothesized that DCs recognize and respond to biomaterials 
either indirectly through the adsorbed protein layer, specifically through 
carbohydrate modifications of these proteins, or through carbohydrates inherent in 
the biomaterial chemistry, using PRRs to initiate an immune response. Although the 
various stages of the biomaterial - host response, including but not restricted to, non-
specific host protein adsorption, complement activation, coagulation, inflammatory and 
immune cell recruitment and activation and wound healing processes have been 
examined, the adjuvant effects of biomaterials remains to be thoroughly characterized. 
Furthermore, the roles of glycosylated moieties in enhancing or mitigating the DC-
mediated responses to biomaterials still need to be elucidated. Biomaterials such as poly 
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(lactic-co-glycolic acid) (PLGA) acted as adjuvants by causing enhanced host responses 
against co-delivered antigens (Newman 2002; Stivaktakis 2005), or by increasing 
antigen-specific host antibody production (Matzelle 2004) in a biomaterial form-
dependant manner (Bennewitz 2005). Differential adjuvant potentials of biomaterials 
were demonstrated; while PLGA enhanced DC maturation in vitro, agarose did not 
(Yoshida 2006a). Self assembled monolayers (SAM) presenting different endgroup 
chemistries (-CH3, -OH, -COOH or -NH2) are a well-characterized model system and 
have been used to study effects of surface chemistry, charge, 
hydrophobicity/hydrophilicity on host responses by several groups (Silver 1995; Mrksich 
1996; Lindbald 1997; Harder 1998; Sigal 1998; Kalltorp 1999; Luk 2000; McClary 2000; 
Tegoulia 2000; Shen 2001; Keselowsky 2003; Michael 2003; Schwendel 2003; Barbosa 
2004; Dadsetan 2004; Barbosa 2005a; Sperling 2005; Barbosa 2006). Since biomaterials 
function as adjuvants in vivo by causing DC maturation and enhancing their ability to 
present antigen to adaptive immune cells, characterization of the DC ligands (with 
emphasis on carbohydrates) on SAM surfaces, their effects on stimulating DC maturation 
and elucidating the mechanisms underlying these responses, are critical for optimal 








To address the above central hypothesis, two specific aims were pursued. 
 
Specific Aim 1: Elucidate the profile of carbohydrates associated with proteins 
adsorbed to model biomaterial surfaces of defined chemistries and examine the role 
of carbohydrate ligands in supporting DC maturation in the context of model 
biomaterial surfaces.  
The working hypothesis for this specific aim was that contact of SAMs presenting 
different endgroup chemistries would direct a differential profile of carbohydrates 
associated with adsorbed proteins. The SAM surfaces were characterized by X-ray 
photoelectron spectroscopy (XPS), contact angle measurements and chromogenic 
substrate endotoxin assay to evaluate the elemental composition, 
hydrophobicity/hydrophilicity and endotoxin content of the surfaces, respectively. An 
Enzyme Linked Lectin Assay (ELLA) was developed using lectin probes to detect the 
presence of carbohydrate ligands of DC CLRs associated with adsorbed proteins on SAM 
surfaces that were pre-incubated with 1% or 10% human serum in phosphate buffered 
saline (PBS) or 1% or 10% human plasma in PBS, similar to % serum/plasma used for 
DC culture. The ELLA absorbances were normalized against amounts of mean adsorbed 
total human immunoglobulin (IgG) or human serum albumin (HSA) measured using 
Enzyme Linked Immunosorbent Assays (ELISAs).  To distinguish the proteins adsorbed 
to different SAM chemistries, bound proteins were eluted with sodium dodecyl sulfate 
(SDS)/dithioerithritol (DTE) and characterized using polyacrylamide gel electrophoresis 
(PAGE), with immunoblotting to identify the presence of specific proteins.  
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Specific Aim 2: Characterize DC responses to model biomaterial surfaces having 
different chemistries and elucidate the mechanisms underlying these responses. 
 The working hypothesis for this aim was that DCs would interact differently with 
biomaterial SAM surfaces having different chemistries and hence undergo differential 
morphological, phenotypic and functional responses as a function of biomaterial surface 
properties. For this aim, DCs derived from peripheral human blood mononuclear cells 
were cultured on these SAMs surfaces and the types and compositions of cells present in 
culture were characterized. The extent of maturation was determined as compared to 
negative control of immature DCs (iDCs) and positive control of mature DCs (mDCs) 
induced with lipopolysaccharide (LPS) treatment. The phenotype of DCs was examined 
by morphology in Giemsa-stained cytospins and expression of activation markers by flow 
cytometry. The allostimulatory capacities of DCs cultured on different SAM endgroups 
were assessed using a mixed lymphocyte reaction (MLR). Secretion of pro- and anti-
inflammatory mediators were measured using ELISAs and cellular apoptosis was 
determined using a variety of assays.  
 Taken together, these studies are an initial step towards understanding the 
mechanisms involved in differential DC responses to biomaterials of well-defined and 
different chemistries. Results presented here include novel approaches to measure 
carbohydrates moieties associated with proteins presented by biomaterials and to 
investigate their immune and inflammatory roles. Furthermore these results represent in-
depth analyses of DC phenotypic and functional responses to different biomaterials, 
essential in ultimately having controlled and predictable host responses to combination 
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products where biomaterials having well-understood host responses may potentiate a 





















 Glycosylations are present ubiquitously as post-translational modifications of 
proteins in the extracellular matrix (ECM), on cellular surfaces and within cells (Varki 
1999; Shriver 2004). Although glycans have been implicated in multiple biological 
phenomena including in development (Ioffe 1994; Perrimon 2000), coagulation (Jin 
1997) and in mediating bacterial as well as viral infections (Fu 2003), these biological 
moieties have been comparatively unexploited in developing novel therapeutic agents 
(Shriver 2004). Several promising studies have suggested critical roles for glycans in 
regulating many diseases including cancer (Smorenburg 2001; Liu 2002b; Wahrenbrock 
2003) and cardiovascular disease (Shriver 2002), thereby making them ideal targets for 
biomedical interventions. The enormous motivation for developing glycan-based 
therapeutic drugs has been enhanced by their small size, increased stability, high 
specificity and potentially lower immunogenicity compared to other biomolecules 
(Shriver 2004; Sioud 2004). However, the immense heterogeneity and complexity of 
glycan structures and associated linkages that allows them to participate in varied 
biochemical processes (Iozzo 2001) also renders their study extremely challenging. This 
difficulty is exacerbated by the lack of currently available methods to amplify glycans for 
analysis (Shriver 2004), as well as the weak interactions between glycans (Yang 2002).  
Another area in which glycans may play vital roles is in the orchestration of the 
host immune/inflammatory responses to biomaterials. The adsorbed protein layer that 
masks implanted devices almost instantaneously upon implantation may be composed of 
glycan post-translational modifications of proteins. The interactions of glycosylated 
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biomolecules associated with implant surfaces as well as those present in solution and on 
surfaces of recruited immune cells may be important mediators of host responses, but 
have not been previously studied. This thesis research attempts to characterize a novel 
class of biomolecules which not been formerly investigated, namely carbohydrates and 
examine their roles in regulating inflammatory cell/biomaterial interactions such as those 
associated with tissue engineered (TE) devices. 
The vast numbers of people awaiting organ transplants in the United States 
(94,086 at the end of 2005, Transplant Statistics: National Reports, Scientific Registry of 
Transplant Recipients) has lead to the emergence of TE alternatives to transplant organs 
and tissue. In both TE devices and biological drug delivery systems, the combination 
products are composed of biomaterial components that impart physical and structural 
integrity to the biological components such as cells, proteins, DNA or RNA (Langer 
1993; Atala 2004; Kulig 2004). The recipient immune and inflammatory responses 
generated against the combination product may however substantially limit its integration 
with host tissue and its efficacy in vivo (Babensee 1998a; Llull 1999; Lavik 2004). The 
host response is expected to be composed of a specific adaptive response against the 
biological components as well as a non-specific inflammatory response against the 
biomaterial scaffold (Babensee 1998a). At present, several efforts are underway to 
advance the field of biomaterials to synthesize novel biomaterials and modify existing 
ones to meet biocompatibility requirements. An important step in furthering this process 
would be to extensively examine biomaterial interactions with host immune and 
inflammatory systems, when biomaterials are present as combination products. 
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 Unforeseen device failure may occur as a result of the synergism between the 
immune and inflammatory responses between the biological and biomaterial components, 
respectively. Biomaterials may augment the specific immune response developed against 
the biological component due to their adjuvant effects (Babensee 1998a). This property 
of biomaterial adjuvancy may be critical in selecting appropriate biomaterial constituents 
of combination products and hence needs to be investigated in depth. In the research 
presented herein, the ability for biomaterials to support the in vitro maturation of 
professional antigen presenting dendritic cells (DCs) that form the pivotal link between 
innate and adaptive immunity has been investigated, with especial emphasis on 
carbohydrates in supporting DC maturation. The ultimate goal would be to use this in 
vitro measure of DC activation to predict the in vivo adjuvancies of these biomaterials.  
 Although the inflammatory potentials of biomaterials have been examined in TE, 
their interactions with DCs and capacities to stimulate DC maturation have not yet been 
comprehensively explored. The goal of this thesis research was to characterize the DC 
ligands that were presented by different functional chemistries on the extensively studied 
model biomaterial monolayer systems, the effects of these ligands on stimulating DC 
maturation and the elucidation of DC receptors and cellular mechanisms involved in 
mediating these DC responses. This research project is unique and different from other 
studies that have examined biomaterial-DC interplay in order to evaluate biomaterials for 
specific end applications; such as in TE where low adjuvancy is required or in vaccine 
delivery where high adjuvancy is desired to enhance the host response, in that the 
objective here is to not only screen the abilities of biomaterials to stimulate DC 
maturation but also to understand ensuing DC responses in the context of the biomaterial 
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associated host ligands, specifically carbohydrates. This information would be useful in 
designing suitable biomaterials with a wide spectrum of adjuvant potentials for diverse 
applications.  
In meeting this goal, differential effects of model self assembled monolayers 
(SAM) that present different functional chemistries on DC maturation were examined 
and the underlying cellular processes were probed; while contact with OH, COOH or 
NH2 SAM endgroups triggered modest DC maturation, in contrast, contact with CH3 
SAM endgroups resulted in lowest DC maturation, augmented by the presence of anti-
inflammatory DC apoptosis and T cell immunosuppressive mechanisms on this surface. 
The differential profiles of DC carbohydrate ligands associated with proteins presented 
by different SAM chemistries implied that there may exist a correlation between 
carbohydrate ligands and DC maturation. Since DCs play a central role in mediating host 
responses, establishing a clear understanding of DC maturation in response to 
biomaterials in vitro would be expected to be representative of the adjuvant effects of 
these biomaterials in vivo.  
On a separate note, either DCs, or macrophages, another class of professional 
antigen presenting cells (APCs), could be derived in vitro from primary peripheral blood 
mononuclear cells (PBMCs) when cultured with or without DC differentiation cytokines 
respectively and could be distinguished morphologically as well as phenotypically. 
Macrophages have been studied extensively in terms of their responses to biomaterials, 
since they are the primary immune cell type recruited to implant sites, are present in close 
proximity with biomaterial implants throughout their presence in vivo and are key 
regulators of the intensity and length of host responses, by secreting cytokines, 
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chemokines and growth factors (Anderson 1988; Brodbeck 2002a; Labow 2005; Xia 
2006; Kao 2007). Both macrophages as well as DCs are professional APCs (Sallusto 
1994; Triozzi 1997) and have the capacities to stimulate adaptive immune responses 
against implant associated pathogens. Macrophages are the major mediators of 
inflammatory responses to biomaterials (Anderson 1988), while DCs are more efficient at 
eliciting adaptive immune responses (Setum 1991; Sallusto 1994; Triozzi 1997). Hence, 
DCs may be involved in initiating cellular and humoral immunity against implant 
associated antigens (Babensee 1998a), thereby playing distinctive roles from 
macrophages. While macrophages have formed the focus for previous studies that 
examined host responses to biomaterials, this work compares DCs with macrophages and 
extends that focus to DCs by examining DC-mediated host responses.  
Finally, information from this attempt to explore the interconnections between 
innate/inflammatory and adaptive immunity, with a focus on DCs, in the context of host 
responses to TE devices may then be used to allow for a biomaterial-centered approach to 
generate predictable and controlled host responses. This thesis work is significant as it 
aims to ultimately provide design criteria for biomaterials, based on an understanding of 
the mechanisms involved in biomaterial-induced DC maturation, thereby regulating DC 
phenotype at the cellular level, and advancing host acceptance and tissue integration of a 







Innate and adaptive immunity 
Innate immunity 
The initial response against host invasion either by pathogen ingestion or by 
receptor-mediated recognition of conserved pathogenic molecules, is mounted by innate 
immunity comprising host white blood cells including phagocytic macrophages or 
dendritic cells (DCs), eosinophils, basophils, mast cells, lymphocytes, neutrophils and 
natural killer (NK) cells (Janeway 2001). Recognition of foreign agents by these cells 
triggers the secretion of pro-inflammatory cytokines including interleukin-1 (IL-1), IL-12 
or IL-8 which may act locally, or systemic activators such as tumor necrosis factor- α 
(TNF-α), to generate a potent and non-specific protective host response against the target 
pathogens. Neutrophil activation leads to the initiation of inflammation accompanied by 
increased vascular permeability to allow for increased leukocyte recruitment to the 
infected area (Janeway 2001). 
Professional antigen presenting cells (APCs) including DCs or macrophages 
express pattern recognition receptors (PRRs) that recognize conserved pathogen 
associated molecular patterns (PAMPs), leading to their enhanced abilities to stimulate 
naïve adaptive immune cells such as T and B cells to cause directed antigen lysis or 
synthesize antigen-specific antibodies (Medzhitov 1997). Since DCs form the critical link 
between a non-specific innate response and a specific adaptive response, they are referred 
to as „bridging‟ the two arms of arms of immunity (Banchereau 1998a). 
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Innate immunity includes the complement system, a set of plasma proteins that 
exist in an inactive form, but yield active inflammatory fragments upon enzymatic 
cleavage that are recognized by innate immune cells (Janeway 2001). The three known 
pathways of complement activation; complement 1(C1)-complex stimulation and 
antibody or pathogen-bound C1q that gives rise to C3- convertase, or C3 hydrolysis, or 
binding of mannan binding lectin (MBL) to mannose on pathogens causing protease 
activation and the generation of C4b and C2 from C4 and C2 respectively, all trigger the 
formation of C3-convertase, that ultimately leads to the establishment of the 
C5bC6C7C8C9 membrane attack complex (MAC) that ruptures pathogenic membranes 
and induces target cell lysis (Janeway 2001).  
 
Adaptive immunity 
 The adaptive immune system primarily comprises T and B lymphocytes that are 
activated by interactions between T cell receptor (TCR) or B cell receptor (BCR) 
complexes respectively, with major histocompatibility complex (MHC) molecule 
counterparts on APCs such as DCs or macrophages. The APC activation is associated 
with upregulated MHC expression and increased presentation of peptide antigen to 
lymphocytes in the context of MHC (Janeway 2001). This TCR-mediated antigen 
recognition event leads to a complex cascade of intracellular events that drives the clonal 
expansion of T lymphocytes in an IL-2-mediated manner. During this process of clonal 
expansion and differentiation of naïve T lymphocytes into effector cells which occurs 
slowly and confers target specificity and memory on adaptive immunity, T lymphocytes 
migrate from lymphoid organs where the APC binding event takes place, into the lymph 
nodes, where they come into contact with the antigen. The effector T lymphocytes 
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function either as CD8+ cytotoxic T (Tc) lymphocytes that act by directly killing specific 
antigen or as CD4+ helper T lymphocytes (Th) that provide other B lymphocyte 
activation signals that are necessary for their transformation into mature terminally 
differentiated plasma cells, capable of secreting antibodies. In addition to the primary 
MHC-TCR signal required for activation, a secondary signal provided by co-stimulatory 
molecules that are upregulated on activated APCs such as DCs or macrophages 
(Banchereau 1998a) involving CD40 receptor expressed on APCs and CD40 ligand 
(CD40 L) on T lymphocytes that stimulates B-7 family co-stimulatory receptor 
interactions are necessary for lymphocyte stimulation (O'Sullivan 2003). A tertiary signal 
for activation is provided by release of cytokines and chemokines (Banchereau 1998a). 
Although many effector cells finally undergo apoptosis and are cleared from the system, 
a small number remain in circulation as memory effector cells and counter subsequent 
attacks by the same antigen (Janeway 2001).  
 Immunity is tightly regulated, since the signals required for T lymphocyte 
stimulation: antigen peptide presentation by MHC and co-stimulation by APC can only 
be provided by professional APCs (Janeway 2001). The presentation of intracellular 
cytosolic (viral or other) antigens to CD8+ T lymphocytes by APCs is mediated by MHC 
class I receptors, which respond by secreting perforins or granzymes that result in target 
lysis or apoptosis. On the other hand, endocytosed extracellular antigens are processed 
and presented via MHC II to CD4+ T lymphocytes which assist CD8+ T and/or B 
lymphocyte functions. In certain cases „cross-presentation‟ may occur wherein exogenous 
antigens may be endocytosed and broken down in the cytosol and then loaded onto MHC 
I molecules in the endoplasmic reticulum (ER) (Banchereau 1998a; Rock 2005). 
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Alternatively, as reviewed in (Rock 2005) antigen lysis and loading onto MHC I may 
occur in the endosome. As a result of cross presentation, both CD4 as well as CD8+ T 
lymphocytes may be activated or undergo tolerization for the specific antigen (Rock 
2005). The CD4+ T lymphocytes may be Th1 which stimulate the secretion of interferon-γ 
(IFN-γ) and promote macrophage bactericidal functions and B lymphocyte synthesis of 
antigen-coating antibodies that are recognized and destroyed by „cellular immunity‟, or 
Th2 which stimulate IL-4 secretion and humoral immunity via B lymphocyte production 
of neutralization antibodies. While humoral immunity comes into contact with pathogens 
in blood and extracellular fluids, cellular immunity has access to tissues as well. In 
addition to T lymphocyte IL-2-mediated proliferation regulated by APCs, inhibition of T 
lymphocytes has been linked to high affinity interactions between the B-7 family of co-
stimulatory molecules on APCs and cytotoxic T lymphocyte associated antigen receptor-
4 (CTLA-4) expressed by activated T lymphocytes via signaling cascades that are 
activated upon CTLA-4 ligation. This inhibitory mechanism limits T lymphocyte 
proliferations and hence by extension, the adaptive response. Finally, immune tolerance 
against antigens may be generated by MHC-TCR signaling in the absence of co-
stimulation, resulting in Th3 and anergic regulatory T lymphocytes that act through anti-
inflammatory mediators including IL-4, IL-10 and the potently immunosuppressive 







Immature dendritic cells and capture of antigens 
 Dendritic cells originate from bone marrow progenitors and circulate the body 
through blood to ultimately reach peripheral tissues (Banchereau 1998a). Here, the DCs 
search for pathogens which they detect, process, degrade and present as foreign to 
effector cells, thereby initiating primary responses and may also orchestrate rapid 
secondary responses by inducing immunological memory. Immature DCs capture 
pathogens via phagocytosis, an efficient means of antigen uptake, pinocytosis by forming 
large vesicles to partake of fluids or via receptor-mediated endocytosis of picomolar and 
nanomolar amounts of antigen (Sallusto 1995; Banchereau 1998a). Recently DCs have 
been shown to phagocytose biomaterial microparticles as well (Reece 2001; Walter 2001; 
Lutsiak 2002; Newman 2002).  
Immature DCs (iDCs) express intracellular and extracellular germline-encoded 
PRRs such as Toll-like receptors (TLRs) (Kaisho 2001; Medzhitov 2001), C-type lectin 
receptors (CLRs) (Sallusto 1995; Geitjenbeek 2000; Brown 2001a; Figdor 2002), 
scavenger receptors (SRs), surfactant proteins (SPs) and complement receptors (CRs) as 
recently reviewed in (Brown 2006), that bind conserved PAMPs and may trigger the 
release of cytokines and other inflammatory mediators depending on the specific 
stimulus, upon ligand uptake. Immature DCs also express chemokine co-receptors, FC 
antigen-uptake receptors, and exhibit low levels of IL-2Rα/CD25, adhesion moecules 
[intercellular adhesion molecule-1 (ICAM-1)/CD54, lymphocyte function-associated 
antigen-3 (LFA-3)/CD58), co-stimulatory receptors (B7-2/CD86, B7-1/CD80), MHC and 
CD40 receptors (Banchereau 1998b).  
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The type I transmembrane TLRs encode an extracellular leucine-rich repeat 
(LRR) and an intracellular Toll/IL-1 (TIR) domain and trigger different responses to 
varied stimuli (Medzhitov 1997; Iwasaki 2004). So far, over ten different toll-like 
receptors have been identified; although more may exist in mammals. Among known 
ligands, TLR2 recognizes bacterial (Henderson 1996) and mycoplasmal lipopeptides 
(Aliprantis 1999; Brightbill 1999; Hirschfeld 1999; Lien 1999) and peptidoglycans 
(PGN) (Schwander 1999; Yoshimura 1999); TLR3 recognizes poly (I:C) groups 
(Alexopoulou 2001); TLR4 recognizes bacterial lipopolysaccharides (LPS) (Poltorak 
1998; Lien 2000; Poltorak 2000); flagellin is recognized by TLR5 (Hayashi 2001); TLR6 
recognizes mycoplasmal lipopeptides (Takeuchi 2001); TLR7 recognizes 
imidazoquinolines (Hemmi 2002); TLR9 recognizes CpG DNA (Hemmi 2000). 
Signaling via several TLRs involves recruitment of myeloid differentiation primary 
response gene (MyD88), nuclear translocation of nuclear factor- кB (NF-кB) and 
triggering of mitogen activating protein (MAP) kinases such as c-Jun N-terminal protein 
kinase (c-JNK) and p38 (Simon 2003). 
 The transmembrane CLRs may be type I or II lectins based on the outward or 
inward orientation of their N termini with respect to the cytoplasm, respectively (Figdor 
2002). The type I lectins possess multiple carbohydrate recognition domains (CRDs) 
while type II lectins contain one CRD, specific for a carbohydrate moiety, each (Figdor 
2002). The CLR family has been broadly classified as mannose or galactose binding 
(McGreal 2004) – the mannose receptor (MR) (Sallusto 1995), DC-specific ICAM-3 
grabbing non-integrin (DC-SIGN) (Geitjenbeek 2000), Dectin-1 (Brown 2001a), are 
examples of CLRs that bind mannose moieties, while asialoglycoprotein receptor 
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(ASGPR) (Valladeau 2001) and macrophage galactose N-acetyl-galactosamine (GalNAc) 
specific lectin 1 (MGL) bind α- and/or ß -galactose or GalNAc (Valladeau 2001; Figdor 
2002; van Kooyk 2003). The carbohydrate-binding specificities of different CLRs vary 
and have been reviewed in (Figdor 2002; van Kooyk 2003); while MR recognized 
terminal mannose, fucose, sialyled groups or N-acetylglucosamine (GlcNAc), DC-SIGN 
recognized mannose-enriched internal residues. Binding of carbohydrates occurs via co-
ordination bonds with Ca
2+
 and hydrogen bonds formed between acid and amide side 
groups which also bind the Ca
2+ 
(Figdor 2002). Certain CLRs are also expressed on 
Langerhans cells, plasmacytoid DCs, monocytes, macrophages, polymorphonuclear cells 
(PMNs), B cells and thymic endothelial cells (Figdor 2002) and are involved in a variety 
of functions including antigen uptake, T-cell interaction and migration (Jiang 1995; 
Sallusto 1995; Ariizumi 2000a; Ariizumi 2000b; Ariizumi K. 2000; Geijtenbeek T. B. 
2000; Geijtenbeek 2000; Geitjenbeek 2000). Dectin-1 receptor that possesses an 
intracellular ITAM (immunoreceptor tyrosine-based activation motif) and binds ß-
glucans (Brown 2000; Brown 2001a; Gantner 2003; Brown 2006) has been the only DC 
CLR implicated in Syk-mediated signaling (Rogers 2005), enhancement of TLR2-based 
NF- кB activation (Gantner 2003). Also, binding of mannose-capped
 
lipoarabinomannan 
(ManLAM) to DC-SIGN skewed the response from a pro-inflammatory Th1 response to a 
Th2 response (van Kooyk 2003; Geitjenbeek 2005). Furthermore, galactose/GalNAc has 
been associated with enhanced presence of TLR2 mRNA, implying a link between CLRs 
and TLRs. Others studies have demonstrated dectin-1 cross-talk with TLR2 signaling 
pathways, suggesting linked synergistic responses to antigens from the two PRR families 
(Gantner 2003; Dillon 2006). On the other hand, dendritic cell immunoreceptor (DCIR) 
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which has been associated with inhibitory functions possesses an ITIM motif (Kanazawa 
2002). 
 
Maturation of dendritic cells and migration to secondary lymphoid organs 
The transition from iDCs to mature DCs (mDCs) is triggered by “danger signals” 
such as PAMPs, damage-associated molecular patterns (DAMPs), pro-inflammatory 
cytokines or necrotic cells. During this process, iDCs transition into mDCs, transforming 
from mediating antigen capture functions to antigen presentation functions and may 
direct either immune or tolerogenic outcomes (Banchereau 1998a). Mature DCs exhibit 
fewer endocytic vesicles and Fc receptors implying limited antigen uptake and 
phagocytic capabilities and high levels of CD54, CD58, CD80, CD86 receptors that 
facilitate communication with T lymphocytes (Banchereau 1998a; Banchereau 2000; 
Adams 2005), enhanced expression of MHC and co-stimulatory complexes to display 
antigen to T lymphocytes and reorganization of actin cables to facilitate migration from 
sites of pathogen encounter to T lymphocyte areas of the lymphatic system (Banchereau 
1998a). Following maturation, DCs alter their abilities to respond to microenvironmental 
chemokines, by upregulating macrophage inflammatory-3β (MIP-3β) and secondary 
lymphoid organ chemokine (SLC) chemokines that drive DC and T lymphocytes to 
secondary lymphoid organs, thereby assisting in the stimulation of adaptive immunity 
(Banchereau 2000). The signaling mediators that are critical in regulating DC maturation 
include NF- кB, mitogen-activated protein kinase (MAPK), p38 and c-JNK, that are also 




Dendritic cell subsets  
 Dendritic cells exist as different subsets and lineages and exhibit considerable 
flexibility in terms of function, hence differentially modulating the final host response 
(Liu 2001). Common myeloid progenitors (CMP) in the bone marrow (Patwa 2006) 
differentiate into CD34+ CD11c+ CD1a+ iDCs (Strunk 1997) that develop into skin 
Langerhans cells (LCs), while CD34+ CD11c+ CD1a- iDCs give rise to interstitial DCs 
in tissues (Ito 1999). These two types of DCs vary in their expression of cell surface 
receptors and also exhibit functional differences; interstitial DCs but not LCs uptake 
antigen and stimulate naïve B cells in a CD40 and IL-2-dependant manner. Besides this 
classification, two types of pre-DCs also exist; monocytes (pre-DC1) or plasmacytoid 
cells (pre-DC2) (Liu 2001), that are different from iDCs in that they are less migratory in 
culture, exhibit fewer dendritic extensions of the plasma membrane and have reduced 
abilities to stimulate naïve T cells, in agreement with their lower expression of co-
stimulatory receptors. While pre-DC1s are different from pre-DC2s, both are involved in 
mediating microbial immunity (Spits 2000; Bendriss-Vermare 2001; Liu 2001). In 
culture pre-DC1s differentiate into immature myeloid DC1s (im-DC1) upon treatment 
with granulocyte macrophage colony-stimulating factor (GM-CSF) and IL-4 or following 
bacterial contact, CD40 stimulus or endotoxin (Cella 1997b), derived by similar methods 
as DCs used in this thesis research. Alternatively, pre-DC2s generate im-DC2s in 
response to IL-13 in culture or following viral activation. The im-DC1s potentiate IL-12 
mediated Th1 responses, while im-DC2s direct IL-4-responsive Th2 responses (Rissoan 
1999). Finally, lymphoid DC subsets were identified, that generated DCs from early 
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thymic T cell precursors (Shortman 2000), which are CD8+ in contrast to CD8- myeloid 
DCs and are distinguished by their abilities to trigger Th2 and Th1 responses, respectively 
(Pulendran 2001), although the presence of CD8 on lymphoid DCs is controversial 
(Brasel 2000; Traver 2000). Others have demonstrated that pre-DC2s may qualify for 
classification as „lymphoid‟. Cumulatively, DCs are remarkably flexible in their abilities 
to adapt themselves based on environmental stimuli and may undergo modifications 
based on the specific stimulus to be countered (Liu 2001). 
 
Adjuvants 
 Adjuvants have been used in vaccine applications, to enhance the mild protective 
response elicited against the antigen. Adjuvants may be particulate or 
immunostimulatory. While particulate antigens function by APC- mediated endocytosis 
and stimulation, the latter are derived from pathogens and include LPS (Singh 1999) that 
functions as an adjuvant by binding TLR4 and inducing TLR4-mediated stimulation of 
DC maturation, the activation of NF-κB and antigen presentation via MHC complexes 
(Akira 2001; Medzhitov 2001; An 2002). Inorganic agents such as aluminum hydroxide, 
aluminum phosphate (Baylor 2002) potassium alum (Glenny 1926) and calcium 
phosphate have been used clinically as adjuvants.  Complete Freunds adjuvant (CFA) has 
common applications in animal models (Alving 2002).  Natural adjuvants include 
streptococcal nucleic acids (Bültmann 1975), bacterial peptidoglycans (Nauciel 1974) 
necrotic products, liposomes (Smith Korsholm 2007), double-stranded (ds) RNA, single-
stranded (ss) DNA (Busconi 2006), unmethylated CpG DNA (Verthelyi 2006) and 
bacterial cell walls – all of which are TLR ligands. In pharmacologic applications, 
caffeine, by itself a minimal adjuvant, acts as a potent adjuvant when dispensed in 
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combination with acetaminophen (Zhang 2001). On the other hand, virosomes have been 
shown to generate adjuvant effects with nominal inflammatory responses by mediating 
fusion, uptake and antigen processing by host APCs (Gluck 2005). Adjuvants are 
modified to induce mitigated host responses that increment responses to co-delivered 
antigens by imitating, but not reaching the full potential as in normal infections. 
 
Host response associated with biomaterial implants 
Protein adsorption 
 The introduction of medical devices induces the host response against the implant 
itself as well as against the injury sustained by the host as a result of implantation 
(Anderson 1988). The initial stages of this host response include the non-specific 
adsorption of host proteins onto the implant biomaterials surface, directed by surface 
properties such as porosity, topography, chemistry, hydrophobicity/hydrophilicity and 
charge (Mrksich 1996; Shen 2001; Thiele 2003a). Prominent among the host proteins 
found adsorbed to surfaces are albumin, fibrinogen, fibronectin, vitronectin, plasminogen, 
immunoglobulins (Ig) and complement proteins, several of which have been implicated 
in immune and inflammatory consequences (Brash 1987; Tang 1993b). Host immune and 
other cells interact therefore with the adsorbed protein biofilms (Tang 1993b) and not 
with the bare biomaterial itself, since protein adsorption precedes the recruitment of 
immune or inflammatory cells to the biomaterial site (Tang 1993b). However, the 
amounts, profiles or conformations of adsorbed proteins vary based on surface properties, 
implying that characterization of these variations would provide initial clues regarding 
the bi-directional interplay between cells and cell-modified biofilms. In most cases, 
hydrophobic surfaces allow higher protein adsorption as compared to hydrophilic 
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surfaces, which are able to hydrogen bond with water molecules, therefore making it 
energetically more favorable for proteins to adsorb to hydrophobic materials (Collier 
1997; Otto 2003). Polyethylene terephthalate (PET) surfaces that were pre-incubated with 
albumin had greater passivating effects and permitted lower cell adhesion compared to 
uncoated PET. On the other hand, PET surfaces pre-incubated with pro-inflammatory 
proteins such as fibrinogen triggered higher inflammatory responses (Tang 1993a). 
Adsorption of fibrinogen on biomaterial surfaces, a major component of adsorbed 
proteins (Pankowsky 1990; Nimieri 1994), has also been linked to promoting monocyte 
adhesion (Shen 2001), while others have shown that the conformation in which 
fibrinogen adsorbed is significant (Hu 2001; Keselowsky 2003), as modifications in 
conformation may trigger the complex cascade of events leading to the inflammatory 
response. Furthermore, the adsorption of other serum or plasma proteins such as 
thrombin, anti-thrombin III and plasminogen have been linked to coagulation and 
thrombus formation and presence of C3 of biomaterials surfaces may be an important 
link to complement activation, as discussed next. 
 
Complement activation 
 As discussed earlier, the classical, alternative and mannose-binding lectin-
mediated pathways of complement activation unite at C3 convertase, which ultimately 
leads to the formation of MAC (Ratner 1996). The prevalent view in biomaterial 
literature is that biomaterial activation of complement primarily occurs via the alternative 
pathway of spontaneous C3b binding to nucleophiles on hydroxyl or amine terminal 
surfaces, in contrast to non-activators such as anionic terminal carboxyl or heparinized 
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materials, that promote the existence of inactive form of C3b bound to Factor H, even 
though polyacrylamides activate complement in a non-nucleophile-mediated manner 
(Ratner 1996; Gorbet 2004). Others have suggested that biomaterial complement 
activation may occur via the classical pathway as observed by delayed onset of activation 
in the absence of C4 components in vivo (Tulunay 1993; Lhotta 1998; Videm 1999), 
while others have shown its involvement in vitro as well (Nilsson 1993; Thylen 1996; 
Sefton 2000). The possibility that the two pathways are linked either by the same 
biomaterial or by each other, has also not been ruled out (Gorbet 2004). Furthermore, 
while certain biomaterials generate elevated levels of C3b and MAC, others may trigger 
augmented levels of the former but not of the latter, as reviewed (Gorbet 2004). In terms 
of the mannose-binding lectin pathway of complement activation, direct evidence of its 
involvement in biomaterial-based activation has not yet been demonstrated, but this 
pathway may play a role particularly in polysaccharide-based polymers. 
 Connections have been made between complement activation and non-specific 
protein adsorption, or with leukocyte activation, since low levels of MAC are sufficient 
to activate leukocytes, or even with platelet activation in a multiple ways; since C1q 
activates platelets to secrete glycoprotein (GP)IIb/IIIa, a mediator of platelet attachment 
to biomaterials, expression of P-selectin on platelets that is important in mediating 
platelet interactions with endothelial cells (ECs), among others (Gorbet 2004). Also, 
while inhibitors of classical complement had similar inhibitory effects on platelet 
activation (Bing 1970; Rinder 1999), the effects of terminal complement mediators have 
been less clear (Larsson 1997). Taken together, this implies that not only is it likely that 
multiple factors link complement and platelets, but also that a model is emerging, 
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wherein a complex network of activating and inhibitory interactions exist between 
several of these players in transitioning between homeostasis and inflammation (Gorbet 
2004). 
  Pre-adsorption of C3b onto cellulose acetate (CA) beads triggers interactions with 
monocytes and granulocytes, in a calcium-dependant manner and may be mediated by 
leukocyte complement receptors such as CR3 (Hiraishi 2003), while others have shown 
that pre-incubation of C3a or C5a on CA beads may regulate granulocyte-mediated anti-
inflammatory effects (Nishise 2006), implying a role of complement in biomaterial-
mediated host immune/inflammatory responses. More recently, the specific type of 
polysaccharide; dextran, dextran sulfate or chitosan and the accessibility of their hydroxyl 
moieties was linked to the conversion of C3 in serum to C3b (Bertholon 2006). Finally, 
another study demonstrated that the effects of poly(styrene sulfonic acid) (PSSa) on 
activating the alternative serum complement pathway varied as a function of PSSa 
concentration, stimulating complement activation at low concentrations in a factor H-
mediated manner, or inhibiting complement at higher PSSa concentrations via 
interactions with factor D (Murakami 2005). Furthermore, the current approach to limit 
blood complement activation upon exposure to artificial biomaterials by maintaining an 
unactivated endothelial cell layer on these biomaterials, indicates the complex and 
dynamic nature of biomaterial-complement-cell interactions (McGuigan 2007). While the 
effect of complement on leukocyte adhesion and activation may vary for different 
biomaterials and biocompatibility issues may be overcome by blocking complement, this 
was found to be true only for certain biomaterials, further highlighting the complexity of 
these interactions (Gorbet 2004).  
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Acute and chronic inflammation 
 The inflammatory processes accompanying implantation of biomaterials have 
been classified as acute or chronic based on the different cell types involved and the 
timelines during which these processes occur (Anderson 1988; Tang 1995). During acute 
inflammation, which occurs within minutes to days after injury, phagocytic neutrophils 
are recruited to sites of implants by chemokine factors by extravasation through activated 
endothelium via interactions mediated by chemokine, integrin and selectin receptors on 
neutrophils (Ratner 1996). Neutrophil adhesion and interaction with biomaterial surfaces 
occurs through the adsorption of proteins such as IgG or fibrinogen or via complement 
proteins (Tang 1993a). Neutrophils uptake biomaterials and trigger the release of organic 
or inorganic reactive oxygen species (ROS) that damage biomaterials including 
polyurethanes (PU) (Labow 2001) via secretion of hydrolytic or proteolytic mediators. 
Alternatively, neutrophils may undergo „frustrated phagocytosis‟ when they fail to uptake 
larger biomaterials (Henson 1971). The release of ROS, also secreted during stress, has 
degradative effects on not only the biomaterial but also has cytotoxic effects on bystander 
cells.  
 On the other hand, chronic inflammation, which occurs within a day of 
implantation, is mediated by monocytes, macrophages and lymphocytes and is 
characterized by increased vascularization and presence of connective tissue (Ratner 
1996). Macrophages penetrate the tissue surrounding biomaterial implants and are the 
principal cell type associated with them as observed on surfaces of medical devices 
(Anderson 1988) and tissue engineering scaffolds (Brodbeck 2002a; Xia 2006). Besides 
their ability to respond to a wide range of materials including metals (Takebe 2003), 
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polymers (Solheim 2000; Labow 2005), collagen (Khouw 1998; Xia 2006), monocytes 
and macrophages are „professional phagocytes‟ similar to neutrophils and uptake 
particulate wear debris (Tondravi 1997), partly responsible for the slackening of joint 
replacements, associated bone degradation, that ultimately results in unsuccessful joint 
replacements (Garrigues 2005). Although it is clear that macrophages respond to 
biomaterials by releasing cytokines, chemokines, angiogenic factors and even regulate 
tissue restoration, the link between biomaterial properties, adsorbed proteins and 
complement fragments and their interactions with macrophage receptors such as TLRs 
(Akira 2001; Gordon 2002), SRs (Palecanda 2001; Peiser 2002) and CLRs (Zamze 2002), 
as well as integrin molecules (Berton 1999; Phillips 2005) that mediate extracellular 
matrix (ECM) interactions via restructuring of the cytoskeletal elements of the plasma 
membrane (Kwiatkowska 1999) that mediate recognition and antigen uptake, remains to 
be fully elucidated. Following the recognition of pathogens or biomaterials, macrophages 
may release extracellular superoxide, hydrogen peroxide, nitric oxide (Strvrtinova 1995), 
potent pro-inflammatory cytokines, chemotactic factors growth factors, proteases, 
arachidonic acid metabolites and coagulation factors (Ratner 1996; Bosca 2005), to 
regulate reparative wound healing processes as well as inflammatory mediators such as 
bioactive lipids, acid hydrolases and inducers of tissue damage (Xia 2006) and direct 
responses of multiple cell types.    
 
Granulation tissue  
 The formation of granulation tissue that takes place about a day after biomaterial 
implantation marks the initiation of wound healing (Ratner 1996). Fibroblasts and 
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vascular endothelial cells migrate towards the site of implantation in response to soluble 
factors secreted by macrophages. Endothelial cells proliferate and are organized into 
capillary tubes towards the formation of newly sprouted blood vessels 
(neovascularization) or vessels that arise from pre-existing ones (angiogenesis) (Ratner 
1996). On the other hand, fibroblasts multiply and initially generate proteoglycans, 
subsequently followed by the formation of collagen. Typical vascularized granulation 
tissue is therefore characterized by the presence of fibroblasts, myofibroblasts that 
assume a smooth muscle-like phenotype and usually also by macrophages. In special 
cases where a significant loss of tissues and cells has occurred which cannot be 
completely regenerated, increased amounts of granulation tissue are formed, leading to 
scar formation (Ratner 1996). Therefore, depending on the specific characteristics of the 
injury site, granulation tissue formation occurs in a process initiated upto about 3 days 
after implantation and lasting until 5 days after. 
  In the context of biomaterials, neovascularisation and granulation tissue formation 
may vary according to the biomaterial. In particular, expression of vascular endothelial 
growth factor (VEGF) mRNA, critical for endothelial cell survival, migration and hence 
angiogenesis, increased in macrophages but not fibroblasts exposed to 
hydroxyethylmethacrylate (HEMA), implying the complex nature of these interactions 
(Mantellini 2006). Also, poly(DL-lactide-co-glycolic acid) (PLGA) that was processed to 
exhibit nanostructured roughness enhanced fibronectin adsorption and adherence (Miller 
2006) and proliferation (Miller 2004) of vascular cells as well as endothelial cells (Miller 
2004). Concurrently, other studies showed that adhesion of smooth muscle cells also 
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increased on polymers that were processed to present nanostructured topographies (Thapa 
2003).  
  
Foreign body reaction 
 Granulation tissue and foreign body giant cells (FBGCs) are the primary 
components of the foreign body reaction (Anderson 1988). The large multinucleated 
FBGCs are formed when monocytes or macrophages fuse on biomaterial surfaces in an 
effort to uptake larger biomaterials and remain at implant sites throughout their in vivo 
durations (Ratner 1996; Shen 2001). The exact role of FBGCs at host-implant interfaces 
remains unclear.  In certain cases FBGCs completely isolate the implant from the local 
microenvironment, as part of a protective mechanism for either the host or implant. On 
the other hand, FBGCs that are in contact with biomaterial surfaces may be secreting 
hydrolytic enzymes and other mediators that are responsible for biomaterial degradation. 
For instance, stress cracking as observed with poly(etherurethane urea) (PEUU) surfaces 
(Kao 1994). Biomaterial properties such as chemistry, form, surface topography, and 
implant surface area to volume ratios are critical in directing the foreign body response as 
characterized by macrophage fusion (Collier 1997; Shen 2001; Collier 2004; Dadsetan 
2004). Porous biomaterials that have higher such ratios attract more macrophages and 
foreign body giant cells and are hence associated with increased fibrosis as compared to 
smooth surfaces (Ratner 1996). Furthermore, flat smooth surfaces have been associated 
with one to two cell thick macrophages (Anderson 1988; Anderson 2000), while rougher 
poly(tetrafluoroethylene) PTFE surfaces have macrophages as well as FBGCs present at 
the surface (Ratner 1996). In addition, the foreign body response is directed by the 
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differential amounts and profiles of host proteins that commonly adsorb to biomaterials 
having different surface properties (Collier 1997; Kao 1999; Jenney 2000; Collier 2002) 
as well as differential cytokine, chemokine and growth factors present in the local milieu 
(Kao 1995). It was observed in vitro that FBGCs could be generated from macrophages 
that were cultured in the absence of any cytokines (McNally 1995; McNally 2002), or 
with IL-4 (McInnes 1988; McNally 1995) and IL-13 (DeFife 1997). The IL-4 stimulated 
fusions of these macrophages were regulated by key receptor-mediated interactions, 
including those of ß1, ß2 integrins (McNally 2002) and CD206/macrophage mannose 
receptor (MMR) (McNally 1996), CC chemokine ligand 2 (CCL2)/ macrophage chemo 
attractant protein-1 (MCP1) (Kyriakides 2004) and α-tocopherol (McNally 2003), but 
limited by inhibitors of diacylglycerol kinase (McNally 2003). In contrast, polymer 
networks composed of polyacrylamide and poly(ethylene glycol) (PEG) did not support 
macrophage fusion into FBGCs, but retained macrophages as monocytes aggregates 
(Collier 2004). Finally, macrophage induction with GM-CSF and IL-4 (Kyriakides 2004) 
is similar to methods for DC induction (Romani 1996) used in this thesis work with a 
starting population of peripheral blood mononuclear cells (PBMCs). 
  
Fibrosis 
 The formation of fibrous tissues surrounding implants indicates the final phase of 
the regenerative response (Ratner 1996). The extent of fibrosis depends on the site of 
implantation, the proliferative ability of the surrounding cells, site vascularity and the 
degree to which the tissue framework has been destroyed by injury. The greater this 
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disruption, the lower is the likelihood of original parenchymal tissue restoration in 
injured implant sites and higher the possibility of fibrosis occurring (Ratner 1996).  
 Differential biomaterial chemistries have been associated with differentially 
regulating the properties of associated fibrous capsules (Barbosa 2006). Specifically, 
methyl terminal implants elicited the formation of thicker fibrous capsules as compared 
to carboxyl or hydroxyl chemistries, demonstrating an effect of biomaterial chemistry on 
host wound healing responses (Barbosa 2006). Furthermore, the presence of fibrous 
capsules may interfere with controlled release of drugs from biomaterial-based carrier 
systems (Anderson 1981), while other studies have addressed the issue of drug release 
despite fibrous capsule formation in response to radiofrequence ablation to tumor sites, 
by locally releasing anti-inflammatory agents such as dexamethasone that has been 
shown to reduce capsule thickness (Blanco 2006). In certain cases, formation of a mature 
fibrous capsule for thin, macroporous condensed PTFE (cPTFE) with low polymer 
surfaces areas that contact cells may be associated with increased tissue integration in 
comparison to expanded PTFE and low or high weight polypropylene and may hence be 
beneficial depending on the specific application (Voskerician 2006). 
 
Biomaterials in combination products 
 Biomaterials have been used in tissue engineering (Hubbell 1995) as 3-
dimensional scaffolds for adhesion and delivery of viable cells for restoring or renewing 
tissue or organ function (Ratner 1996). The biomaterial component is critical in steering 
cell adhesion, proliferation, differentiation, survival, migration and vascularization and 
should therefore have good biocompatibility, mechanical and physical properties and 
controllable degradable properties. Furthermore, the convenient large scale production of 
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biomaterials having consistent properties which are unaffected by sterilization processes 
required for in vitro and in vivo applications, are other important criteria (Peppas 1994; 
Ratner 1996; Langer 2004). 
 The ongoing thrust in the field of biomaterials is to advance the development of 
synthetic biomimetic materials that seek to combine the key properties of natural 
biomaterials such as purified proteins including collagen which encode ligands of cellular 
receptors responsible for critical cellular processes and undergo material restructuring in 
response to cellular proteases, implying a beneficial two-way communication between 
the cells or tissues and the materials, along with advantageous properties of synthetic 
biomaterials (Lutolf 2005). In an effort to create an ECM-like cellular microenvironment, 
micro- (Oberpenning 1999) and nano-fibrillar materials have been synthesized 
mimicking ECM properties of complex fine, fibers, non-fibrillar hydrogels using 
hydrophilic polymers which mimic the properties of viscosity, elasticity and diffusivity of 
ECM (Menger 2002; Zhang 2003; Estroff 2004), into which biological factors may be 
incorporated (Niece 2003), novel protease or matrix metalloproteinase (MMP)-
responsive hydrogels  that allow for cell-directed remodeling (Basbaum 1996), coating of 
critical ECM components such as laminin, fibronectin, collagen and glycosaminoglycans 
(GAGs) as whole proteins or specific peptide sequences of these proteins, essential for 
cell and tissue survival and regeneration (Hersel 2003; Shin 2003), growth factor 
localization and controlled temporal release by biomaterials (Mahoney 2001) 
representative of similar release mechanisms provided by ECM components, are 
underway (Lutolf 2005). 
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Self-assembled monolayers (SAM)  
Self-assembled monolayers (SAM) presenting robust, well-controlled surface 
properties have been used extensively as model biomaterial systems, to examine the 
effects of varying biomaterial surface chemistry, charge and 
hydrophobicity/hydrophilicity on host inflammatory and immune responses (Maoz 1988; 
Ulman 1991; Whitesides 1991; Ratner 1996). The SAM chemistries focused on in this 
thesis research presented terminal methyl (-CH3), hydroxyl (-OH), carboxyl (-COOH) or 
amine (-NH2) and have been previously characterized as hydrophobic, neutral 
hydrophilic, anionic hydrophilic or cationic hydrophilic respectively. The SAMs are 
composed of alkanethiols [e.g., CH3(CH2)nSH] that firmly attach gold-coated substrates 
via functional thiol bonds. Different SAM chemistries have been shown to differentially 
direct host protein adsorption as well as immune and inflammatory cell recruitment, 
proliferation, adhesion and survival. In particular, higher amounts of pro-inflammatory 
fibrinogen (Fg) was adsorbed to OH SAM than to CH3 SAM (Tegoulia 2000), although 
others have found otherwise (Shen 2001; Dadsetan 2004; Barbosa 2005a). It was also 
observed that higher amounts of pro-inflammatory C3 (Hirata 2003) was measured on 
OH SAM than on CH3 SAM, although highest amounts of human IgG were detected on 
CH3 SAM compared to OH, COOH or NH2 SAM (Silin 1997). In contrast, adsorption of 
anti-inflammatory protein albumin was higher on CH3 SAM compared to either OH or 
COOH SAM (Martins 2003). More recently, the adsorption of human fibrinogen was 
demonstrated to decrease with increased presence of OH in the monolayer (Rodrigues 
2006). Along with this decrease, the ability of platelets to adhere and be stimulated 
decreased with greater hydrophilicity (increased –OH groups) (Rodrigues 2006). On the 
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other hand, pre-adsorbed Fg activated platelets, in contrast with pre-adsorbed albumin 
that had anti-inflammatory effects on –OH monolayers but not on –CH3 monolayers 
(Rodrigues 2006). In agreement with this finding, others have shown that OH SAMs 
allow high leukocyte adhesion linked to their abilities to support high complement 
activation regulated by C3b binding to –OH terminal monolayers that was proportional to 
the numbers of acidic sites on the endgroup, while the –CH3 endgroups allowed least 
leukocyte adhesion (Sperling 2005). The exact opposite was seen for platelet adhesion 
(Sperling 2005).  
Different SAM chemistries have also varied in their recruitment of 
immune/inflammatory cells such as monocytes and PMNs (Barbosa 2005a), activated 
Mac-1 positive leukocytes in vivo to implanted materials in mice air pouch cavities 
(Barbosa 2005b). Although the CH3 SAM endgroups were observed as recruiting highest 
PMNs, these surfaces least supported cell adhesion of neutrophils or leukocytes, but 
allowed platelets to adhere (Sperling 2005). As discussed previously, the CH3 SAM 
endgroups also supported the formation of thicker fibrous capsules (Barbosa 2006), hence 
implying that these may support highest inflammatory responses among the SAM 
endgroups tested, that are similar to those used in this thesis research. Others have 
demonstrated that differential monolayer chemistries direct the conformations of 
adsorbed fibronectin and hence cell integrin-mediated interactions and cell adhesion 
(Keselowsky 2003). Finally, sophisticated protein adsorption (Mrksich 1996) or cell 
adhesion (Mrksich 1997) studies have been performed using microcontact printing to 





Significant efforts are ongoing in the field of biomaterials science to advance our 
understanding of the host responses to biomaterials, especially in the area of host protein 
adsorption and biomaterial-mediated inflammatory responses. However, the roles of 
biomaterials in combination products remain to be fully elucidated. It is possible that the 
inflammatory response against the biomaterial have synergistic effects with the host 
adaptive response specific against the biological components, resulting in potent and at 
present, insufficiently characterized host responses. It is crucial therefore, to examine the 
interactions between these two arms of the immune system in the context of biomaterials, 
with emphasis on DC-orchestrated „bridging‟ of innate and adaptive responses as well as 
to characterize DC ligands present in adsorbed „biofilms‟ on biomaterials, towards 















COMPARATIVE CHARACTERIZATION OF CULTURES OF PRIMARY 




 The success of tissue engineered (TE) substitutes of organs for transplantation 
depends on transplanted cell viability and functionality in vivo. Furthermore, to achieve 
successful integration of the implanted device with the host system, it is important that 
the implant should trigger negligible host inflammatory as well as immune responses. 
Currently, primary causes leading to implant failure include the foreign body response, 
fibrosis, scar tissue formation and device degradation mediated by host immune cells 
(Babensee 1998a). 
 In combination products such as those used in TE, the host response may consist 
of a non-specific inflammatory response against the biomaterial component as well as a 
specific immune response directed against the biological component. The biomaterial 
component may boost the immune response against the cellular component by enhancing 
the recruitment of innate immune antigen presenting cells (APCs) such as dendritic cells 
(DCs) or macrophages and supporting their activation and hence ultimately augmenting 
adaptive immunity as well (Matzelle 2004). In this process, biomaterials may act as 
adjuvants that augment the specific immune response towards incorporated or shed 
biological constituents of combination products (Matzelle 2004). This enhancement of 
the specific immune response against device-associated antigens may finally result in 
device malfunction (Babensee 1998a). 
 Professional APCs such as DCs or macrophages bridge innate and adaptive 
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immunity (Banchereau 1998). Macrophages are recognized as playing arguably the most 
important role in mediating host foreign body responses to implanted materials. 
Macrophages are crucial regulators of inflammation and wound regeneration (Anderson 
2001; Brodbeck 2002a; Kao 2007; Van den Beucken 2007). Biologically active 
macrophages at implant or tissue damage sites are the major phagocytes of biomaterial 
particles and debris, adhere to biomaterial surfaces via interactions with adhesive proteins 
fibronectin and vitronectin and secrete a wide gamut of cytokines, chemokines, growth 
factors and matrix metalloproteases (MMPs) (Kao 2007; Van den Beucken 2007(Dinnes 
2007). Persistent activation of macrophages triggers their fusion and the formation of 
foreign body giant cells (FBGCs) that remain associated with implants until explantation 
(Kao 2007). Macrophages are widely distinguished as pivotal controllers of the strength 
and extent of the host response (Van den Beucken 2007). Additionally, macrophages 
present antigen and activate adaptive immunity (Anderson 2004; Kao 2007). While 
macrophages are key mediators of inflammatory responses, DCs are more potent inducers 
of immune responses and may act by stimulating lymphocyte responses against foreign 
antigens (Setum 1991; Sallusto 1994; Triozzi 1997; Banchereau 2000; Janeway 2001), 
even those that are associated with implants (Babensee 1998a). Taken together, 
macrophages and DCs function centrally in regulating fundamental biomaterial 
inflammatory responses, although the distinctness of their roles has not yet been fully 
appreciated. These APCs detect conserved distinct moieties on pathogens using pattern 
recognition receptors (PRRs) that trigger DCs to mature and result in efficient 
presentation of antigens by DCs or macrophages (Janeway 1998). Since adjuvants 
function by stimulating APCs as demonstrated by increased secretion of pro-
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inflammatory cytokines by DCs and upregulated expression of major histocompatibility 
complex (MHC) and co-stimulatory receptors (Banchereau 1998a; Singh 1999; Tsuji 
2000), biomaterials may act as adjuvants by regulating APC responses. Since APCs form 
the critical link between innate and adaptive immunity, their responses to biomaterials in 
vitro have formed the focus for several studies. 
Macrophages are the primary infiltrating cells associated with implanted 
biomaterials during the majority of their in vivo lifetimes and are involved in immune, 
inflammatory and foreign body responses as reviewed in (Xia 2006). Primary 
macrophages have previously been derived from monocytes isolated from peripheral 
blood mononuclear cells (PBMCs) in the absence of any cytokines, generating an 
assortment of fusing macrophages and FBGCs (McNally 1995; McNally 1996; McNally 
2002). The interleukin-4 (IL-4) stimulated fusions of these macrophages were regulated 
by key receptor-mediated interactions, including those of ß1, ß2 integrins and 
CD206/macrophage mannose receptor (MMR) (McNally 1995; McNally 1996; McNally 
2002). Macrophage adhesion, fusion and apoptosis on differentially modified 
polyurethanes were dependant on the specific surface modification, leading to the 
formation of fused adherent FBGCs with IL-4 stimulation, or apoptosis in the absence of 
IL-4 (Jones 2004). Furthermore, albumin-coated polyesther terephthalate (PET) surfaces 
decreased macrophage recruitment and adherence, while naturally adsorbed fibrinogen 
(Fn) or Fn-coated PET surfaces increased macrophage recruitment (Tang 1993a). 
Dendritic cells play diverse roles in vivo and their differentiation has been induced 
through a variety of methods in vitro. Typically, blood monocytes or CD34+ 
hematopoietic stem cells (HSCs) are induced to differentiate into DCs by exposure to 
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granulocyte macrophage colony-stimulating factor (GM-CSF) and IL-4 or in certain 
cases with tumor necrosis factor-α (TNF-α), or certain interleukins and/or Hepatocyte 
Growth Factor (HGF), or even in the absence of GM-CSF (Permonti 1995; Xu 1995; 
Bender 1996; Brossart 1998; Zou 2002; Sprague 2005; Tang 2005). Primary human DCs 
have been cultured in vitro from PBMCs by several groups since their initial 
characterization (Thiele 2001). In our laboratory DCs were cultured as per methods 
described in (Romani 1996) starting with PBMCs isolated from healthy donors, selecting 
for monocytes via plastic adherence and inducing the differentiation of DCs by culturing 
with GM-CSF and IL-4. It has been reported that the culture of immature DCs (iDCs) in 
DC media with 75:25 poly(lactic-co-glycolic acid) (PLGA) microparticles (MP) or films 
increased expression of DC maturation markers and induced phenotypic changes 
indicative of maturation, indicating that biomaterials acted as adjuvants by enhancing the 
immune response to co-delivered antigens (Yoshida 2004; Babensee 2005; Yoshida 
2006b; Yoshida 2006c). It was observed that the form of PLGA (MPs or film) affected 
maturation since PLGA MPs triggered higher allogeneic T cell proliferation in a mixed 
lymphocyte reaction (MLR) and a greater delayed type hypersensitivity (DTH) response 
than the response triggered by PLGA films. It has also been demonstrated that DCs 
mature differentially upon contact with different biomaterials; although PLGA caused 
DC maturation, culture with agarose did not (Yoshida 2006a). Furthermore, it has been 
shown that biomaterials modulate immune responses to co-delivered antigens in vivo, 
thereby explaining in part the biomaterial adjuvant effect observed (Bennewitz 2005). 
Recently, DCs were shown to mature in response to biomaterial contact in vitro, 
providing in part an explanation for the biomaterial adjuvant effects observed in vivo 
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(Newman 2002; Yoshida 2004; Babensee 2005; Bennewitz 2005; Stivaktakis 2005; 
Yoshida 2006a; Yoshida 2006b).  
Although macrophages and DCs are both professional APCs, macrophages 
expressed adhesion and co-stimulatory molecules at earlier time points during culture; 
however, the increases in CD1a or MHC II, CD86, CD80, CD40 maturation markers 
expression was sustained until later time points for DCs (Pickl 1996; Triozzi 1997; Santin 
1999) and may account for their enhanced efficiencies in presenting soluble protein 
antigens to naïve T cells and initiating adaptive immune responses (Setum 1991; Sallusto 
1994; Triozzi 1997). Macrophages are more proliferative (Santin 1999) and phagocytic 
(Sousa 1993; Aderem 1999; Banchereau 2000; Kiama 2001; Thiele 2001; Thiele 2003b)  
than DCs, differ in their mechanisms of antigen loading onto MHC II complexes (Bryant 
2004) and are better able at degrade whole bacteria (Guidos 1987). While DCs and 
macrophages may activate differential pathogen-stimulated signaling cascades (Visintin 
2001; Hornung 2002; Werling 2004), both types of APCs have been implicated in the 
induction of tolerance (Guidos 1984; Finkelman 1996; Hoves 2006). In this study, the in 
vitro cultures of macrophages derived from monocytes in the absence of cytokines 
(McNally 1995; McNally 1996; Brodbeck 2002a; McNally 2002; Jones 2004; Brodbeck 
2005) were compared with those of DCs derived from monocytes using GM-CSF and IL-
4 (Newman 2002; Yoshida 2004; Babensee 2005; Stivaktakis 2005; Yoshida 2006a; 
Yoshida 2006b) at relevant time points during APC-biomaterial studies, such as isolation 
of adherent PBMCs, harvesting of DCs or macrophages for biomaterial plating and after 
biomaterial exposure. Our findings were evaluated in the light of relevant literature that 
compares DCs versus macrophages based on phenotype and function both in vitro and in 
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vivo.  
 It was hypothesized that the relative compositions of the different cell types 
present in the DC or macrophages cultures would change with time and that cultures 
containing primary DCs or macrophages would be phenotypically distinct albeit starting 
from the same PBMC population. In this way, the distinct effects of the culture systems 
would be elucidated in deriving in vitro primary cultures of macrophages or DCs for 
further studies in the inflammatory response to biomaterials.  Therefore, the objective of 
this work was to present a systematic study comparing DCs and macrophages in terms of 
morphologies and phenotype at significant time points during biomaterial studies under 
culture conditions known to induce their derivation while starting with the same PBMC 
population. Furthermore, the goal was to characterize the various other cell types present 
in cultures of primary DCs or macrophages derived from monocytes isolated from 
PBMCs, which may be important in driving the differentiation of these APCs and 
mediating cell-cell and cell-biomaterial immune/inflammatory outcomes. These studies 
characterize lymphocytes and DCs or macrophages in situations that are analogous to 
those occurring upon biomedical device implantation and the commencement of the host 
foreign body response. 
 
METHODS: 
Blood Collection and Isolation of Adherent PBMCs 
 Peripheral human blood was collected from consenting donors using heparin (333 
U/ mL blood) (Baxter Healthcare Corporation, Deerfield, IL) as an anticoagulant.  This 
procedure was performed by phlebotomists at the Georgia Tech Student Health Center in 
 44 
accordance with the Georgia Institute of Technology‟s Institute Review Board (IRB)-
approved protocol # H05012. All subjects enrolled in this research responded to an 
Informed Consent which was approved by the IRB of Georgia Institute of Technology.  
The PBMC layer was separated using lymphocyte separation medium (LSM) (Cellgro 
MediaTech, Herndon, VA) by differential gradient centrifugation [400 g, 30 minutes, 
room temperature (RT)] (Thermo Fisher Scientific Inc., Waltham, MA) (Model # 5682, 
Rotor IEC 216). The PBMC layer was collected and erythrocytes lysed [155 mM 
ammonium chloride, 10 mM potassium bicarbonate (both from Sigma, St. Louis, MO) 
and 0.1 mM ethylene diamine tetra-acetic acid (EDTA) (Gibco, Grand Island, NY)] and 
washed twice with sterile phosphate buffered saline (PBS) (Gibco) at RT as described in 
(Yoshida 2004). The PBMCs were resuspended at 5x10
6 
cells/ mL in media containing 
RPMI-1640 having 25 mM HEPES [4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid] 
and L-glutamine (Gibco), 100 U/ mL penicillin/streptomycin (Cellgro) and 10% (v/ v) 
fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA)  and 10 mL of the cell suspension 
was plated onto tissue culture (TC) plates [Falcon 353803 (Primaria) 100 mm x 20 mm 
(Becton Dickinson, Franklin Lakes, NJ)] and incubated for adherence (2 hrs) at 37°C 
with 95% relative humidity and 5% CO2 to select for adherent monocytes. Adherent 
PBMCs that remained following three washes with pre-warmed media were collected for 
further analysis as described below. Dendritic cells or macrophages were each derived 
three times from three different donors, using a different set of three donors for DCs or 




Human PBMC-derived DC Culture  
 Dendritic cells were derived in vitro from human PBMCs using a previously 
described method (Romani 1996) as reported elsewhere (Sallusto 1994; Yoshida 2004).  
For culture to derive DCs, adherent PBMCs that remained following three washes with 
pre-warmed media were cultured in fresh media supplemented with GM-CSF (1000 U/ 
mL) and IL-4 (800 U/ mL) (both from Peprotech, Rocky Hill, NJ) (DC media) for 5 days.  
On the fifth day of culture, loosely adherent and non-adherent cells containing DCs were 
gently harvested by centrifuging at 1100 rpm for 10 minutes and plated at 1.5x10
6 
cells/ 
well in 3 mL/ well in DC media into 35 mm X 10 mm polystyrene TC treated sterile 
suspension culture dishes (Corning, Corning, NY) and left untreated (negative control) to 
yield iDCs, or treated with 1 µg/ mL lipopolysaccharide (LPS) (E.Coli 055:B5) (Sigma) 
(positive control) to yield mature DCs (mDCs). On day 5 of culture or on day 6 of culture 
following treatment with or without LPS, both the loosely adherent and adherent cell 
fractions containing DCs were collected for further analysis as described below. 
 
Human PBMC-derived macrophage culture  
Macrophages were derived from human PBMCs based on modifications of a 
previously published method (McNally 1995; McNally 1996; McNally 2002). To derive 
macrophages, adherent cells that remained following three washes with pre-warmed 
media were resuspended at 5x10
6
 cells/ mL in macrophage media [RPMI-1640 
containing 25 mM HEPES and L-glutamine (Gibco), 100 U/ mL penicillin/streptomycin 
(Cellgro) and 25% (v/ v) filter sterilized autologous human serum]. To obtain autologous 
human serum, non-heparinized human blood was centrifuged at 3000 rpm for 10 minutes 
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at RT. The supernatant was collected to remove red blood cells. Clots were pushed down 
manually using a sterile pipette tip, where necessary. Autologous human serum was then 
prepared by allowing clotting at RT for 90 minutes in the TC hood. Clear serum was 
obtained by centrifugation at 3000 rpm for 15 minutes at RT after gently pushing down 
residual clots/precipitates and was filter-sterilized. Ten mL of this cell suspension was 
plated onto a 100 mm TC plate [Falcon 353803 (Primaria) 100 mm x 20 mm (Becton 
Dickinson)] and incubated for adherence (2 hours) at 37°C with 95% relative humidity 
and 5% CO2 at a concentration of 5x10
6
 cells/ mL with pre-warmed macrophage media to 
select for adherent monocytes. After the incubation, plates were washed 3 times with 
warm media to remove non-adherent cells and cultured without cytokines. On day 3 of 
culture, media was replaced with warmed macrophage media. On day 6 of culture, media 
was replaced with warmed media containing 25% (v/ v) filter sterilized autologous heat 
inactivated serum (heat-inactivated at 56˚C for 30 minutes). On days 6 and 10 of culture, 
both the loosely adherent and adherent cell fractions containing macrophages were 
collected for further analysis as described below.  
 
Morphology of adherent PBMCs, DCs or Macrophages 
 Initial monocytes in the adherent PBMC population and DC or macrophage 
morphologies as a function of time were examined throughout the culture duration by 
phase contrast microscopy. Cells were processed for Cytospin preparations as described 
earlier by us and others (Sallusto 1994; Yoshida 2004) (Cytospin Cytocentrifuge, Thermo 
Shandon, Pittsburg, PA) and stained with Differential Hematology Stain (Astral 
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Diagnostics, West Deptford, NJ).  Three images were taken at three different regions for 
each cytospin and a representative image was chosen. 
 
Characterization of adherent PBMCs and DC or Macrophage culture systems 
            The levels of initial adherent PBMC and DC or macrophage surface markers 
expression were monitored at relevant time points in biomaterial culture studies, in both 
adherent and loosely-adherent fractions; on day 0 (adherent PBMCs), for DC cultures on 
day 5 (as for harvesting of loosely-adherent DCs for 24-hour biomaterial culture) and 6 
(as for harvesting of loosely adherent DCs after 24-hour biomaterial culture) and for 
macrophage cultures on day 6 (as for macrophage media change – replacement with heat-
inactivated serum) and 10 (harvesting of loosely-adherent macrophages for biomaterial 
studies), using a flow cytometric technique as described previously by us and others 
(Sallusto 1994; Yoshida 2004), using cell type identification markers as listed in Table 1.  
Table 1 was prepared with reference to technical product sheets. Loosely adherent and 
adherent cells that were removed using cell dissociation solution (CDS) (Sigma), were 
collected and resuspended in Hank‟s HEPES buffer (120 mM NaCl, 10 mM KCl, 10 mM 
MgCl2, 10 mM glucose, 30 mM HEPES) (all from Sigma) containing 1% (v/ v) human 
serum albumin (HSA) (EMD Biosciences, San Diego, CA) and 1.5 mM CaCl2 (Sigma) 
and stained with mouse anti-human mAb CD11c (clone 3.9; IgG1), CD19 (clone SJ25-
C1; IgG1), CD14 (clone UCHM-1; IgG2a) (all from Southern Biotech, Birmingham, AL), 
CD1c (clone AD5-8E7; IgG2a), (Miltenyi Biotec, Auburn, CA), CD3 (clone SK7; 
IgG1κ), CD123 (clone 9F5; IgG1κ), CD4(clone L200; IgG1κ), CD45RO (clone UCHL1; 
IgG2aκ), CD25 (clone 2A3; IgG1κ), CD64 (clone 10.1; IgG1κ), CD15 (clone H198; 
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IgMκ), CD24 (clone ML5; IgG2aκ), CD8 (clone RPA-T8; IgG1κ), CD206 (clone 19.2; 
IgG1κ) (all from Becton Dickinson Biosciences, San Jose, CA) for 1 hour at 4°C 
maintained on ice and in the dark. Samples were strained via cell strainers (40 µm nylon 
pore) (Becton Dickinson) into 200 µl of flow cytometry buffer and analyzed immediately 
using BD LSR flow cytometer (Becton Dickinson) and 5000 events were collected per 
sample. Autofluorescence was used as negative controls.  Analysis was performed using 
BD LSR flow cytometer (Becton Dickinson), based on gating cell clusters from 
previously identified positions on forward scatter (FSC) versus side scatter (SSC) dot 
plots (Setum 1991; Banchereau 1998a; Thiele 2003b). Data analysis was performed using 
BD FACS DIVA v. 4.1.2 (Becton Dickinson) and using WinMDI 2.8 (Scripps Research 
Institute, La Jolla, CA).     
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Table 1: Cell sources and expression profiles of leukocyte and lymphocyte cell 
surface markers labeled for using flow cytometry 
 
A subset of B and T cells, granulocytes, monocytes, macrophages, DCs and NK cellsCD1c
High expression in peripheral blood on plasmacytoid DCs and basophils, low on 
monocytes, eosinophils, myeloid DCs and subsets of hematopoietic progenitor cells
CD123
NK cells, a subset of B and T cells, granulocytes, monocytes macrophages and DCsCD11c
Human macrophages, cultured DCs, not on resting monocytesCD206 (MMR)
Present on monocytes and macrophages but not on lymphocytes or resting 
granulocytes
CD64
Present on granulocytes including neutrophils, eosinophils, varying extents on 
monocytes, not on lymphocytes or basophils
CD15
Monocytes, macrophages, DCs and Langerhans cellsCD14
Present on B cells, granulocytesCD24
All stages of B cell differentiation except terminal plasma cells. Also present on 
follicular DCs
CD19
Subset of peripheral blood lymphocytesCD25
Present on Thymocytes, activated T cells, memory T cells, granulocytes, monocytes, 
only certain resting T cells
CD45RO
Normal human lymphocytesCD45RA
Present on normal PBMCs, thymocytes, Purkinje cells in cerebellumCD3
T cytotoxic/ suppressor populations, peripheral blood lymphocytes, thymocytesCD8






Initial adherent PBMC morphologies 
 Initial adherent PBMC populations were composed of monocytes and 
lymphocytes both between 6-8 µm in diameter. Cytospin images of the initial adherent 







Figure 4-1: Immature DCs are rounded in morphology while LPS-matured DCs 
exhibit cellular processes and exist as distinct clusters of singly nucleated cells. 
Conversely, macrophages/FBGCs exhibit fewer membrane projections, exist as 
fused clusters of cells with indistinct membranes and form large, firmly adherent 
multinucleated FBGCs with extensive cytoplasm. 
Initial adherent PBMCs were isolated from human blood at day 0 (a). Immature DCs 
derived from human PBMCs were cultured in the presence of GM-CSF and IL-4 until 
Day 5 and then plated on polystyrene surfaces without (b) or with (c) LPS. On Day 6 of 
culture, LPS-treated mDCs exhibited extensive dendritic processes in contrast to iDCs 
that exhibited fewer processes. Macrophages cultured on polystyrene surfaces in the 
adherent fraction from day 6 (d), the loosely adherent fraction from day 10 (e) and the 
adherent fraction from day 10 (f, g) exhibited fewer membrane projections as compared 
to mDCs, endocytosed lipid droplets and fused to form large multinucleated FBGCs. 
Original magnification: 40x.  Geimsa-stained cytospins were prepared for three donors 
and a representative set of images for one donor has been shown. Horizontal arrows in 
red indicate the presence of lipid droplets and vertical arrows in green indicate the 
presence of very large macrophages/FBGCs that were multinucleated in certain cases. 
 
Differential cell types in initial adherent PBMCs population 
The adherent cell fraction derived from PBMCs on day 0 (2 hours after plating for 
plastic adherence in DC media without GM-CSF and IL-4 cytokines) consisted of two 




 and a lymphocyte population which was comprised of CD3+, CD8+, CD45RO+ 
T lymphocytes and CD24+ CD19+ B lymphocytes (Table 2).  
To examine the hypothesis that the relative compositions of cells in culture 
changed with time, the percentages of each cell type present were measured at all time 
points and in all fractions.  The adherent cell fraction derived from PBMCs on day 0 was 
comprised of 38 ± 19% CD14+ monocytes, about 62 ± 15% CD3+ T lymphocytes or 52 
± 4% CD24+ or CD19+ B lymphocytes (Table 2).  In the FSC/ SSC flow cytometry dot 
plots, T cells were clustered in the upper half of lymphocyte gate while B lymphocytes 
were present throughout this gate. 
 
Table 2: Cell populations, expression of cell surface markers, and percentages of 
each cell type present in the initial adherent PBMC population (day 0) 
 
T cells:
CD3+, CD8+, CD45RA+, 
CD45RO+
(62 ± 15% CD3
B cells: 
CD24+, CD19+








Dendritic cells:   
DC morphologies  
Dendritic cells were about 15 µm in diameter by day 5 of culture with GM-CSF 
and IL-4 and remained as such until the final day 6 time point tested. Based on cytospin 
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images, the morphology of iDCs was smooth and rounded (Figure 4-1b), while 
maturation induced by LPS treatment resulted in mDCs that exhibited several dendritic 
processes of the plasma membrane (Figure 4-1c).  Dendritic cells were loosely adherent 
on days 5 and 6 of culture and existed as clusters of individual cells both as iDCs (Figure 
4-1b) or mDCs (Figure 4-1c). Light microscopy as well as cytospin images revealed the 
presence of DC-DC clusters or of DCs clustered with several smaller lymphocytes (about 
6-8 µm in diameter). 
 
Differential cell types in cultures during differentiation of DCs  
 To further examine this hypothesis, the percentages of different cell types present 
in DC cultures were measured at all time points and in both adherent and non-adherent 
fractions for DCs when cultured in DC media with GM-CSF and IL-4 with or without 
maturation stimuli. At day 5 of culture with DC differentiation cytokines, the loosely 
adherent cell fraction was composed of a DC population which was CD14+, CD11c+, 
CD123+, CD1c+, CD4+, MMR+
 
and a lymphocyte population which was comprised of 
CD3+, CD4+, CD45RO+ T lymphocytes and CD24+ CD19+ B lymphocytes (Table 3). 
Upon treatment with the maturation stimulus, LPS, for one day, as compared to iDCs, on 
day 6, the same DC and lymphocyte populations were observed as at day 5 (Table 3). 
Cells positive for CD1c, which is known to be expressed on both on B cells and DCs 
(Cao 2002; van der Wel 2003), also expressed DC markers CD123 and CD11c by day 6 
(Table 3). The adherent cell fractions on days 5 and 6 of culture had similar expression of 
DC and lymphocyte cell surface markers as the loosely adherent cell fraction (data not 
shown).  
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 The percentages of different cell types present in the DC cultures varied at 
different time points during culture. By day 5 of culture, the loosely-adherent DC cultures 
were comprised of 43 ± 10% CD1c+ DCs and 29 ± 11% of a mixture of CD3+ T 
lymphocytes and 24 ± 8% CD24+ or CD19+ B lymphocytes. By day 6 of culture, 
loosely-adherent iDC or mDC cultures were comprised of about 60 ± 5%  or 57 ± 6% 
CD1c+ DCs, respectively and 51 ± 14% or 34 ± 10% CD3+ T lymphocytes or CD19+ or 
CD24+ B lymphocytes or 50 ± 5% or 40 ± 10% T or B lymphocytes, respectively (Table 
3).  
Table 3: Cell populations, expression of cell surface markers, and percentages of 
each cell type present in the loosely adherent DC population (day 6) 
 
T cells:
CD3+, CD8+, CD45RA+, 
CD45RO+
(29 ± 11% CD3+)
B cells:
CD24+, CD19+
(24 ± 8% CD24+)
CD4+ Dendritic cells:
CD11c+, CD1c+, CD14+, 
CD123+, MMR+




CD3+, CD8+, CD45RA+, 
CD45RO+
(51 ± 14% CD3+ with iDCs)
(50 ± 5% CD3+ with mDCs)
B cells
CD24+, CD19+
(34 ± 10% CD24+ with iDCs)
(40 ± 10% CD24+ with mDCs)
CD4+ Dendritic cells (iDCs or 
mDCs):
CD11c+, CD123+, CD14+, 
MMR+
(60 ± 5% CD1c+ iDCs)





Macrophages:   
Macrophage morphologies 
Macrophages and/or FBGCs were about 15-20 µm in diameter. Furthermore, 
cytospin images revealed that huge FBGCs and several giant cells with widespread 
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cytoplasms, similar to those described in (McNally 1995), were present in both non-
adherent and adherent fractions of macrophage cultures as shown for adherent cells on 
days 6 (Figure 4-1d) and 10 (Figures 4-1 e and f, g respectively) of culture, especially by 
the latter time point. Based on cytospin images, these cells were less rounded than 
adherent PBMCs but more rounded than DCs and contained several lipid droplets, 
possibly internalized by phagocytosis (Figure 4-1d). Macrophages mostly adhered to the 
polystyrene substrate especially by day 10 of culture and adhered in large clusters of cells 
having fused plasma membranes (Figures 4-1 f, g). In certain cases, multinucleated giant 
cells were observed (Figure 4-1 g). Light microscopy revealed the presence of highly 
granular macrophages in both non-adherent and adherent fractions.  
 
Differential cell types in cultures during differentiation of macrophages  
 The percentages of different cell types present in macrophage cultures were 
measured at all time points and in all fractions.  At day 6 of macrophage culture, the 
loosely adherent (data not shown) and adherent fractions of cells were composed of a 
macrophage population which was MMR+, CD64+, CD14+, CD11c+ and a lymphocyte 
population which was comprised of CD3+, CD45RO+ and CD4low T lymphocytes and 
CD24+ and/or CD19+ B lymphocytes (Table 4).  By day 10, the final time point of 
culture, both the loosely adherent (data not shown) and adherent cell fractions (Table 4) 
were composed of macrophages and T or B lymphocytes having similar profiles of cell 




 The percentages of different cell types present in the macrophage culture system 
varied at different time points and in different cell fractions during culture. By day 6 of 
culture, the loosely adherent fraction were comprised of 33 ± 15% CD64+ macrophages 
with associated 62 ± 14% CD3+ T or 59 ± 13% CD24 or CD19+ B lymphocytes present 
as a separate population in the dot plot. The adherent fraction yielded a higher percentage 
of about 53 ± 21% CD64+ macrophages with associated lymphocytes and about 43 ± 
22% T or 45 ± 23% B lymphocytes (Table 4). By day 10 of culture, the loosely adherent 
fraction was composed of 36 ± 18% CD64+ macrophages with associated lymphocytes 
and 60 ± 18% T or B lymphocytes (data not shown).  By day 10 of culture, the adherent 
fraction was composed of 61 ± 18% CD64+ macrophages with associated T lymphocytes 
and about 26 ± 14% T or 27 ± 15% B lymphocytes (Table 4). 
 
Table 4: Cell populations, expression of cell surface markers, and percentages of 
each cell type present in the adherent macrophage population (day 10) 
 
T cells:
CD3+, CD4+, CD45RA+, 
CD45RO+
(43 ± 22% CD3+)
B cells:
CD24+, CD19+
(45 ± 23% CD24+)
Macrophages:
CD11c+, CD64+, CD14+, 
MMR+




CD3+, CD4+, CD45RA+, 
CD45RO+
(26 ± 14% CD3+)
B cells:
CD24+, CD19+










 To summarize, the initial adherent PBMCs present at day 0 of human blood 
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collection were comprised of 38 ± 19% monocytes and 62 ± 15% associated T or 52 ± 
4% B lymphocytes (Table 2). Treatment of these initial populations with DC 
differentiation cytokines GM-CSF and IL-4 induced the differentiation of monocytes into 
loosely adherent DCs by day 5 of culture along with 29 ± 11% associated T and 24 ± 8% 
B lymphocytes (Table 3). By day 6 of culture, about 60 ± 5% iDCs or 57 ± 6% mDCs 
were present along with associated lymphocytes (Table 3). Alternatively, culture of the 
initial adherent PBMCs on day 0 in the absence of any cytokines led to the differentiation 
of monocytes into 53 ± 21% adherent macrophages by day 6 along with 43 ± 22% 
associated T or  45 ± 23% B lymphocytes (Table 4). At day 10 of macrophage culture 61 
± 18% adherent cells were macrophages and 26 ± 14% associated T or 27 ± 15% B 
lymphocytes were present (Table 4). Adherent PBMCs were 6-8 µm in diameter at day 0, 
loosely adherent DCs were approximately 15 µm at day 6 and adherent macrophages 
were 15-20 µm at day 10. While mDCs exhibited multiple dendritic processes, 
macrophages and FBGCs exhibited fewer processes (Figure 4-1). 
Dendritic cells or macrophages derived from the same initial adherent PBMC 
populations could be distinguished phenotypically. The DCs were CD14+, CD64-, 
MMR+ (Table 3) and the firmly adherent macrophages were CD14+, CD64+, MMR+ 
(Table 4).  The presence of MMR detected on monocytes is not usually observed on 
resting monocytes, but may have been detected on these monocytes due to their 
activation during the isolation procedure. Both myeloid (CD11c+) and lymphoid 
(CD123+) DC subsets were present in the DC cultures (Table 3) in agreement with 
previous findings (Donaghy 2001). It has been previously shown that DCs cultured with 
GM-CSF and IL-4 were positive for CD40, CD80, CD83, CD86, HLA-DQ, HLA-DR 
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and maturation induced by LPS treatment resulted in an upregulation of these maturation 
markers (Sallusto 1994; Yoshida 2004). However, no differences were observed between 
iDCs and mDCs for the cell identification markers tested in this study (Table 3). From the 
initial cell population composed of about 38 ± 19% monocytes (Table 2), the final 
harvest yielded about 60 ± 5%  or 57 ± 6% loosely adherent iDCs or mDCs respectively 
(Table 3) or about 61 ± 18% adherent macrophages (Table 4) and about 36 ± 18% 
macrophages in the non-adherent fraction (data not shown). To summarize, the profiles of 
the key cell type identification markers were as follows: CD14+, CD64+, MMR+ 





, monocytes. The percentage of DCs reported in this study is lower than 
in another study that reported a 95% DC yield from PBMC-derived monocytes, possibly 
due to differences in donors and reagents (Pickl 1996). 
Dendritic cells or macrophages derived from the same initial adherent PBMC 
populations could also be distinguished based on morphology. Loosely adherent iDCs 
(Figure 4-1b) exhibited fewer dendritic extensions as compared to loosely adherent LPS-
treated mDCs (Figure 4-1c) on day 6 of culture, consistent with earlier findings (Sallusto 
1994; Yoshida 2004). Macrophages presented fewer processes compared to DCs and 
adhered in groups of cells having fused plasma membranes (Figures 4-1f, g), in contrast 
to DCs that existed as clusters of loosely adherent distinct cells (Figure 4-1c). These 
clusters may be composed of DCs and/or T and B lymphocytes or macrophages 
surrounded by multiple lymphocytes (Figure 4-1e) as observed by us in cytospin images 
and other groups that have reported the formation of DC: B cell (Kushnir 1998) and 
DC:T cell (Inaba 1987) clusters in vitro.  As expected, macrophages and FBGCs were 
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larger than DCs (15 µm for DCs versus about 15-20 µm for macrophages and/or 
FBGCs). In agreement with our observations, other studies have observed that 
macrophages had higher adherence to plastic than DCs and also had consistently higher 
expression of adhesion receptor lymphocyte function-associated antigen-1 (LFA-1) 
(Santin 1999). 
Another goal was to present a systematic study of the different cell types present 
in the adherent and non-adherent fractions during different time points in cultures of 
macrophages or DCs. It was observed that CD3+, CD4+ T lymphocytes and CD19+, 
CD24+ B lymphocytes were present until day 6 in the DC cultures in both fractions 
(Table 3). Similarly, both T and B lymphocytes were present for longer, until day 10 in 
the macrophage cultures in the loosely adherent fraction (data not shown). Lymphocytes 
were observed in the monocytes/macrophages or monocytes/DCs clusters at different 
time points throughout the culture, possibly supplying differentiation and other signals to 
these cells. The percentages of T and B lymphocytes remained between 24-51% of all 
cells present for DC cultures (Table 3) and about 60% of all adherent cells for 
macrophage cultures (Table 4) and between 26-45% of all non-adherent cells (data not 
shown) for macrophage cultures. 
 While it has been well-established that DCs play a major role in directing B and T 
cell activation and function, the reverse is also true. Increasingly, the cross-talk between 
DCs and B cells (Bayry 2004; Bayry 2005) and/or T cells (Latour 2001; Johansson 2003) 
both in in vitro and in vivo settings are thought to play a role in regulating the 
differentiation, migration and maturation of DCs. B cells play an important role in 
regulating the ability of DCs to present antigen both in vitro and in vivo and produce 
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cytokines and chemokines that direct DC migration (Bayry 2005). The MHC-T cell 
receptor (TCR) (Banchereau 1998a), CD40-(CD40L and CD80/86 – CD28 (Van Gool 
1999) interactions trigger DC-mediated T cell activation.  In contrast, others including 
CD80/86 – cytotoxic T lymphocyte associated antigen receptor-4 (CTLA-4) result in T 
cell anergy (Lenschow 1993). In addition, other interactions between DCs and T cells 
may direct the activation states of both. For instance, the interaction between CD47 on T 
cells and signal-regulator protein-α (SIRP-α) on myelomonocytic cells prevents DC 
maturation and lowers T cell sensitivity to IL-12 (Latour 2001). Another study observed 
that the presence of lymphocytes in vitro enhanced the adhesion and fusion of monocytes 
into macrophages even in the absence of cell-cell contact and also that the proliferation of 
lymphocytes increased while in co-culture with macrophages (Brodbeck 2005). Despite 
these indications that B and T lymphocytes present in vitro may regulate DC or 
macrophage differentiation and responses to biomaterials, the presence of these cell types 
in in vitro culture systems have not been well-characterized previously, to the best of our 
knowledge, except when intentionally added to specifically examine cross-talk 
(MacEwan 2005).  
It is important to characterize the various cell types present in the two well-
established protocols for generating macrophages or DCs in vitro and to measure the 
purity of these cultures. These results also suggest time points and cell fractions that may 
be optimal for isolation of specific cell types from this culture. The optimal time point for 
isolation of macrophages is on day 10 of culture (~ 60% macrophages) and from the 
adherent fraction (Table 4).  This observation may partly account for the longer lifetimes 
of lymphocytes in macrophage cultures. Similar to these observations, others have 
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demonstrated that macrophages stimulate lymphocyte proliferation throughout co-culture 
durations (Brodbeck 2005). While it may be possible to separate the cell types, the DC, B 
and T cell interactions may be important in guiding DC differentiation. In the MLR 
assay, DCs are co-cultured with allogeneic T cells from day 6 of culture to examine their 
ability to stimulate naïve T cells. The lifetimes of these different cell types in vitro may 
be significant in evaluating the contributions of antigen-presenting B cells in DC cultures 
in enhancing allogeneic T cell responses mediated by DCs. While previous studies have 
demonstrated LPS as being a strong maturation stimulus for DCs as exemplified by an 
upregulation of co-stimulatory and MHC II molecules (Sallusto 1994; Yoshida 2004), an 
effect of LPS stimulation was not observed on the expression of T or B lymphocyte 
markers measured in this study (Table 3). Future work may include further understanding 
the interactions between the different cell types present in culture that are critical in 
guiding DC or macrophage differentiation in vitro. 
 Characterization of the DC culture derived from PBMCs may also be important in 
areas where PBMCs have therapeutic applications. Dendritic cells are important 
regulators of host responses against viral diseases such as human immunodeficiency virus 
(Brodbeck) (Wu 2006), different forms of cancers (Fazle Akbar 2006), parasitic 
infections, tuberculosis (Rubakova 2007), rheumatoid arthritis (Zvaifler 1985), multiple 
sclerosis (Duddy 2001), bipolar disorder (Knijff 2006) and the strategies involving DCs 
to combat these diseases include adoptive transfer of ex vivo modified-stimulated DCs. 
Therapeutic approaches may commence with ex vivo cultures of DCs or even PBMCs 
that are similar to those characterized here.  This study therefore, is a first step towards 
characterizing the other cell types in the co-culture, in order to ultimately better account 
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for their contributions in directing DC or macrophage differentiation and responses.  
 Although previous groups have described primary DC or macrophage cultures, 
this study is unique as it performs a thorough characterization both of primary DCs or 
macrophage as well as other immune cell types present in the cultures which are used to 
study the inflammatory cell responses to biomaterials in vitro. As a result, immune 
responses at different time points during biomaterial exposure would be considered not 
only from the perspective of the APC alone but also taking into account the effects of 
lymphocytes in culture, which may play a role in regulating APC differentiation, 
survival, adherence and immune/inflammatory outcomes. Furthermore, the absence of 
neutrophils, cellular mediators of host inflammatory responses, at all time points during 
either DC or macrophage cultures, implies that this DC culture system would be optimal 
to examine the effects of biomaterials in mediating DC-orchestrated specific adaptive 
immune responses. Finally, this physiologically representative DC culture system 
provides a robust platform to assess the abilities of biomaterials that are present in 
combination products along with biological components, similar to those used in TE or 
vaccine delivery applications, to support DC maturation in vitro.  This in vitro readout 
would therefore be an initial step towards correlating the in vivo adjuvant effect of 
biomaterials in potentiating a broad spectrum of adaptive immune responses. These 
specific immune responses are directed against the biological component in combination 
products such as those used in TE applications and are distinct from the non-specific host 
inflammatory responses elicited against the biomaterial. The biomaterial adjuvant effect 
could ultimately be tuned to meet the immune/inflammatory criteria desired in the 




GLYCOPROTEIN-MEDIATED INTERACTIONS OF DENDRITIC CELLS 
WITH BIOMATERIALS. PART 1. DENDRITIC CELL RESPONSES TO SAM 
ENDGROUPS AND UNDERLYING MECHANISMS. 
 
INTRODUCTION:  
 Tissue engineering (TE) has arisen as an attractive alternative to the field of organ 
transplantation, due to the scarcity of healthy organ donors. Along with the development 
of TE devices composed of biomaterials scaffolds that provide structural integrity to the 
incorporated biological components such as autologous, allogeneic or xenogeneic cell, 
protein or DNA sources that ultimately develop into well-integrated, functional tissue, the 
science of advancing biomaterial surface and bulk properties to meet these needs has 
progressed rapidly (Langer 1993; Atala 2004; Kulig 2004; Tseng 2005). Furthermore, the 
non-specific inflammatory responses mounted against these biomaterials that impede 
their functioning have been examined extensively in order to engineer biomaterials with 
suitable in vivo properties (Anderson 1988; Ratner 1996; Llull 1999; Stock 2001; Lavik 
2004). In addition to the non-specific inflammatory response, the biomaterial component 
in combination products can boost the specific host immune response against the 
biological component, indicating that biomaterials may play the role of adjuvants 
(Babensee 1998a). The adjuvant effect of biomaterials may be desired in biomaterial 
vaccine delivery systems to augment the host response; however, for TE applications, 
biomaterials with nominal to no adjuvant potential are ideal. The adjuvant effects of 
biomaterials need to be completely described before biomaterials having predictable and 
fine-tuned adjuvant effects can be applied in diverse situations. 
 The objective of this study was to assess the immune and inflammatory roles of 
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biomaterials, with especial emphasis on their abilities to initiate dendritic cell  (Tabares 
2006) maturation. The maturation of professional antigen presenting cells (APCs) such as 
DCs is accompanied by increased expression of Major Histocompatibility Complex 
(MHC) or co-stimulatory molecules such as CD40, CD80/B7-1 and CD86/B7-2 (Kurts 
1996; Banchereau 1998a; Janeway 1998; Aderem 2000; Guyton 2000; Akira 2001; 
Brown 2001a; Medzhitov 2001; Janeway 2002).  Since DCs are the link between innate 
and adaptive immunity and DC maturation leads to enhanced antigen presentation for an 
adaptive immune response, the underlying hypothesis is that DC maturation, in response 
to biomaterials in vitro would correlate with the adjuvant effects of these biomaterials in 
vivo. Dendritic cells have been shown to undergo differential activation in a biomaterial-
dependent manner in vitro.  Dendritic cells treated with chitosan or poly (lactic co-
glycolic acid) PLGA films increased expression of CD86, CD40 or HLA-DQ (MHC II 
molecule) while alginate or hyaluronic films had the opposite effects (Babensee 2005). 
The adjuvancy of biomaterials such as PLGA has been demonstrated in vivo, where co-
delivery of antigen with PLGA resulted in increased antigen-specific antibody levels (Ertl 
1996; Walker 1998; Raghuvanshi 2001; Matzelle 2004; Bennewitz 2005) which has 
correlated with the observed in vitro maturation of DCs upon treatment with PLGA 
(Yoshida 2004). However, biomaterials such as agarose demonstrated weak abilities to 
stimulate DC maturation in vitro (Yoshida 2006a). It was hypothesized that DCs would 
interact differentially with diverse biomaterials that presented distinct DC ligands as a 
function of surface properties such as chemistry, charge and 
hydrophobicity/hydrophilicity, leading to differential DC responses and maturation. 
 The overall goal is to examine the interconnections between innate/inflammatory 
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and adaptive immunity, with emphasis on the role of DC receptors and cellular 
mechanisms involved in regulating these interactions, in the context of host responses to 
combination products. Particularly, the objective was to examine the effect of biomaterial 
chemistry on DC maturation using well studied model self-assembled monolayers (SAM) 
presenting different endgroup chemistries (Silver 1995; Mrksich 1996; Lindbald 1997; 
Harder 1998; Sigal 1998; Kalltorp 1999; Luk 2000; McClary 2000; Tegoulia 2000; Shen 
2001; Keselowsky 2003; Michael 2003; Schwendel 2003; Barbosa 2004; Dadsetan 2004; 
Barbosa 2005a; Sperling 2005; Barbosa 2006). The broad hypothesis is that these 
materials presumably interact with DCs through the adsorbed host protein layer including 
associated carbohydrate post-translational modifications, that may be analogous to 
pathogen associated molecular patterns (PAMPs) which are recognized by DC pathogen 
recognition receptors (PRRs) (Banchereau 1998a; Janeway 2001) such as Toll-like 
receptors (TLRs) (Akira 2001; Medzhitov 2001) or carbohydrate-binding C-type lectin 
receptors (CLRs) (Geitjenbeek 2000; Brown 2001a; Figdor 2002; van Kooyk 2003), 
resulting in DC maturation.  Based on an understanding of the mechanisms involved, the 
ultimate goal is to provide design criteria for biomaterials thereby regulating DC 
phenotype at the cellular level, and advancing host acceptance and tissue integration of a 
tissue engineered graft, long-term. 
 
METHODS:  
Self-Assembled Monolayer preparation 
 Self-assembled monolayer endgroups were assembled on 35 mm X 10 mm tissue 
culture (TC)-treated polystyrene dishes (Corning, Corning, NY) used for DC culture or 
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on 16-well glass chamber slides (LAB-TEK, Nalge Nunc International, IL) for 
measurement of endotoxin content (Keselowsky 2003). Clean substrates were 
sequentially coated with 50 Å Ti followed by 150 Å Au using an electron beam 
evaporator (CVC Products/ Veeco, Rochester, NY) and stored under vacuum at room 
temperature (RT) up to two weeks until used.  The following alkanethiols were used as 
received from commercial sources (1 mM in absolute ethanol): 1-dodecanethiol (SH-
(CH2)11-CH3) (CH3 SAM), 11-mercapto-undecanol (HS-(CH2)11OH) (OH SAM), 11-
mercaptoundecanoic acid (HS-(CH2)10-COOH) (COOH SAM), (Aldrich Chemical, 
Milwaukee, WI) and 11-amino-1-undecanethiol, hydrochloride (C11H26ClNS) (NH2 
SAM) (Dojindo Laboratories, Gaithersburg, MD). The SAM endgroups were allowed to 
assemble by incubation for 12 hrs at RT by immersing the Ti/Au-coated slides or 
coverslips in alkanethiol solutions, after which the dishes or slides were opened and air-
dried for ten minutes, both under sterile conditions.  Prior to cell culture, SAM-coated 
dishes and lids or slides were washed once with absolute ethanol (Sigma, St. Louis, MO) 
and then five times with filter sterilized (0.22 µm) (Corning) phosphate buffered saline 
(PBS) (Gibco, Grand Island, NY) at RT and used fresh for each experiment. From other 
studies, CH3 SAMs were highly hydrophobic, while OH SAMs were least hydrophobic 
(Keselowsky 2003). 
 
Chromogenic Endotoxin Assay 
 Endotoxin content of biomaterials was measured using a chromogenic Limulus 
Amebocyte Lysate (LAL) assay (QCL-1000 Chromogenic LAL Endpoint Assay, 
Cambrex, Walkersville, MD) using the 96-well microplate method. Standards in 96-well 
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flat-bottomed microplates and sample wells in 16-well chamber slides coated with 
different SAM endgroups were treated with endotoxin-free water (Cambrex) in triplicate. 
Since the LAL assay was designed to be performed on samples in solution, freshly 
prepared SAM endgroups in endotoxin-free water were used as samples to detect 
endotoxin present on SAM endgroups wherein LAL was added and incubated (10 
minutes, 37°C) in the presence of the biomaterials. Next, the chromogenic substrate (Ac-
lle-Glu-Ala-Arg-pNA) was added to each well, including the SAM surfaces, and 
incubated (6 minutes, 37°C), thereby allowing the LAL-substrate reaction to proceed as 
indicated by color development. Glacial acetic acid (25% v/ v) (J.T.Baker, Phillipsburg, 
NJ) at RT was added as a stop solution to standard or sample wells and the mixture in 
SAM-coated sample wells was transferred into 96-well flat-bottomed microplates to 
avoid interference with the reading by the SAM surfaces. Absorbances were measured 
immediately using a SpectraMax Plus 384 plate reader (Molecular Devices, Sunnyvale, 
CA) at 405 nm. Endotoxin content in the samples was read off standards generated from 
the manufacturer‟s kit. For all SAM endgroups, endotoxin amounts were below detection 
(detection limit: 0.1 endotoxin units (EU)/ mL; i.e., absorbance readings below blank 
sample) and well below the approved FDA endotoxin limit for implantable devices; 0.5 
EU/ mL. 
 
Human PBMC-derived dendritic cell culture  
 Dendritic cells were derived from human peripheral mononuclear cells (PBMC) 
using a previously described method (Romani 1996) as reported elsewhere (Sallusto 
1994; Romani 1996; Yoshida 2004). Briefly, peripheral human blood was collected from 
 67 
consenting donors using heparin (333 U/ mL blood) (Baxter Healthcare Corporation, 
Deerfield, IL) as an anticoagulant.  This procedure was performed by phlebotomists at 
the Georgia Tech Student Health Center in accordance with the Georgia Institute of 
Technology‟s Institute Review Board (IRB)-approved protocol # H05012. All subjects 
enrolled in this research responded to an Informed Consent which was approved by the 
IRB of Georgia Institute of Technology.  The PBMC layer was separated using 
lymphocyte separation medium (LSM) (Cellgro MediaTech, Herndon, VA) by 
differential gradient centrifugation (400 g, 30 minutes, RT) (Thermo Fisher Scientific 
Inc., Waltham, MA) (Model # 5682, Rotor IEC 216). The PBMC layer was collected and 
erythrocytes lysed [155 mM ammonium chloride, 10 mM potassium bicarbonate (both 
from Sigma) and 0.1 mM ethylene diamine tetra-acetic acid (EDTA) (Gibco)] and 
washed twice with sterile PBS. The PBMCs were resuspended at 5x10
6
 cells/ mL in DC 
media [RPMI-1640 containing 25 mM HEPES [4-(2-hydroxyethyl)piperazine-1-
ethanesulfonic acid)] and L-glutamine] (Gibco), 100 U/ mL penicillin/streptomycin 
(Cellgro) and 10% (v/ v) FBS and 10 mL of the cell suspension was plated onto TC 
plates [Falcon 353803 (Primaria) 100x20mm (Becton Dickinson, Franklin Lakes, NJ)] 
and incubated for adherence (2 hrs) at 37°C with 95% relative humidity and 5% CO2 to 
select for adherent monocytes. Adherent cells that remained following three washes with 
pre-warmed media were cultured in fresh media supplemented with granulocyte 
macrophage colony-stimulating factor (GM-CSF) (1000 U/ mL) and interleukin-4 (IL-4) 
(800 U/ mL) (both from Peprotech, Rocky Hill, NJ) (DC media) for 5 days.  On day 5 of 
culture, loosely adherent and non-adherent cells containing DCs were gently harvested by 
centrifuging at 1100 rpm for 10 minutes, and plated at 1.5x10
6 
cells/ well in 3 mL/ well in 
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DC media into 35 mm X 10 mm sterile suspension culture dishes and left untreated 
(negative control) to yield immature DCs (iDCs), or treated with 1 µg/ mL 
lipopolysaccharide (LPS) (E.Coli 055:B5) (Sigma) (positive control) to yield mature DCs 
(mDCs) or treated with the different SAM endgroup surfaces. On day 6, cells were 
harvested for further analysis.    
 
Dendritic cell morphology 
 Dendritic cell morphology was examined throughout the culture duration by 
phase contrast microscopy. Dendritic cells cultured in DC media were processed for 
Cytospin preparations as described earlier (Yoshida 2004) (Cytospin Cytocentrifuge, 
Thermo Shandon, Pittsburg, PA) and stained with Differential Hematology Stain (Astral 
Diagnostics, West Deptford, NJ). Giemsa-stained cytospin images were obtained on day 
5 or on day 6 for loosely-adherent iDCs, mDCs or DCs treated for 24 hrs with different 
SAM endgroup surfaces. Three images were taken at three different regions for each 
cytospin and a representative image was chosen. 
 
Flow cytometry for determination of maturation marker expression 
 To examine the effects of DC culture on the different SAM endgroups, the levels 
of DC surface marker expression were measured on day 6 using a flow cytometric 
technique as described previously (Yoshida 2004).  Loosely adherent cell fractions 
containing DCs for iDCs, mDCs or DCs treated with different SAM endgroup surfaces 
were collected and resuspended in Hank‟s HEPES buffer (120 mM NaCl, 10 mM KCl, 
10 mM MgCl2, 10 mM glucose, 30 mM HEPES) (all from Sigma) containing 1% Human 
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Serum Albumin (HSA) (EMD Biosciences, San Diego, CA) and 1.5 mM CaCl2 (Sigma) 
and stained with saturating concentrations of mouse anti-human monoclonal antibody 
against CD14 (clone UCHM1; IgG2a), CD40 (clone B-B20; IgG1), CD80 (clone BB1; 
IgM, CD86 (clone BU63; IgG1CD19 (clone SJ25-C1; IgG1), CD14 (clone UCHM-
1; IgG2a) (all from Southern Biotech, Birmingham, AL), CD83 (clone HB15a; IgG2b) 
(IO Test Immunotech Beckman Coulter, Marseille, France) HLA-DQ (clone TU169; 
IgG2a), HLA-DR (clone TU36; IgG2a), CD3 (clone SK7; IgG1κ) (all from Becton 
Dickinson Pharmingen, San Diego, CA) or cytotoxic T lymphocyte associated antigen 
receptor-4  (CTLA-4-Ig) (clone 48815; IgG2b) (R&D Systems, Minneapolis) while 
maintained on ice and in the dark. Samples were strained via cell strainers (40 µm nylon 
pore) (Becton Dickinson, San Jose, CA) into 200 µl of flow cytometry buffer and 
analyzed immediately using BD LSR flow cytometer (Becton Dickinson) and 5000 
events were collected per sample. Autofluorescence was used as negative controls.  
Analysis was performed using BD LSR flow cytometer (Becton Dickinson).  Data 
analysis was performed using BD FACS DIVA v. 4.1.2 (Becton Dickinson Biosciences) 
or WinMDI 2.8 (Scripps Research Institute, La Jolla, CA).     
 In order to demonstrate that typically harvested loosely adherent DCs for further 
analysis were representative of the entire DC population in a well (loosely 
adherent/nonadherent and adherent), in some experiments, the adherent cell fractions 
were removed from cell culture dishes using pre-warmed cell dissociation solution (CDS) 
(Sigma). Dendritic cells or associated lymphocytes present in DC cultures were identified 
based on size separation and counted using Coulter Multisizer III (Beckman Coulter) for 
both fractions, for all treatments. Data has been presented as % adherent DCs of the total 
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DCs present for different treatments. Furthermore, adherent cell fractions were also 
analyzed by flow cytometry as described above. Both DCs as well as associated 
lymphocytes remained adherent to TC dishes at the 24 hr timepoint measured, under iDC 
or mDC treatments (28 ± 18% or 35 ± 21% mean adherent DCs of total DCs present in 
cell culture wells, respectively) or different SAM treatments; CH3, OH, COOH or NH2 
SAM (45 ± 32%, 54 ± 19%, 34 ± 28% or 53 ± 25% mean adherent DCs of total DCs 
present in cell culture wells, respectively), as measured using six different donors. 
However, both loosely adherent fractions as well as adherent fractions on all treatments, 
as determined from three different donors, were composed of similar cell types; CD3+ T 
cells, CD19/CD24+ B cells as well as CD1c+ DCs and were therefore not distinct 
populations. Furthermore, although no significant differences in expression were 
observed for maturation markers CD83, CD86, HLA-DQ or HLA-DR between the DCs 
in the loosely adherent or adherent cell fractions, higher expression of CD80 was 
observed for DCs present in the adherent fraction as compared to DCs in the loosely 
adherent fraction. This was observed with multiple treatments and may be as a result of 
the DC maturation induced while instigating the detachment of trigger-sensitive DCs 
from well bases. Hence, throughout this study, loosely adherent DCs [similar to loosely 
adherent migratory blood-resident DCs (Banchereau 2000)] were collected and examined 
using different assays. 
 
Mixed lymphocyte reaction (MLR) 
 The allostimulatory capacities of DCs treated with different SAM endgroups were 
assessed using a mixed lymphocyte reaction (MLR) as per methods in (Yoshida 2004) 
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using an allogeneic MLR. On day 6 of DC culture, allogeneic T cells were isolated from 
PBMCs by negative selection using Pan T cell magnetic isolation (Miltenyi Biotech, 
Auburn, CA) according to manufacturer‟s protocols. These cells were used as responder 
cells. The T cells were resuspended in RPMI-1640 supplemented with 25 mM HEPES 
and L-glutamine (Gibco BRL) with additional 100 U/ mL penicillin- streptomycin 
(Cellgro) and heat inactivated filter sterilized (0.22 μm) (Corning) 10% human AB serum 
[RPMI-10AB media] and plated at a concentration of 10
5
 cells/ well in a 96- well flat- 
bottomed plate (Corning) in triplicate for treatment groups or controls. Dendritic cells 
cultured in DC media with or without maturation stimulants (LPS) or treated with 
different SAM endgroup surfaces were resuspended at 1.6x10
5
 cells/ mL, and treated 
with 25 µg/ mL mitomycin C (Sigma) for 30 minutes at 37ºC to prevent their 
proliferation. Upon extensive washing with RPMI-10AB media, DCs were counted, 
resuspended and added to responder cells in triplicates at graded DC: T cell ratios. Cells 
were co-cultured for 4 days at 37ºC, with the addition of 10 µM 5-bromo-2-deoxyuridine 
(BrdU) for the last 24 hrs of culture. Dendritic cell-induced T cell proliferation was 
measured using BrdU colorimetric cell proliferation ELISA (Roche Applied Science, 
Indianapolis, IN) according to manufacturer‟s directions. 
 
Cytokine secretion per DNA amount in cell culture supernatants 
 Levels of pro-inflammatory cytokines such as tumor necrosis factor- α (TNF-α) or 
IL-6 or anti-inflammatory mediators such as IL-10, transforming growth factor-ß (TGF-
ß) or prostaglandin E-2 (PGE-2) or other factors such as shed soluble TNF Receptor 
Inhibitor (sTNFRI) normalized to DNA amount present in the cell culture supernatants 
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were detected using appropriate sandwich ELISAs (R&D Systems) and DNA amounts 
were measured using PicoGreen DNA kit (Molecular Probes, Oregon, USA) for both 
loosely adherent cells and the non-adherent cell fractions (removed using trypsin/ 0.05% 
EDTA) (Sigma), following manufacturer‟s protocols.  Levels of shed CTLA-4 per DNA 
amount was measured using ELISA (Bender Med Systems, Burlingame, CA). 
Supernatants were collected by swirling cell culture dishes clockwise, anti-clockwise, 
from left to right and from right to left, ten times in each direction on Day 6 of culture 
following 24-hr treatment with different SAM endgroup surfaces, cleared by 
centrifugation at 1100 rpm for 10 minutes and stored at -20°C for analysis. Amounts of 
pro-inflammatory cytokines were presented normalized against total DNA amounts for 
each treatment group. 
 
Detection of apoptosis  
 Apoptotic cells were identified by staining using Annexin V labeled with 
Fluorescein Isothiocyanate (FITC) for 1 hr at 4°C in the dark and on ice, and adding 
Phycoerithrin (PE) -propidium iodide in the dark immediately prior to analysis (both 
from BD Pharmingen). Apoptotic controls of staurosporine (Sigma)-treated apoptotic 
DCs incubated for 1, 3 or 6 hrs [optimal concentration of 10 mM in Dimethylsulfoxide 
(DMSO (Sigma)) determined by dose response] and of 70% ethanol- treated necrotic 
DCs incubated at 4°C for 1 hr were stained with FITC-Annexin V alone, or PE-
Propidium iodide alone, or both and were used to identify populations by defining the 
positions of horizontal and vertical quadrant axes. To further elucidate mechanism, the 
levels of active Caspase-8/FLICE (Molecular Probes, California, USA) or active 
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Caspase-3 (R&D Systems) that were present in the cell lysates of DCs and associated T 
cells as a result of different SAM treatments were measured. Finally, apoptotic DNA 
fragmentation induced by cell culture on the different SAM endgroups was measured by 
Terminal transferase dUTP nick end labeling (TUNEL) staining (R&D Systems) for DCs 
or associated T cells. 
 
Statistical Analysis 
            Statistical analysis was performed using two-way mixed model analysis of 
variance (Young 2001), setting variance due to treatments as the fixed factor and variance 
due to donors or due to different draws performed for the same donor as the random 
factors (for pooled data) and performing pairwise comparisons between treatments with a 
Tukey post-test using Minitab software (Version 13.20, Minitab Inc., State College, PA).  
To observe the effects of different treatments compared to iDCs, one-sided Student‟s T 
Test was performed (Microsoft Excel v. 2003). The p value of less than or equal to 0.05 
was considered significant. 
 
RESULTS:  
Human PBMC-derived DCs exhibit rounded morphology when treated with CH3 SAM 
endgroups or dendritic morphologies when treated with other SAM endgroups 
 Dendritic cells were treated with the different SAM surfaces in DC media and 
their morphology compared with that of iDCs or LPS-treated mDCs. Mature DCs showed 
extensive cellular processes in contrast to the smooth iDCs. Among SAM endgroups, 
DCs treated with CH3 SAM in DC media demonstrated rounded cellular morphology 
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similar to iDCs while DCs treated with OH, COOH or NH2 SAM which exhibited 







Figure 5-1: Dendritic cells treated with different SAM endgroups show variations in 
cell morphology.  
Immature DCs derived from human PBMCs were cultured in the presence of GM-CSF 
and IL-4 until Day 5 and then plated on polystyrene surfaces without (a) or with (b) LPS 
or on CH3 (c), OH (d), COOH (e), or NH2 (f) SAM endgroups for 24 hrs. Giemsa-stained 
cytospins taken on Day 6 of culture indicated that DCs treated with OH, COOH or NH2 
SAM endgroups exhibited dendritic processes similar to positive control LPS-treated 
mDCs and unlike those treated with CH3 SAM endgroups which were similar to iDCs. 
Original magnification: 40x.  Cytospins were prepared for six donors with similar results, 
and representative results are shown. 
 
Dendritic cells treated with CH3 SAM endgroups are less allostimulatory than iDCs 
while DCs treated with all other SAM endgroups are more allostimulatory than iDCs at 
different DC: T cell ratios  
 The allostimulatory capacities of DCs treated with the different SAM endgroups 
in DC media were assessed using an MLR. In Figure 5-2, the Y-axis represents the 
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absorbances associated with induced T cell proliferation as measured using a colorimetric 
BrDU assay and the X-axis represents the different DC:T cell ratios. As expected, mDCs 
were more allostimulatory than iDCs at lower DC:T cell co-culture ratios. Among SAM 
endgroups, DCs treated with NH2, COOH or OH SAM endgroups in DC media were 
more allostimulatory than iDCs at different DC: T cell ratios. In contrast DCs treated 
with CH3 SAM endgroups in DC media were less allostimulatory than iDCs at higher 
DC: T cell ratios. At the DC: T cell ratio of 1:3.125, DCs treated with COOH SAM 






















































































Figure 5-2: Dendritic cells treated with different SAM endgroups exhibit differential 
allostimulatory profiles in an MLR. 
Mature DCs were significantly more allostimulatory than iDCs at lower DC: T cell ratios. 
Dendritic cells treated with NH2, COOH or OH SAM endgroups were significantly more 
allostimulatory than iDCs at different DC: T cell ratios. In contrast, DCs treated with CH3 
SAM endgroups were less allostimulatory than iDCs at higher DC: T cell ratios. This 
experiment was repeated six times with different donor combinations. Data represented 
as treatment control ratios of the absorbances associated with induced T cell proliferation 
for each treatment revealed statistical significance of the findings; mean ± SEM, n=3 
wells. „+‟ indicates greater than iDC, „*‟ indicates less than iDC, differences between 
SAM endgroups in words, p≤ 0.05. 
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Dendritic cells exhibit differential expression of maturation markers when treated with 
SAM endgroups having different surface chemistries 
The expression levels of various markers of DC phenotype were assessed using 
flow cytometry. As shown in Figure 5-3, generally, iDCs expressed low levels of these 
markers and maturation induced by LPS treatment resulted in an increase in the 
expression of these markers, as observed with CD80, CD83 or HLA-DQ. Among SAM 
endgroups, DCs treated with OH, COOH or NH2 SAM in DC media had higher 
expression of maturation markers CD80, CD83 or CD86 than iDCs. In contrast DCs 
treated with CH3 SAM in DC media had higher expression of HLA-DQ receptor, that has 
strong anti-inflammatory apoptosis-inducing effects upon ligation (Leverkus 2003; Zang 
2005a; Zang 2005b), compared to iDCs. Furthermore, mature DCs had higher expression 





























































Figure 5-3: Dendritic cells treated with different SAM endgroups exhibit differential 
expression levels of DC maturation markers.  
Dendritic cells matured with LPS exhibited higher expression of CD80, CD83 or HLA-
DQ compared to iDCs. Dendritic cells treated with OH, COOH or NH2 SAM endgroups 
increased expression of CD80, CD83 or CD86 as compared to iDCs, but to a lower extent 
than DCs treated with LPS as observed with CD80 expression. In contrast, DCs treated 
with CH3 SAM endgroups had higher expression of HLA-DQ as compared to iDCs. This 
experiment was performed using six independent donors in triplicate. Data represented as 
treatment control ratios for each treatment revealed statistical significance of the findings; 
mean ± SEM, „+‟ indicates increase over iDC, differences between SAM endgroups in 
words, p≤0.05.   
   
Human PBMC-derived DCs secrete high TNF-α or IL-6 in response to CH3 SAM contact   
 As another method of evaluating DC responses to different SAM endgroups, 
levels of pro-inflammatory cytokines such as TNF- or IL-6 present in cell culture 
supernatants of iDCs, mDCs or DCs treated for 24 hrs in DC media with different SAM 
endgroups were measured using ELISAs and the amounts were normalized against total 
cellular DNA amount. For TNF-, as expected, LPS-treated mature DCs secreted 
significantly higher levels of TNF-than iDCs, across combined values for three 
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different donors performed in triplicate (Figure 5-4a) or as indicated for a representative 
donor (Figure 5-4b). Among SAM endgroups however, surprisingly, it was observed that 
DCs treated with CH3 SAM in DC media secreted highest levels of pro-inflammatory 
TNF-and DCs treated with OH SAM in DC media instigated higher TNF-secretion 
than DCs treated with COOH or NH2 SAM (Figure 5-4b).   
 Similar results were obtained for amounts of IL-6 secreted by DCs treated with 
different SAM endgroups in DC media normalized against total DNA amounts. As 
expected, LPS-treated mature DCs secreted significantly higher levels of IL-6 than iDCs, 
across pooled values for three different donors performed in triplicate (Figure 5-4c) or as 
indicated for a representative donor (Figure 5-4d). As shown in Figure 5-4d, DCs treated 
with CH3 or OH SAM endgroups in DC media were associated with higher secreted IL-6 





































































































































Figure 5-4: Contact with CH3 SAM induces highest secretion of pro-inflammatory 
cytokines from human PBMC-derived DCs compared with other SAM endgroups. 
Supernatants from iDCs, LPS-matured DCs, or DCs treated with different SAM 
endgroups were collected and TNF- α (a, b) or IL-6 (c, d) content was measured and 
shown normalized against DNA content. The figures for TNF- α (a) or IL-6 (c) indicate 
combined data from all three different donors in triplicate and hence a representative 
figure from one donor has been shown for TNF- α (b) or IL-6 (d). The DCs treated with 
LPS secreted high levels of both pro-inflammatory cytokines with all donors. Among 
SAM endgroups, contact with CH3 SAM induced highest TNF- α or IL-6 secretion by 
DCs. For (b) or (d); mean ± S.D, „+‟: indicates greater than iDCs; „*‟: indicates less than 
iDC, differences between SAM endgroups in words, p≤0.05.  
 
Secretion of anti-inflammatory mediators – IL-10, TGF-ß or stimulators of anti-
inflammatory alternatively activated DCs (AA-DCs) – PGE2 
 To assess levels of anti-inflammatory mediators that may be present in the media 
of DCs treated with CH3 SAMs in DC media and counteract the effects of high pro-
inflammatory cytokine levels and account for lower DC maturation observed on this 
surface, ELISAs were performed to measure levels of IL-10, TGF-ß or PGE2 in the DC 
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supernatants per total DNA amount. Undetectable levels of IL-10 were present in 
supernatants of all SAM endgroups (data not shown). No clear trends were observed in 
levels of TGF-ß or PGE2 in supernatants from different SAM endgroups (data not 
shown).   
 
Human PBMC-derived DCs undergo high apoptosis in response to CH3 SAM contact 
 To examine if more DCs on CH3 SAM were undergoing apoptosis and causing 
DC immunosuppression, since phagocytosis of apoptotic DCs has strong anti-
inflammatory effects on DCs (Ferguson 2002; Clayton 2003; Duffield 2003; Newton 
2003; Skoberne 2005a; Wallet 2005a; Chen 2006b), the percentages of live, early 
apoptotic, late apoptotic or necrotic, or non-viable DCs were assessed by flow cytometry 
by staining for annexin V and propidium iodide as presented as treatment control ratios. 
Interestingly, contact with CH3 SAM induced higher early apoptosis of DCs in 
comparison to iDCs. Furthermore, contact with CH3 SAM induced lowest levels of live 













































































































































Figure 5-5: Contact with CH3 SAM induces fewer live human PBMC-derived DCs 
than all other treatments and enhances early apoptosis of DCs compared to iDCs. 
Cells were harvested following 24 hrs of biomaterial culture and stained for annexin V 
and propidium iodide.  Data is presented as treatment control ratios of cells present in 
each group; Annexin V/ propidium iodide -/-, +/-, +/+, -/+ indicating cells that were live 
(a), early apoptotic (b), late apoptotic or necrotic (c) or non-viable (d) respectively. 
Contact with CH3 SAM resulted in least live DCs compared to mDCs and to all other 
SAM endgroups as well as higher early apoptosis of DCs as compared to iDCs. This 
experiment was repeated six times with six different donors; mean ± S.D, „+‟ indicates 
greater than iDC, differences between SAM endgroups in words, p≤0.05.   
 
Human PBMC-derived DCs undergo high caspase- 8 - mediated apoptosis in response to 
CH3 SAM contact 
 To investigate if the mechanism of apoptosis observed with cells on SAM 
endgroups was mediated by cytosolic caspase proteins, ELISAs were performed to 
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measure amounts of active caspase-8 or active caspase-3 present in cell lysates. Contact 
with CH3 SAM induced highest levels of active cellular caspase-8 compared to iDCs, 
mDCs and DCs treated with OH or NH2 SAM chemistries (Figure 5-6). Undetectable 
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Figure 5-6: Contact with CH3 SAM induces higher levels of active caspase-8 from 
lysed cells compared with mDC treatment or compared to cells treated with OH or 
NH2 SAM endgroups. 
Following 24 hrs of biomaterial culture, cells were lysed and active caspase-8 content 
was measured. Contact with CH3 SAM induced higher levels of active caspase-8 
compared with cells treated with OH or NH2 SAM endgroups or cells exposed to LPS. 
This experiment was performed six times with six different donors; mean ± S.D, „+‟: 
indicates greater than iDCs; differences between SAM endgroups in words, p≤0.05. 
 
Human PBMC-derived autologous T cells exhibit higher TUNEL positive staining in the 
presence of mDCs or DCs treated with CH3 SAM or NH2 SAM 
 DNA fragmentation associated with end stage apoptosis was measured by 
quantification of TUNEL positive cells. The autologous T cells present in the DC culture 
under LPS, CH3 SAM or NH2 SAM treatments had higher TUNEL positive staining as 
compared to T cells cultured in the presence of iDCs. Among treatment groups, no 
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Figure 5-7: Associated T cells present in DC cultures treated with different SAM 
endgroups exhibit differential TUNEL staining. 
Dendritic cells treated with different SAM endgroups exhibited no differences in TUNEL 
staining (a). However, higher TUNEL positive staining was observed for was observed 
for associated T cells present in DC cultures with certain treatments including for those 
on CH3 SAM as compared to iDCs (b). This experiment was performed six times with six 
different donors; mean ± S.D, „+‟ indicates greater than iDCs, p≤0.05.  
 
Human PBMC-derived DCs shed similar amounts of sTNFRI on different SAM 
endgroups 
 The levels of shed sTNF RI that negatively regulates TNF-α-mediated apoptosis 
by competitively binding soluble TNF-α were measured (Brodbeck 2002b). However, no 
differences were observed in sTNFRI levels in supernatants from different SAM 
endgroups (data not shown) across all donors tested.  
 
Human PBMC-derived DCs or T cells demonstrate high positive staining for CTLA-4 in 
response to CH3 SAM contact; undetectable levels of shed CTLA-4 with all SAM 
endgroups 
 To identify if CTLA-4 expressed by activated T cells that binds the B-7 family of 
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co-stimulatory receptors on DCs and causes T cell inhibition, was involved in 
immunosuppression observed on CH3 SAM (Walunus 1998; Oosterwegel 1999; Orabona 
2006), levels of shed or bound CTLA-4 were measured for DCs or T cells treated with 
the different SAM endgroups in DC media. Interestingly, highest bound CTLA-4 was 
measured for DCs treated with CH3 SAM endgroups in DC media compared to all other 
treatments (Figure 5-8a) or for T cells treated with CH3 SAM endgroups compared to 
iDCs, mDCs or DC treated with OH or NH2 SAM (Figure 5-8b). No differences were 
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Figure 5-8: Dendritic cells and associated T cells treated with CH3 SAM endgroups 
increase expression of bound CTLA-4; no differences in shed CTLA-4 levels among 
SAM endgroups. 
Contact with CH3 SAM endgroups triggered increases in expression of CTLA-4 for DCs 
as compared to all other treatments (a). Furthermore, contact with CH3 SAM endgroups 
triggered increases in expression of CTLA-4 for associated T lymphocytes present in DC 
cultures as compared to iDC treatment or to DCs exposed to OH, COOH or NH2 SAMs 
(a) or to T cells exposed to COOH or NH2 SAM endgroups (b). This experiment was 
repeated six times with six different donors; mean ± S.D, „+‟ indicates greater than iDCs; 




 Dendritic cells treated with different SAM endgroups showed differential levels 
of maturation as assessed by examining morphology, maturation marker expression and 
allostimulatory capacities. Based on morphology, DCs treated with CH3 SAM in DC 
media were least mature (Figure 5-1). In a functional MLR assay, DCs treated with CH3
 
SAM endgroups in DC media were also less allostimulatory than iDCs at different DC: T 
cell ratios while DCs treated with other SAM endgroups were more allostimulatory 
(Figure 5-2). Furthermore, from maturation marker expression, DCs treated with OH, 
COOH or NH2 SAM endgroups in DC media showed modestly higher activation than 
iDCs (Figure 5-3). In contrast, DCs treated with CH3 SAM endgroups in DC media 
expressed highest levels of HLA-DQ receptor (Figure 5-3), which upon ligation induces 
immunosuppressive DC apoptotic death (McClary 2000; Keselowsky 2003; Barbosa 
2004). To summarize, OH, COOH or NH2 SAM endgroups caused modest DC 
maturation while CH3 SAM endgroups caused lower DC maturation.  
 The interesting contradiction observed was that DCs treated with CH3 SAM 
endgroups in DC media were less mature than those treated with other SAM endgroups, 
but were so in the presence of highest levels of pro-inflammatory cytokines (Figure 5-4). 
An analogous situation was observed in vivo using a rodent air pouch model where CH3 
SAM endgroups showed low cell adhesion density even though OH or CH3 SAM 
implants recruited highest inflammatory cells (Barbosa 2004). To probe the mechanism 
by which DCs remained less mature while being exposed to high levels of pro-
inflammatory cytokines in our system, the levels of immunosuppressants such as IL-10, 
TGF-ß or stimulators of AA-DCs such as PGE2 in media on CH3 SAM endgroups that 
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may counteract the effects of pro-inflammatory cytokines and cause lower DC maturation 
were assessed, but found to not be responsible. Low DC maturation on CH3 SAM may be 
explained by highest presence of apoptotic DCs and high presence of apoptosis-induced 
non-viable autologous T cells on these surfaces. High T cell apoptosis on CH3 SAM may 
have been induced by high TNF-α in the microenvironment or by ligation of highly 
expressed HLA-DQ (Leverkus 2003; Zang 2005a; Zang 2005b). It is worth noting 
however that although both DCs and autologous T cells on CH3 SAM were undergoing 
apoptosis, autologous T cells were TUNEL+ indicative of end stage apoptosis, while DCs 
were positive for caspase-8 and Annexin V/ propidium iodide, which are markers of early 
apoptosis (Figures 5-7). If lower sTNFRI levels had been observed in CH3 SAM 
supernatants, thereby accounting for the high measured soluble TNF-α on these surfaces, 
this mechanism of triggering TNF-α-mediated apoptosis may have been implicated. 
Taken together, these results explain in part why lower DC maturation was observed on 
CH3 SAM endgroups and also shed light on the possible role played by high secreted 
TNF-a in the microenvironment, which acts not only as a DC maturation stimulus 
(Bertho 2001), but also plays a role as a potent inducer of DC apoptosis (Bertho 2001), as 
previously described in the literature.  
 These findings are supported by recent literature that implicates apoptosis as a 
mechanism for DC-mediated tolerance (Ferguson 2002; Clayton 2003; Duffield 2003; 
Newton 2003; Skoberne 2005a; Wallet 2005b; Chen 2006c). Apoptotic cell uptake by 
DCs results in downregulation of DC maturation markers and allogeneic T cell responses 
(Ferguson 2002; Clayton 2003; Duffield 2003; Newton 2003; Skoberne 2005a; Wallet 
2005b). This is cell-type specific.  Although the engulfment of neutrophils or other DCs 
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causes DC tolerization, phagocytosis of autologous T or B cells does not, hence only DCs 
have been gated for Figure 5-5. Finally, high bound CTLA-4 was measured on DCs 
(Figure 5-8a) or autologous T cells (Figure 5-8b) treated with CH3 SAM endgroups in 
DC media. Binding of CD86 on DCs to CTLA-4 on T cells acts as an inhibition signal for 
T cells via decreased IL-2 synthesis and triggers a tolerogenic response (Walunus 1998; 
Oosterwegel 1999; Orabona 2006).  The presence of CTLA-4 on DCs which normally do 
not express the receptor may represent an instance of transfer of cell surface proteins 
between different cell types of which only one type characteristically expresses the 
protein, but then bestows it upon the other cell type. This suggestion stems for a recent 
review (Davis 2007) that proposes a mechanism whereby proteins channeled from 
anergic T cells to APCs, possibly mediated by exosomes, may then induce APC tolerance 
against the agonist peptide. Although the nature of the agonist remains unclear for 
biomaterials, a similar mechanism of regulatory T cell-induced DC tolerization may 
occur on CH3 SAM. These findings are supported in part by studies that have 
demonstrated that the presence of lymphocytes in the DC culture may be significant in 
providing necessary DC differentiation signals. Specifically, cell-cell communication 
between DCs and associated B (Bayry 2004; Bayry 2005) or T cells (Latour 2001; 
Johansson 2003) has been shown to affect DC maturation as well as migration events. 
Furthermore, these results suggest that the presence of associated lymphocytes may also 
be involved in influencing DC-mediated host responses to biomaterials. This study is 
novel as it further elucidates the mechanisms responsible for DC immunosuppression on 
model SAM biomaterials.   
 Interestingly, both the loosely adherent as well as adherent cell fractions for all 
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treatments comprised similar cell types, namely CD3+ T cells, CD19/CD24+ B cells as 
well as CD1c+ DCs. Dendritic cells present in both fractions exhibited similar levels of 
most maturation markers: CD83, CD86, HLA-DQ or HLA-DR, but demonstrated 
significantly increased levels of CD80 expression following induced detachment from 
multiple biomaterial treatments using CDS. Therefore, in order to focus solely on the 
abilities of the different biomaterials to support DC maturation and ignore the 
contributions of other effects, the gently-harvested DCs present in the loosely adherent 
fraction alone was considered in this study. Future work may include the characterization 
of the expression of integrin receptors including CD50, CD54, CD58, CD11b or CD11c 
that mediate cell adhesion and are also known to have differential expression on iDCs 
and mDCs and mediate maturation or apoptotic functional events in DCs (Janeway 1998; 
Nasr 2006; Skoberne 2006), to gain additional insights regarding mechanisms behind DC 
adherence and their significance if any, in regulating DC responses.  
The pro-inflammatory nature of OH SAM endgroups observed here is supported 
in the literature. The OH SAMs have been associated with high leukocyte adhesion 
linked to high complement activation (Tegoulia 2000) and significantly higher amounts 
of pro-inflammatory fibrinogen (Fn) than hydrophobic SAM (Silver 1995), although 
others have found otherwise (Lindbald 1997; Kalltorp 1999; Shen 2001). Furthermore 
OH SAMs have been associated with higher adsorbed pro-inflammatory complement-3 
(C3) or immunoglobulin G (IgG) amounts than CH3 SAM endgroups (Sigal 1998).  
Furthermore, the cationic polysaccharide chitosan when co-administered with antigens, 
caused greater mucosal and systemic immune responses, as demonstrated by an 
upregulation of MHC class II receptors on OX62+ DCs and triggering CD3+ T cell 
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activation in the spleen (Bivas-Benita 2004), in agreement with these findings that 
demonstrate NH2 SAM as a modest stimulator of DC maturation and with other studies 
(Porporatto 2005; Wang 2006).  
 The literature regarding the pro- or anti-inflammatory nature of CH3 SAM 
endgroups is conflicting. Although it was concluded based on in vitro and in vivo studies 
(Lindbald 1997; Barbosa 2004; Barbosa 2005a; Barbosa 2005b; Barbosa 2006) that CH3 
SAM endgroups caused an acute inflammatory response as exemplified by increased 
recruitment of inflammatory cells to CH3 SAM endgroups, higher presence of Mac-1
+
 
cells as well as thicker fibrous capsules, lowest cell adhesion has been observed to CH3 
SAM endgroups (Barbosa 2003; Barbosa 2004; Barbosa 2005a; Barbosa 2005b; Barbosa 
2006). It is unclear if upregulated Mac-1 integrin (CD11b/ CD18) [also Complement 
Receptor-3 (CR3)] on CH3 SAM, which has been implicated in internalization of 
apoptotic cells and DC tolerization (Coxon 1996; Whitlock 2000; Verbovetski 2002; 
Skoberne 2006), potentiates anti-inflammatory effects on CH3 SAM, in accordance with 
our observations. These results suggest that –NH2, OH or COOH terminal materials may 
be suitable for applications where a modest immune response is desired, although the 
mechanisms underlying DC activation may be different, while CH3 SAM may be better 
suited for less immunostimulatory applications. The ultimate goal would be to better 
understand the mechanisms underlying differential DC responses to biomaterials to better 








GLYCOPROTEIN-MEDIATED INTERACTIONS OF DENDRITIC CELLS 
WITH BIOMATERIALS. PART 2. PROFILES OF CARBOHYDRATES 





 An understanding on the host-biomaterial interactions accompanying the 
implantation of combination products composed of a biomaterial component and 
biological components (tissues, cells, proteins or DNA) is important in ascertaining the 
success of these implants. Besides the non-specific inflammatory response against the 
biomaterial, the biomaterial may act as an adjuvant, beneficially, by enhancing the 
desired specific immune response against the biological component in vaccine delivery 
systems, but this enhancement may be disadvantageous when biomaterials are utilized in 
tissue engineering applications, where implant functioning is impaired by fibrous capsule 
and scar tissue formation as part of the host protective response, or even undergo cell-
mediated implant degradation (Langer 1993; Tang 1995; Babensee 1998a; Babensee 
2000; Rihova 2000; Stock 2001). A controlled host response to implanted biomaterials is 
therefore desirable. Although the non-specific host inflammatory response to biomaterials 
has been examined extensively (Anderson 1988; Langer 1993; Tang 1995; Ratner 1996; 
Babensee 1998a; Babensee 2000; Rihova 2000; Stock 2001; Wettero 2002), the adjuvant 
effects of biomaterials have only been recently described (Yoshida 2004; Babensee 2005; 
Bennewitz 2005; Yoshida 2006a; Yoshida 2006b). The co-delivery of the biomaterial 
poly (lactic-co-glycolic acid) (PLGA) along with model shed antigen (Ag) ovalbumin 
                                                 
*
 Galactose data was provided by Inn Inn Chen during her time as an Undergraduate Research Scholar at 
the Babensee laboratory in Georgia Tech, Atlanta, USA. 
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(OVA) increased the levels of antibodies generated again OVA, demonstrating the 
adjuvant effects of biomaterials in vivo (Ertl 1996; Walker 1998; Bennewitz 2005). 
Furthermore, since Ag presenting cells (APCs) such as dendritic cells (DCs) mature in 
response to adjuvants and upregulate their expression of co-stimulatory and major 
histocompatibility class II (MHC II) molecules and have reduced endocytic and 
phagocytic functions (Sallusto 1994; Zhao 1996; Cella 1997a; Winzler 1997; Banchereau 
1998a; Singh 1999; Banchereau 2000; Sun 2003), the effects of biomaterials in causing 
DC maturation have been studied in vitro. While certain biomaterials such as PLGA 
caused DC maturation, others such as agarose were less effective at triggering the 
transition from immature DCs (iDCs) to mature DCs (mDCs) in vitro, and would thereby 
presumably act as weaker adjuvants (Yoshida 2004).  
 Dendritic cells are professional APCs that connect innate and adaptive immunity 
and therefore play a vital role in directing the immune response. Upon encountering 
pathogens or „danger signals‟ including heat-shock proteins and necrotic cells indicative 
of tissue injury, iDCs, that express high levels of Pathogen Recognition Receptors 
(PRRs) that recognize Pathogen Associated Molecular Patterns (PAMPs) transform into 
mDCs that have increased expression of CD80, CD86 co-stimulatory molecules and 
MHC II complexes and present internalized processed Ags on MHC complexes to naïve 
T or B lymphocytes (Zhao 1996; Cella 1997a; Winzler 1997; Babensee 1998a; Singh 
1999; Banchereau 2000; Sun 2003). The conserved moieties recognized in PAMPs 
include bacterial lipopolysaccharide (LPS) (Banchereau 1998a; Gallucci 1999; 
Banchereau 2000; Figdor 2002; Janeway 2002; van Kooyk 2003; Pulendran 2004), N-
acetylglucosamine (GlcNAc) and N-acetylmuraminic acid (MurNAc) in peptidoglycans 
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(Banchereau 1998a), ß(1-3) glucans in zymosan (Brown 2001a; Brown 2003; Brown 
2006) and mannose-containing bacterial pili (Silverblatt 1983). Toll-like receptors 
(TLRs) and C-type lectin receptors (CLRs) are PRRs expressed by DCs that recognize 
conserved epitopes on PAMPs (Bhardwaj 1994; Lotze 1999; Aderem 2000; Guyton 
2000; Termeer 2000; Akira 2001; Brown 2001a; Medzhitov 2001; Okamura 2001; 
Smiley 2001; Valladeau 2001; Engering 2002; Geitjenbeek 2002; Termeer 2002; Gantner 
2003; McGreal 2004; Rogers 2005; Dillon 2006). While the importance of TLR-PAMP 
interactions in stimulating DC maturation has been well characterized due to (nuclear 
factor-B) NF-B mediated regulation of pro-inflammatory/immunoregulatory genes 
(Termeer 2000; Akira 2001; Medzhitov 2001; Smiley 2001; Termeer 2002), the role of 
CLR-mediated recognition, uptake, processing and presentation of carbohydrate Ags has 
emerged recently (Brown 2001a; Valladeau 2001; Engering 2002; Geitjenbeek 2002; 
Gantner 2003; McGreal 2004; Rogers 2005; Dillon 2006). The CLRs and their 
carbohydrate ligands in the context of biomaterials have been poorly understood thus far 
and form the focus of this work.  
 The CLR family has been broadly classified as mannose or galactose binding 
(McGreal 2004).  Examples of CLRs that bind mannose moieties are mannose receptor 
(MR), DC-specific ICAM-3 grabbing non-integrin (where ICAM-3 is intercellular 
adhesion molecule 3) (DC-SIGN) (van Kooyk 2003), and Dectin-1 (Rogers 2005; Brown 
2006).   Examples of CLRs that bind bind α- and/or ß -galactose or GalNAc moieties are 
asialoglycoprotein receptor (ASGPR) (Valladeau 2001) and macrophage galactose N-
acetyl-galactosamine (GalNAc) specific lectin 1 (MGL) (van Villet 2005). The 
carbohydrate binding specificities of different CLRs vary and have been reviewed in 
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(Figdor 2002; van Kooyk 2003).  For example, MR recognized terminal mannose, fucose, 
sialylated groups or GlcNAc and DC-SIGN recognized mannose-enriched internal 
residues (Geitjenbeek 2002). Carbohydrate recognition by certain CLRs has been linked 
recently with endocytosis and processing of cargo (Jiang 1995; Mahnke 2000; Cobb 
2004), activation of intracellular signaling mediators and differential downstream 
immune consequences via ITAM (immunoreceptor tyrosine-based activation motif) 
(Jiang 1995; Gantner 2003; Cobb 2004; Rogers 2005; Brown 2006; Dillon 2006) or ITIM 
(immunoreceptor tyrosine-based inhibitory motif) (Kanazawa 2002) residues. Dectin-1 
that possesses an ITAM motif and binds β-glucans, has been implicated in the activation 
of Syk-mediated signaling pathways (Rogers 2005; Brown 2006). Furthermore, Dectin-1 
has been shown in upregulate TLR 2-mediated activation of NF-B and exhibit 
synergism in the regulation of IL-1 and tumor necrosis factor- α  (TNF-α) (Gantner 
2003).  
  It is therefore important to characterize the DC carbohydrate ligands present on 
biomaterial surfaces that may be recognized by CLRs and hence mediate DC interactions. 
The roles of glycans in controlling fundamental immune/inflammatory responses to 
biomaterials have been poorly studied thus far. It is hypothesized that DCs may respond 
to biomaterials by recognizing „biomaterial associated molecular patterns‟, analogous to 
PAMPs, through the adsorbed protein layer, specifically through carbohydrate 
modifications of these proteins using PRRs to initiate an immune response. To 
characterize the presence of carbohydrate ligands of DC CLRs, self-assembled 
monolayers (SAMs) with –CH3, -OH, -COOH, or –NH2 endgroups that present a broad 
spectrum of surface properties such as charge, hydrophobicity or hydrophilicity, 
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topography, surface energy and chemistry and have been thoroughly characterized in 
(Mrksich 1996; Lindbald 1997; Harder 1998; Sigal 1998; Kalltorp 1999; Luk 2000; 
McClary 2000; Tegoulia 2000; Shen 2001; Barbosa 2003; Keselowsky 2003; Michael 
2003; Schwendel 2003; Dadsetan 2004) were chosen. These SAM surfaces were used as 
model biomaterials to observe the effect of distinct surface properties on directing protein 
adsorption and carbohydrate presentation on the surface. We have previously 
characterized DC responses to different SAM chemistries, and observed that while OH, 
COOH or NH2 SAM triggered modest DC maturation, least maturation was observed on 
CH3 SAM.  This was likely due to highest immunosuppressive DC apoptosis upon CH3 
SAM contact (CHAPTER 5). The importance of understanding differential DC responses 
on different chemistries from the perspective of distinct DC ligands regulated by 
biomaterial chemistry formed the motivation for this paper.  
 
METHODS:  
Self-assembled monolayer preparation 
 Self-assembled monolayers presenting –CH3, -OH, -COOH or –NH2 chemistries 
were assembled on 16-well glass chamber slides (LAB-TEK, Nalge Nunc International, 
Rochester, NY) for carbohydrate or protein measurement assays or on 9 mm X 9 mm 
glass coverslips for material characterization assays (Bellco Glass, Inc., Vineland, NJ) 
(Keselowsky 2003) as described previously (CHAPTER 5) The SAM endgroups were 
allowed to assemble by 12 hr incubation at room temperature (RT) by immersing the 
Ti/Au-coated slides or coverslips in alkanethiol solutions, following which the chamber 
slides were washed with 95% ethanol (Sigma, St. Louis, MO), dried with N2 gas (Airgas 
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South, Chamblee, GA) for 10 minutes in a fume hood, equilibrated with Phosphate 
Buffered Saline (PBS) (Gibco, Grand Island, NY) for 5 minutes at RT and used fresh. 
 
X-ray photoelectron spectroscopy  
 Characterization of surface chemistries of the SAM endgroups was performed by 
low resolution survey scans (spot size 400 µm) or high resolution C1s spectra (spot size 
200 µm) x-ray photoelectron spectroscopy (XPS) using a Surface Science model SSX-
100 (Surface Sciences Laboratories, Mountain View, CA), with monochromatized AlKα 
X-rays at 10 kV, at the Microelectronic Research Center at Georgia Institute of 
Technology.  Atomic percentages of elements were obtained from low resolution scans 
and high resolution scan curves were fit based on software provided by the manufacturer, 
with placement of the hydrocarbon peak at 284.6 eV. Different takeoff-angles of 0°, 20°, 
55° or 70° were used (angle between the beam and the normal to the surface) to permit 
measurements at varying depths from the film surface. The detection limit for angle 
resolved XPS is ~0.1 atom% in composition and 10-250 Ǻ in depth (Yoshida 2006a), 
with maximum and minimum depths attained at takeoff angles of 0° and 90° respectively. 
Scans were taken on two spots per sample per take-off angle. Prior to XPS, freshly-
prepared SAM samples were washed with 95% ethanol and dried with N2 and analyzed 
immediately. Theoretical values were determined based on known chemical structure.  
 
Contact angle measurements  
 Advancing contact angles between freshly-prepared flat SAM and 5 µm drops of 
de-ionized (DI) H2O were determined in ambient air using a Rame-Hart model # 100-00 
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goniometer (Mountain Lakes, NJ). For each surface, contact angles were measured for 
three water droplets, on two sides of each droplet and the values presented denote the 
average and standard deviations for three measurements in total. 
 
Preparation of human serum or human plasma 
 Human blood was obtained from healthy volunteers with informed consent, 
according to a protocol approved by the Institute Review Board (IRB) # H05012. All 
subjects enrolled in this research signed an Informed Consent which was approved by the 
IRB of Georgia Institute of Technology. Peripheral human blood was collected using 
sterile 60 mL syringes (Becton Dickinson, Franklin Lakes, NJ) and needles (Becton 
Dickinson) using heparin (333 U/ mL blood) (Baxter Healthcare Corporation, Deerfield, 
IL) as an anticoagulant. The clear yellowish human plasma (HP) layer was separated 
using lymphocyte separation medium (LSM) (Cellgro MediaTech, Herndon, VA) by 
differential gradient centrifugation of blood diluted 1:1 with sterile PBS (400 g, 30 
minutes, RT) (Thermo Fisher Scientific Inc., Waltham, MA) (Model # 5682, Rotor IEC 
216), filtered sterilized (0.22 µm) (Corning, Corning, NY) and heat inactivated for 30 
minutes in a water bath pre-warmed to 56°C, aliquotted and stored at -20°C. A stock 
solution of pooled HP from three donors was used for experiments.   
 For preparation of human serum (HS), peripheral human blood was collected 
without heparin, so that HS could be isolated from clotting factors.  The HP was isolated 
from non-heparinized blood by centrifugation of blood at 3000 rpm for 10 minutes, RT, 
after clots were pushed down manually using a sterile pipette tip, where necessary. The 
HS was then prepared from non–heparinized HP by allowing the HP to remain at RT for 
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90 minutes in the tissue culture (TC) hood and cleared by further centrifugations at 3000 
rpm for 15 minutes after gently pushing down residual precipitates and was filter 
sterilized (0.22 µm) (Corning) and heat inactivated for 30 minutes in a water bath pre-
warmed to 56°C, aliquotted and stored at -20°C. A stock solution of pooled HS from the 
same three donors as used for HP was used for experiments.   
 
Enzyme linked lectin assay for detection of carbohydrates associated with adsorbed 
proteins on SAM endgroups or control polystyrene 
 Enzyme Linked Lectin Assays (ELLAs) were performed on SAM endgroups 
having pre-adsorbed HS or HP proteins using a previously described method with some 
modifications (Leriche 2000). The SAM endgroups were incubated with 60 l/ well of 
serial half dilutions of HS or HP in PBS starting from 20%, down to 2.5% and then from 
1% down to 0.25% (v/ v) or with PBS alone (1 hr, 37C) in duplicate wells in two 
chamber slides leading to a total of 4 wells per HS or HP concentration. After aspirating 
out HS, HP or PBS samples from wells, wells were blocked with 0.5 mg/ mL of freshly 
prepared Bovine Serum Albumin (BSA) (Sigma) in PBS (block buffer; 1 hr, 37C), 
washed three times for 5 minutes each with block buffer at RT and incubated with 
biotinylated lectin [Narcissus pseudonarcissus (NPA; 12.5 g/ mL), Sambucus nigra 
(SNA-1; 12.5 g/ mL), Ulex europeaus I (UEA-1; 50 g/ mL), Ulex europaeus II (UEA-
2; 12.5 g/ mL), Pisum sativum (PEA; 25 g/ mL), Hippeastrum hybrid  (HHA; 50 g/ 
mL), Peanut agglutinin (PNA; 12.5 g/ mL), Artocarpus interifolia (AIA; 25 g/ mL) or 
Bauhinia purpurea (BPA; 25 g/ mL)] with the carbohydrate detection specificities 
indicated in Table 5 (all from EY Laboratories, Inc., San Mateo, CA)] in block buffer (2 
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hrs, 37C). For UEA-2 lectin, 1.0 mg/ mL heat inactivated BSA (56°C, 30 minutes) in 
PBS was used in a sensitive blocking step and for PEA or BPA lectins, 1.0 mg/ mL of 
BSA in PBS was used. Following incubation with the biotinylated lectin, wells were 
washed and incubated with 10 µg/ mL avidin/alkaline phosphatase (AV/AP) (EY 
laboratories Inc.) in block buffer (1 hr, 37C) for detection of bound lectin. The 
concentration of AV/AP used was 1.25 µg/ mL for SNA-1, PEA or HHA lectins or 20 
µg/ mL for AIA or BPA lectins. Finally, wells were washed and incubated with 1.0 mg/ 
mL p-nitrophenylphosphate (pNPP) (Sigma) substrate for detecting AV/AP (1 hr, 37C). 
The solutions were transferred to wells of a clear flat-bottomed TC-treated 96-well plate 
(Corning) to avoid interference with the reading by the SAM endgroups, reaction stopped 
at RT with 40 l of 0.4 M NaOH (Sigma) and absorbance read immediately at 405 nm 
using a SpectraMax Plus 384 plate reader (Molecular Devices, Sunnyvale, CA). Positive 
control glycoprotein standard dilutions in PBS (1:1) were run in parallel on TC-treated 
polystyrene (Phillips) 96-well plates (control) for each lectin; α-2-macroglobulin (from 
100 – 12.5 µg/ mL) or (1000 – 3 µg/ mL) for NPA (van Leuven 1993) or HHA (Balzarini 
2005) respectively, glycophorin A (100 – 3 µg/ mL) for SNA-1 (Shibuya 1987), 
lactoferrin (1000 – 62.5 µg/ mL) or (1000 – 15 µg/ mL) for UEA-1 (De Carlos 2002) or 
PEA respectively, bovine fetuin (1000 – 3 µg/ mL) for UEA-2, asialofetuin (5 – 0.6 µg/ 
mL) or (31.25 – 1.9 µg/ mL) for PNA (Balu 2001) or BPA (Sueyoshi 1988) respectively 
and immunoglobulin A (IgA) (50 – 1.5 µg/ mL) for AIA lectin (Roque-Barreira 1985) 
(all from Sigma), and based on lectin probe specificity data from (van Damme 1998). An 
identical set of samples (HS or HP) as those run on SAM were also run on PS for each 
experiment.  
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Table 5: Dendritic cell C-type lectin receptors, their corresponding carbohydrate 
ligands and carbohydrate specificities for plant lectins used as probes  
C-type Lectin Receptor Abbreviations: ASGPR, asialoglycoprotein receptor; MGL, 
macrophage galactose N-acetyl-galactosamine specific lectin 1; MR; mannose receptor; 
DC-SIGN, DC-specific ICAM-3-grabbing non-integrin (where ICAM-3 is intercellular 
adhesion molecule 3). 
Plant Lectin Abbreviations:  AIA, Artocarpus integrifolia; PNA, Arachis hypogaea; BPA, 
Bauhinia pupurea; NPA, Narcissus pseudonarcissus; UEA-1, Ulex europaeus; SNA-1, 
Sambucus nigra; UEA-2, Ulex europaeus-2; PEA, Pisum sativum; HHA, Hippeastrum 
hybrid. 































































Enzyme linked immunosorbent assay (ELISA) for detection of total human 
immunoglobulin (IgG) or human serum albumin (HSA)  
 An enzyme linked immunosorbent assay (ELISA) was performed to measure 
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amounts of total human IgG or total human serum albumin (HSA) adsorbed from 10% 
HS (v/ v) onto SAM endgroups. The SAM endgroups were incubated with 60 µl of 1% or 
10% (v/ v) HS in PBS (1 hr, 37°C), followed by blocking with 1.0 mg/ mL of BSA in 
PBS for HSA ELISA or with 0.5 mg/ mL of BSA in PBS for IgG ELISA (both for 1 hr, 
37°C) and incubating with 1:10000 dilution of monoclonal mouse anti-HSA (clone HSA-
11; IgG2a) (no cross reaction with BSA) or 1:1000 affinity isolated AP-conjugated 
polyclonal goat anti-human IgG (IgGγ) (both from Sigma) (2 hrs, 37°C), for  detection of 
HSA or IgG respectively.  Wells were washed three times for 5 minutes each with PBS at 
RT.  For the IgG ELISA, wells were incubated with 1.0 mg/ mL pNPP (30 minutes, RT) 
after incubating with AP-conjugated primary antibody. For detection of HSA, wells were 
incubated with 1:1000 dilution of affinity isolated AP-conjugated goat anti-mouse IgG 
(IgG) (Sigma) (2 hrs, 37°C), washed and incubated with pNPP substrate (1 hr, RT). The 
reactions were stopped with 40 l of 0.4 M NaOH (Sigma) at RT and the solutions 
transferred to 96-well clear-bottomed plates to avoid interference with SAM and 
absorbance read at 405 nm using a SpectraMax Plus 384 plate reader (Molecular 
Devices). Standard curves were generated with 1:10 dilutions of purified IgG or HSA 
(both from Sigma) in PBS (starting from 100 µg/ mL of IgG or 1 mg/ mL for HSA) on 
96-well PS control surfaces. To confirm that the varying carbohydrate profiles observed 
on different SAM endgroups were in fact different, the ELLA absorbances were 
normalized to amounts of total human IgG or HSA and the ratios were compared. 
 
Statistical analysis 
 Statistical analysis was performed using general linear model analysis of variance 
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(Young 2001) with Minitab software (Version 13.20, Minitab Inc., State College, PA) 
using pairwise comparisons between SAMs, with a Tukey post-test and a p value of less 
than or equal to 0.05 was considered significant. 
 
RESULTS  
Contact angle and XPS characterizations of Self-assembled monolayer surfaces 
endgroups show close agreement with established theoretical values  
 The SAMs presenting endgroup chemistries –CH3, -OH, -COOH, or –NH2 
represented a broad spectrum of surface properties including charge, 
hydrophobicity/hydrophilicity and chemistry. The CH3 SAMs are uncharged, 
hydrophobic and the OH SAM are neutral, hydrophilic. Under physiological pH 
conditions (7.2-7.4), the COOH or NH2 SAM are both hydrophilic, and are negatively or 
positively charged, respectively (Mrksich 1996; Lindbald 1997; Harder 1998; Sigal 1998; 
Kalltorp 1999; Luk 2000; McClary 2000; Tegoulia 2000; Shen 2001; Barbosa 2003; 
Keselowsky 2003; Michael 2003; Schwendel 2003; Dadsetan 2004). The SAM 
endgroups were characterized by XPS analysis (Table 6) and contact angle determination 
(Table 7). The low resolution XPS survey scans showed agreement with estimated 
theoretical values for these surfaces and previously published values (Keselowsky 2003) 
and indicated modification of Au/Ti surfaces with the alkanethiols with appropriate 
changes in C 1s and O 1s percentages as expected, for glass surfaces that were coated 
with Au/Ti and assembled with alkanethiols presenting different functional endgroups. 
Carbon was the predominant element present for all samples. On control samples coated 
with Au/Ti alone, no carbon was detected.  The percentages of different elements 
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measured were similar to expected values based on theoretical estimates for all samples 
using take-off angles of 0°, 20°, 55° and 70° for surface analysis at different depths. 
Overall the SAMs were composed of alkanethiols that were anchored to the substrates at 
the furthest end from the surface and that presented functional endgroups at the end 
closest to the surface (Table 6).  
 
Table 6: Elemental composition of SAM endgroups presenting different chemistries 
using variable-angle XPS where angle is calculated from the surface plane 
 
7786Theoretical
8.92 ± 7.5810.71 ± 6.1380.35 ± 1.4470
5.67 ± 3.6410.98 ± 3.7283.35 ± 7.2355
4.14 ± 2.518.55 ± 1.1387.29 ± 1.3820
14.01 ± 2.028.60 ± 1.5677.31 ± 3.860NH2
71479Theoretical
4.61 ± 1.8613.69 ± 1.8881.68 ± 0.0170
5.2 ± 2.2314.62 ± 1.2180.17 ± 1.0155
6.73 ± 6.559.6 ± 4.3583.65 ± 0.7820
2.21 ± 1.8115.4 ± 4.7782.5 ± 6.40COOH
4.17.784.6Theoretical
3.95 ± 4.8912.27 ± 2.4483.73 ± 7.3970
6.45 ± 1.348.03 ± 1.6485.49 ± 0.355
3.92 ± 0.9111.84 ± 5.0984.23 ± 5.9820
4.84 ± 0.1611.4 ± 3.1883.67 ± 3.010OH
7.792.3Theoretical
4.8 ± 0.6595.19 ± 0.6570
5.35 ± 2.3294.64 ± 2.3155
13.02 ± 7.0386.97 ± 7.0220














Advancing contact angles were measured (on both sides of the drop) between 5-
m drops of DI water and glass coverslips coated with Au/Ti, on which the different 
 103 
SAM endgroups were allowed to assemble, to measure the degree of 
hydrophobicity/hydrophilicity of the surface. The contact angle measurements indicated 
that 11-mercapto-1-undecanol with a terminal hydroxyl group was the most hydrophilic 
surface and that 1-dodecanethiol, with a terminal methyl group, was the most 
hydrophobic (Table 7) (Tanahashi 1997; Sigal 1998; Franco 2000; Keselowsky 2003). 
 
Table 7: Advancing contact angles between different SAM endgroups and water 










Differential ELLA absorbances on different SAM endgroups or control PS 
             The ELLA assays were performed using lectin probes mentioned in Table 5 to 
characterize the carbohydrates ligands of DC CLRs associated with the adsorbed HS or 
HP proteins on different SAM chemistries. On 96-well TC-treated PS surfaces treated as 
control, linear standard curves were generated for each lectin-glycoprotein (Figure 6-1a-
h) to confirm assay reproducibility. In general, absorbances corresponding to the 
presence of specific carbohydrates decreased when PS surfaces were pre-incubated with 
decreasing HS dilutions in PBS (1:1 dilutions between 20% and 2.5% and between 1% 
and 0.25%) when probed with AIA (β-galactose) or BPA (GalNAc) galactose-family 
lectins (Figure 6-2 a-d). In contrast, pre-incubation of PS surfaces with decreasing HS 
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concentrations resulted in increasing absorbances when probed with NPA (mannose) or 
UEA-2 (GlcNAc) mannose-family lectins or unchanged absorbances with different HS 
dilutions for UEA-1 (fucose) or SNA-1 (sialylated groups) (Figure 6-3 a, c-f). For PEA 
(complex mannose) high absorbances were detected when PS surfaces were pre-
incubated with concentrations of 2.5% or 1% HS (intermediate among the range of HS 
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Figure 6-1: ELLA standard curves for lectin probes using positive control adsorbed 
glycoproteins on control polystyrene surfaces. 
Enzyme linked lectin assays were performed using pairs of lectin probe: serial half-
dilutions of glycoprotein in PBS on polystyrene surfaces; PNA: asialofetuin (a), BPA: 
asialofetuin (b), AIA: IgA (c), PEA: bovine fetuin (d), UEA-1: lactoferrin (e) UEA-2: 
bovine fetuin (f), α-2-macroglobulin: NPA (g), glycophorin A: SNA-1 (h), to confirm 
assay reproducibility and sensitivity. Standard curves were resolved using linear curve 


























PNA: B galactose BPA: n-acetyl-galactoseamine AIA: a galactose
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Figure 6-2: Trends of α-galactose or GalNAc presence in the adsorbed protein layer 
on polystyrene surfaces with decreasing concentration of pre-incubating HS in PBS.  
Enzyme linked lectin assays were performed using plant lectins probes for carbohydrate 
ligands of ASGPR or MGL, as shown for all lectins together in (a) or separately for each 
lectin namely -galactose (PNA) (b), n-acetyl-galactoseamine (GalNAc) (BPA) (c) or α-
galactose (AIA) (d) associated with proteins adsorbed on SAM pre-incubated with 
varying concentrations of HS in PBS.  Absorbances corresponding to presence of 
GalNAc (BPA) or α-galactose (AIA) decreased with decreasing concentration of pre-
incubating HS. Presence of β-galactose (PNA) was undetectable with all HS 
concentrations tested. mean±SD, n = 3 independent determinations, „*‟: significantly 
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Figure 6-3: Trends of mannose or sialylated groups presence in the adsorbed 
protein layer on polystyrene surfaces with decreasing concentration of pre-
incubating HS in PBS.  
Enzyme linked lectin assays were performed using plant lectins probes for carbohydrate 
ligands of MR, DC-SIGN or Dectin-1, as shown for all lectins together in (a) or 
separately for each lectin namely complex mannose (PEA) (b), α-fucose (UEA-1) (c), 
GlcNAc (UEA-2) (d), mannose (NPA) (e) or sialylated groups (SNA-1) (f) associated 
with proteins adsorbed on SAM pre-incubated with varying concentrations of HS in PBS.  
Absorbances corresponding to presence of mannose (NPA), or GlcNAc (UEA-2) 
increased with decreasing concentration of pre-incubating HS.  Absorbances 
corresponding to the presence of sialylated groups (SNA-1) or α-fucose (UEA-1) 
remained unchanged across HS dilutions. Absorbances corresponding to presence of 
complex mannose (PEA) was highest at intermediate concentrations of HS tested. 
mean±SD, n = 3 independent determinations, „*‟: significantly different from HS 
concentration, p≤ 0.05. 
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Among SAM endgroups, pre-incubation with 1% HS resulted in absorbances that 
indicated the higher presence of α-galactose on COOH or NH2 compared to CH3 SAM 
(Figure 6-4a). On the other hand, pre-incubation with 10% HS used for DC culture, 
resulted in absorbances that implied higher levels of α-galactose on COOH SAM than on 
NH2 or CH3 SAM (Figure 6-4b). For SAMs that were pre-incubated with 1% or 10% HS 
in PBS, highest presence of complex mannose was detected on NH2 SAMs and also OH 
SAM had higher absorbances compared to CH3 SAM (Figure 6-5). Lowest absorbances 
corresponding to the presence of sialylated groups were detected on CH3 SAM (Figure 6-
5).  In another set of experiments SAM endgroups were incubated with 1% or 10% HP 
and similar results were obtained as observed with incubating solutions of 1% or 10% 
HS, however trends were less defined with HP with both mannose or galactose family 
lectin probes (data not shown). No differences in ELLA absorbances for sialylated groups 
were observed following either 1 hr or 24 hrs incubations of 1% or 10% HS on different 
SAM (data not shown). Similar results were obtained when 1% or 10% HP was incubated 
on different SAM (data not shown). 
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Figure 6-4: Differential presence of α-galactose on different SAM endgroups pre-
incubated with 1% or 10% HS. 
Enzyme linked lectin assay was performed using plant lectins probes for carbohydrate 
ligands of ASGPR or MGL namely -galactose (PNA), n-acetyl-galactoseamine 
(GalNAc) (BPA) or α-galactose (AIA) associated with proteins adsorbed on SAM pre-
incubated with 1% or 10% HS in PBS.  Among SAM endgroups, pre-incubated with 1% 
HS, absorbance corresponding to α-galactose showed trends: COOH or NH2 greater than 
CH3 SAM (a) or with 10% HS in PBS, absorbance corresponding to α-galactose showed 
trends COOH greater than NH2 or CH3 SAM (b), mean±SD, n = 9 independent 
determinations; „*‟: significantly different from indicated SAM endgroup, p≤ 0.05.  
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Figure 6-5: Differential presence of sialylated groups or complex mannose on 
different SAM endgroups pre-incubated with 1% or 10% HS. 
Enzyme linked lectin assay was performed using plant lectins probes for carbohydrate 
ligands of MR, DC-SIGN or Dectin-1, namely complex mannose (PEA), α-fucose (UEA-
1), GlcNAc (UEA-2), mannose (NPA) or sialylated groups (SNA-1) associated with 
proteins adsorbed on SAM pre-incubated with 1% or 10% HS in PBS.  The CH3 SAM 
endgroups were associated with absorbances corresponding to least presence of sialylated 
groups and the NH2 SAM were associated with absorbances corresponding to highest 
presence of complex mannose. mean±SD, n = 9 independent determinations; „*‟: 
significantly different from indicated SAM endgroup, p≤ 0.05. 
 
Normalization of ELLA absorbances to protein amounts  
 The absorbances measured using the ELLA assays were normalized to adsorbed 
protein amounts (human IgG or HSA) to investigate if the differences in glycosylation 
profiles across SAM treatments persisted after accounting for variations in amounts of 
adsorbed proteins (data not shown). The CH3 SAM had significantly higher levels of 
adsorbed IgG compared with COOH SAM with 10% HS. Normalized ratios of ELLA 
absorbance over mean IgG amount indicated similar trends as those observed from ELLA 
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absorbances for both mannose and galactose family lectins, although significance was not 
reached. No significant differences were observed for amounts of adsorbed HSA on 
different endgroups with HS since HSA was not detected on all SAM endgroups and 
hence normalizations of ELLA absorbances over HSA amounts could not be performed.  
 
DISCUSSION 
            Differential carbohydrate absorbance profiles were observed on different SAM 
endgroups, suggesting that different biomaterial chemistries may drive the formation of 
distinct „biomaterial associated molecular patterns‟ composed of proteins and 
carbohydrates. In this study, incubating concentrations of 1% or 10% pooled heat-
inactivated filtered HS or HP were chosen, to allow for comparisons with the in vitro DC 
culture on SAM with media (CHAPTER 5) containing 10% heat-inactivated filtered fetal 
bovine serum (FBS) or 1% autologous heat-inactivated filtered HP. When pre-incubated 
with 10% HS, COOH or NH2 SAM were associated with higher absorbances 
corresponding to the presence of α-galactose than CH3 SAM and undetectable levels of 
GalNAc (Figure 6-4b).  Pre-incubation with 1% HS resulted in higher α-galactose on 
COOH SAM than on CH3 or NH2 SAM and still undetectable levels of GalNAc (Figure 
6-4a). With incubating solutions of 1% or 10% HS, the NH2 SAM were associated with 
highest presence of complex mannose as well as higher complex mannose on OH versus 
CH3 SAM. Finally, the CH3 SAM surfaces were associated with least presence of 
sialylated groups (Figure 6-5). These results have been summarized in Table 8 and imply 
that the profiles of presented carbohydrates varied with different types and concentrations 
of incubating solutions, probably as a result of differential protein adsorption from these 
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solutions.  
Table 8: Summary of results for enzyme-linked lectin assay on polystyrene or SAM 
endgroups for mannose or galactose family lectins 
 
No trendLowest on CH3 SAM
Increasing absorbance trend with 
decreasing serum %
Sialylated groups
Increasing absorbance trend with 
decreasing serum %
GlcNAc





NH2 SAM > All SAM
OH > CH3 SAM
No absorbance trend with decreasing 
serum %
Complex mannose
No trend                         No trendα-Fucose
Low levelsNot DetectableDecreasing absorbance trend with 
decreasing serum %
GalNAc
No trend No trendNot Detectableβ Galactose
COOH > CH3, NH2 No trendDecreasing absorbance trend with 
decreasing serum %
α-Galactose





No trend                            No trend
 
 
In an attempt to quantify the differences in absorbances, and to confirm that the 
differential carbohydrate profiles were in fact different and not solely due to differences 
in amounts of adsorbed HS or HP proteins, ELLA absorbances were normalized to mean 
adsorbed IgG or HSA amounts. Although, significance was not reached in comparisons 
between ratios on different SAM endgroups (data not shown), trends were similar to 
those observed from ELLA absorbances. Furthermore, since several proteins in HS or HP 
are glycosylated, in certain cases with multiple glycosylations and linkages, 
normalization against single proteins such as IgG or HSA (negligible glycosylations) 
performed in this study, alone, may not be sufficient. A more optimal normalization 
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method for future studies would be to quantify adsorption of a panel of glycosylated 
proteins that are commonly adsorbed to biomaterials. 
 In this study, SAMs having -CH3, OH, -COOH or -NH2 chemistries were used as 
model biomaterials to examine the profiles of carbohydrates associated with adsorbed HS 
or HP proteins. The XPS (Table 6) and contact angle (Table 7) characterizations of the 
SAM endgroups in this study revealed close agreement with those described by others 
(Tanahashi 1997; Sigal 1998; Franco 2000; Keselowsky 2003) and showed a broad 
spectrum of surface properties. Differences in amounts and conformations of adsorbed 
proteins have been observed on different SAM. Variations in antibody binding affinities 
against the cell binding domain of fibronectin (Fn) were observed on different SAM 
(McClary 2000; Capadona 2003). Furthermore, significantly higher amounts of pro-
inflammatory fibrinogen (Fg) were adsorbed to OH SAM than to CH3 SAM (Silver 
1995), although others have found otherwise (Lindbald 1997; Kalltorp 1999; Shen 2001; 
Rodrigues 2006). It was observed that higher amounts of pro-inflammatory complement-
3 (C3) (Hirata 2003) was measured on OH SAM than on CH3 SAM, although highest 
amounts of human IgG were detected on CH3 SAM compared to OH, COOH or NH2 
SAM (Silin 1997).  In contrast, adsorption of anti-inflammatory protein albumin was 
higher on CH3 SAM compared to either OH or COOH SAM (Martins 2003).   
 Similar to the pro- or anti-inflammatory roles ascribed to differed HS or HP 
proteins such as C3 or albumin respectively, it may be worth speculating that 
carbohydrates associated with these proteins may also have pro- or anti-inflammatory 
effects. On 96-well TC-treated PS surfaces that served as experimental controls, several 
carbohydrates probed for were associated with differential absorbance patterns following 
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pre-incubations with different concentrations of HS or HP in PBS (1: 1 dilutions between 
20% and 2.5% and 1% and 0.25%) (Figures 6-2 and 6-3). In general, trends indicated 
increasing absorbances for certain mannose group carbohydrates (GlcNAc or mannose) 
on PS (Figure 6-3) with decreasing HS concentrations, suggesting that higher 
presentation of these carbohydrates occurred with decreasing levels of other „masking‟ 
proteins. A notable contrast was observed for galactose group carbohydrates (α-galactose 
or GalNAc) on PS (Figure 6-2), where increasing absorbances corresponded to increased 
presence of these carbohydrates with increasing HS concentrations. These results offer 
indirect support to literature that has implied opposing roles for mannose or galactose 
family proteins in stimulating immune responses. In tumor glycans that have high levels 
of exposed galactose moieties following de-sialylation of O-glycans, the galactose 
molecules were recognized by MGL, leading to the induction of tumor tolerance in the 
absence of TLR signaling (van Villet 2005). While galactose binding to CLRs has been 
linked to anti-inflammatory effects, ligand binding to MR may result in pro-inflammatory 
effects, since blocking of MR inhibited the fusion of macrophages to form foreign body 
giant cells (FBGCs) (McNally 1996), although others have reported observing both pro- 
and anti-inflammatory effects depending on the nature of the MR ligand (Chieppa 2003). 
It may therefore be of importance to further characterize the pro/anti-inflammatory roles 
of the carbohydrate ligands presented by biomaterials, given these findings.   
 It may also be important to characterize a panel of commonly adsorbed proteins 
on biomaterial surfaces that are likely sources of associated carbohydrate moieties. For 
instance, this panel of proteins may be composed of IgG, fibronectin, vitronectin, 
fibrinogen, complement-3 and IgA. The known glycosylations associated with these 
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proteins vary: N-linked glycans with fucose are present on IgG  (Jefferis 1990) and 
fibronectin contains one N-glycosylation and IgA includes terminal sialic acid, galactose 
and GalNAc groups (Xu 2005). Complement-3 contains glucosylated N-linked glycans 
(Crispin 2004), while fibrinogen possesses N-linked glycans  (Henschen-Edman 2001) 
and  vitronectin possesses N-linked glycans and sialylations (Uchibori-Iwaki 2000).  
The CLR family of DC PRRs recognize carbohydrates on pathogens primarily via 
Ca-dependant interactions (formation of co-ordinate and hydrogen bonds) (Weis 1996) 
and possess single (type II) or multiple (type I lectin) carbohydrate recognition domains 
(Figdor 2002; McGreal 2004). The Ags endocytosed by different CLRs were processed 
via MHC class II pathways as reported in (Cobb 2004) but reached different cytosolic 
compartments. For instance although MR and DEC-205 (homologous to MR) (Jiang 
1995; Engering 2002; Chieppa 2003) targeted Ags to early endosomes away from MHC 
II complexes and were less efficient at Ag delivery (Mahnke 2000; Hawiger 2001; 
Chieppa 2003), ASGPR (Valladeau 2001) targeted Ags to late endosomes (Mahnke 2000; 
Hawiger 2001; Chieppa 2003). So far, Dectin-1 receptor that possesses an intracellular 
ITAM and binds ß-glucans (Rogers 2005; Brown 2006) has been the only DC CLR 
implicated in Syk-mediated signaling (Keystone 1977; Yokota 2001; Hoebe 2003; 
Rogers 2005; Brown 2006; Dillon 2006). Furthermore, yeast zymosan-dectin-1-mediated 
enhancement of NF- кB activation by ligand binding to TLR 2 has also been implicated 
(Young 2001; Gantner 2003; Brown 2006). While zymosan-treated DCs had reduced 
abilities to stimulate CD4+ T lymphocytes and co-delivery of zymosan with OVA in 
mice resulted in anti-inflammatory interleukin-10 (IL-10) secretion and in suppression of 




lipoarabinomannan (ManLAM) to DC-SIGN skewed the response from 
a pro-inflammatory Thelper1 (Th1) response to a Th2 response (Jiang 1995; van Kooyk 
2003), in contrast, other CLRs such as MR, that play a significant role in mediating the 
fusion of macrophages and the formation of FBGCs (McNally 1996), may be associated 
with pro-inflammatory effects. This is supported by findings that certain CLRs possess 
intracellular ITAM (Keystone 1977; Yokota 2001; Hoebe 2003; Rogers 2005; Brown 
2006; Dillon 2006) motifs, while others posses ITIM residues (Kanazawa 2002). Taken 
together, the emerging model of PRRs and their ligands indicates that the specific 
carbohydrate ligand bound is important, since the same or different carbohydrate ligands 
may target a different complex network of DC CLRs and other PRRs and hence trigger 
differential DC responses.  
A clear link also exists in the literature between altered glycosylations and disease 
progression (Johnson 2000; Kanoh 2004; Patwa 2006). While normal host proteins have 
relatively low terminal mannose, fucose or GlcNAc (Lee 1991; McGreal 2004), disease 
states are associated with alterations in protein glycosylations.  Tumors have been 
associated with increased sialylation, mannosylation, fucosylation (Tabares 2006) and 
reduction in O-glycan lengths (Turner 1992; Brockhausen 1999).  Liver disease is 
associated with lowered sialylation and increased glycan branching (Turner 1992; 
Tabares 2006) and rheumatoid arthritis by increased fucosylation and presence of sialyl 
Lewis X on alpha-1-acid glycoprotein (Elliott 1997; Havenaar 1998). Finally, it was 
observed that iDCs expressing DC-SIGN, but not mDCs, interacted with 
carcinoembryonic antigen (CEA) having higher Lewis x or Lewis y Ag levels on colon 
epithelial tumor cells than on CEA of normal cells (Okuyama 1998; Cambi 2005; van 
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Gisbergen 2005). Another line of speculation therefore, is that if the proteins adsorbed to 
the biomaterial have undergone conformational changes as reported previously 
(Keselowsky 2003) and hence present an altered profile of carbohydrates, the biomaterial 
may appear analogous to diseased states to circulating immune cells, including migrating 
DCs.  
 These results suggest that different chemically defined biomaterials differentially 
modulate carbohydrate presentation on the adsorbed protein layers, possibly due to 
differences in types or amounts or both of adsorbed proteins. Glycosylations in PAMPs 
or altered glycosylations in diseases initiate DC recognition, and in the same way, 
glycosylations presented by biomaterials may impact DC maturation in a CLR-mediated 
manner. This study is significant as it provides another class of biomolecules which may 












IMMUNOBLOT ANALYSIS OF PROTEIN ELUATES FROM SELF-
ASSEMBLED MONOLAYER SURFACES 
 
INTRODUCTION:  
 New advances in the field of tissue engineering (TE) include the generation of TE 
combination products. These implants that are composed of biomaterial as well as 
biological components are designed to ultimately overcome the current scarcity of organs 
available for transplantation. The field of biomaterials has made rapid strides to meet the 
growing demands for synthesizing biomaterial components of TE products. The 
biomaterial component is crucial in regulating cell adhesion, proliferation, differentiation, 
survival, migration and vascularization. Besides, it is important that the biomaterial be 
biocompatible, have strong physical and mechanical properties and exhibit controlled 
degradability in vivo (Peppas 1994; Hubbell 1995; Ratner 1996; Langer 2004).  
The success of TE devices depends to a large extent on the utilization of optimal 
biomaterials for the specific application, the functionality of the biological component in 
vivo and the capacity of the combination product to be well-assimilated into the host 
immune/inflammatory system (Ratner 1996). With combination products, a non-specific 
inflammatory response may be elicited against the biomaterial component, as has been 
widely studied by several groups (Anderson 1988; Langer 1993; Tang 1995; Ratner 
1996; Sefton 2000). This phenomenon includes a series of processes initiating from the 
non-specific adsorption of host proteins almost instantaneously onto the surfaces of the 
biomaterial (Brash 1987). Subsequently, phagocytic cells such as neutrophils are attracted 




macrophages. These macrophages direct lymphocyte responses and mediate key phases 
of the foreign body response and the formation of the fibrous capsule, while themselves 
remaining throughout at implant sites and eventually fusing to form foreign body giant 
cells (FBGCs) (McNally 1996; Anderson 2000; Brodbeck 2002a; MacEwan 2005; Xia 
2006; Kao 2007; Van den Beucken 2007). The host inflammatory response is eventually 
replaced by a wound healing phase that is accompanied by the formation of fibroblast- 
mediated scar tissue formation (Ratner 1996). 
In addition to the non-specific inflammatory response generated against the 
biomaterial component, the biological component may trigger a specific adaptive 
immune response (Babensee 1998a). This immune response may be exacerbated or 
lessened by the biomaterial component, implying a biomaterial-mediated adjuvant effect 
(Babensee 1998a). Based on their specific surface and bulk properties, biomaterials may 
stimulate a broad range of immune responses. As adjuvants operate by triggering 
dendritic cell (Tabares 2006) maturation, biomaterials may regulate DC responses and 
hence facilitate DC-orchestrated host responses (Babensee 1998a; Yoshida 2004; 
Babensee 2005). Furthermore, DCs, another class of antigen presenting cells (APCs) such 
as macrophages, are pivotal in connecting innate and adaptive immunity and are an 
important immune cell type to focus on for studying fundamental host-biomaterial 
interactions (Cella 1997b; Medzhitov 1997; Banchereau 1998a; Janeway 2002). While 
previous studies have confirmed a central role for macrophages in controlling the host 
inflammatory response (Anderson 2001; Anderson 2004), emerging studies have 
suggested a role of DCs, that are more powerful initiators of adaptive immunity than 




2001), as principal directors of host immune responses. An exacerbation of the host 
response against combination devices due to bi-directional interactions between 
biomaterials and DCs may ultimately lead to device failure and diminish implant 
performance (Babensee 1998a). Hence, a clear understanding of the effects of 
biomaterials on host responses is critical.  
 In this work, model self-assembled monolayers (SAM), a robust, well-described 
system with controlled surface properties (Mrksich 1996; Lindblad 1997; Harder 1998; 
Sigal 1998; Kalltorp 1999; McClary 2000; Tegoulia 2000; Shen 2001; Barbosa 2003; 
Keselowsky 2003; Schwendel 2003; Dadsetan 2004) were used to examine the profiles 
and compositions of spontaneously adsorbed host proteins associated with SAM surfaces 
that presented different terminal endgroup chemistries. Since protein adsorption 
represents an initial, significant event in the host response and is directed by surface 
properties including chemistry, hydrophobicity/hydrophilicity, and charge, the effects of 
varying these characteristics were assessed in this study. The types of proteins adsorbed 
are important as they may differentially allow or inhibit immune/inflammatory cell 
adhesion, survival and differentiation and hence influence the ensuing response (Brash 
1987; Ratner 1996; Collier 1997; Kao 1999; Jenney 2000; Sefton 2000; Collier 2002; 
Gorbet 2004). Furthermore, the presence of distinctly pro- or anti-inflammatory proteins 
may activate or passivate adherent cells and hence indirectly control recruitment of other 
cells (Anderson 1988; Tang 1993a; Tang 1995; Ratner 1996). 
 In this study, proteins associated with different SAM chemistries were 
characterized using sodium dodecyl sulfate (SDS) - polyacrylamide gel electrophoresis 




filtered heat inactivated human serum (HS) or 1% (v/ v) filtered heat inactivated human 
plasma (HP) proteins. Identical serum/plasma preparations were used in previous studies 
characterizing DC responses to the same set of SAM chemistries and were hence used 
here as pre-adsorbing medias. The proteins present in HP or HS were probed using anti-
human polyclonal antibodies and specifically included cell-adhesive proteins, 
complement or coagulation proteins, pro-inflammatory proteins and those present in 
abundance such as albumin or immunoglobulin (IgG). Briefly, differential protein 
profiles were observed in eluates from different SAM chemistries following exposure to 
filtered HS or HP or from unfiltered HS or HP controls. Notably, weak band intensities 
from gels as well as lower amounts of adsorbed protein from radiolabeling experiments 
implied least presence of certain pro-inflammatory mediators of host cell activation such 
as fibrinogen on CH3 SAM endgroups compared to OH, COOH or NH2 SAM with 
filtered HP. With filtered HS, several clotting factors that were observed on OH, COOH 
or NH2 SAM, were absent on CH3 SAM. Finally, the types of medias, concentrations and 
filtration effects employed were found to be extremely important in determining the 
profiles of adsorbed proteins on the different biomaterial surfaces. 
  
METHODS: 
Self-Assembled Monolayer Preparation  
 Self-assembled monolayer (SAM) surfaces were assembled on 35 mm X 10 mm 
sterile, tissue culture (TC)- treated, non-pyrogenic polystyrene (Phillips 2005) dishes 
(Corning, Corning, NY) (Keselowsky 2003) used for HS or HP adsorption and elution 




assembled on both sides of 9 mm X 9 mm glass coverslips (Bellco Glass, Inc., Vineland, 
NJ) for protein quantification assays. Clean dishes or coverslips were coated sequentially 
with 50 Å Ti followed by 150 Å Au films using an electron beam evaporator (CVC 
Products/ Veeco, Rochester, NY) on the bases of the dishes as described in (Keselowsky 
2003), or on both sides of the coverslips and stored under vacuum at room temperature 
(RT) until two weeks until used.  The following alkanethiols were used as received from 
commercial sources (1 mM in absolute ethanol): 1-dodecanethiol (SH-(CH2)11-CH3) 
(CH3 SAM), 11-mercapto-undecanol (HS-(CH2)11OH) (OH SAM), 11-
mercaptoundecanoic acid (HS-(CH2)10-COOH) (COOH SAM), (Aldrich Chemical, 
Milwaukee, WI) and 11-amino-1-undecanethiol, hydrochloride (C11H26ClNS) (NH2 
SAM) (Dojindo Laboratories, Gaithersburg, MD). The SAMs were allowed to assemble 
by 12 hr incubation at RT by immersing the Ti/Au- coated dishes in alkanethiol solutions. 
Following this, the dishes were washed with 95% ethanol (Sigma, St. Louis, MO) dried 
with N2 gas (Airgas South, Chamblee, GA) for 10 minutes in a fume hood, equilibrated 
with Phosphate Buffered Saline (PBS) (Gibco, Grand Island, NY) for 5 minutes and used 
fresh. For coating both sides of the coverslips in alkanethiol solutions, the coverslips 
were immersed in polypropylene vials having outer diameter of 12.5 mm (VWR 
International, San Diego, CA) containing 2 mLs of 1 mM alkanethiol solution each, such 
that both Au/Ti-coated sides were constantly exposed to solution and the edges were in 
contact with the vial walls. Each vial containing coated coverslips was sealed with 
parafilm (VWR) individually and shipped as such at RT to Dr. John Brash‟s laboratory at 
McMaster University, Canada, and used immediately for radiolabeled fibrinogen 




coated on both sides from the coating SAM solutions, the coverslips were air-dried for 5 
minutes, equilibrated with PBS at RT for 5 minutes in separate vials and then placed in 
PBS in 24-well plates for 10 minutes at RT. Advancing contact angles of CH3, OH 
COOH or NH2 SAM surfaces were measured to be 108  2º C, 24  5º C, 31  3º C or 35 
 4º C, respectively. Contact angle determinations were performed at Georgia Tech. 
Unmodified surfaces of TC-PS were used as controls. 
   
Radiolabeling of fibrinogen 
 A solution of human fibrinogen (Enzyme Research Laboratories Inc, South Bend, 
IN, USA) in isotonic Tris-buffered saline (TBS) (50 mM Tris base, 150 mM NaCl; pH 
7.4) was prepared, aliquotted and stored at -70C. The iodine monochloride method was 
employed to label fibrinogen with 
125
I (ICN Pharmaceuticals Inc, Radiochemical 
Division, Irvine, CA, USA). Following this, radiolabeled fibrinogen was flowed through 
an anion exchange column packed with AG-1-X4 resin (BioRad, Richmond, CA, USA) 
for removal of unbound radioactive iodide. The amount of unbound radioactive iodide 
that still remained in the labeled protein solution was measured to be less than 1%. This 
quantification was performed on the supernatant obtained following fibrinogen 
precipitation with trichloroacetic (Fisher Scientific, ON, Canada) (Gluck 2005) solution 
of 20% w/ v in water. In the final solution used, the ratio of labeled to unlabeled 
fibrinogen was maintained at 10%. 
 
Quantification of amounts of adsorbed or eluted fibrinogen  




15 minutes for surface hydration and then pre-incubated in 1 mL of 
125
I –labeled 
fibrinogen solution (0.5 mg/ mL) comprised of 10% of label and less than 1% free iodide 
for 60 minutes at RT and maintained throughout under static conditions (Mulzer 1989; 
Cornelius 1994; Babensee 1998b). For these adsorption studies, PBS solution comprising 
5% NaI was used, since the presence of low levels of non-radioactive iodide was 
observed to reduce non-specific binding of 
125
I- to Au surfaces. This may be significant, 
as Au-I interactions may result in the formation of complex ionic species including AuI2- 
and AuI4-, that may then interfere with protein adsorption. 
The surfaces were then rinsed three times for 2 minutes each with 3 mLs of PBS-
NaI at RT to remove residual non-adsorbed fibrinogen. After this, the surfaces were 
wicked onto filter paper (Bio-Rad) to remove any remaining buffer. The surface 
radioactivity was then measured in conjunction with calibration solutions, as necessary. 
This procedure was followed on four coated coverslips per SAM chemistry, per 
experiment. All observations were recorded in triplicate. To elute the adsorbed protein, 
the surfaces were incubated in 10% SDS/ 2.3% dithioerithritol (DTE) (both from Sigma) 
eluting solution in de-ionized (DI) water on a shaker at RT for 24 hours. The surfaces 
were then rinsed three times with PBS to remove traces of the eluting solution. Finally 
the radioactivity associated with the eluate as well as with the surfaces was determined. 
Again, four replicates were analyzed per surface chemistry in each experiment and all 
experiments were performed in triplicate. 
 
Preparation of human plasma (HP) or human serum (HS) 




according to a protocol approved by the Institute Review Board (IRB) # H05012. All 
subjects enrolled in this research signed an Informed Consent which was approved by the 
IRB of Georgia Institute of Technology. Peripheral human blood was collected using 
sterile 60 mL syringes (Becton Dickinson, Franklin Lakes, NJ) and needles (Becton 
Dickinson) using heparin (333 U/ mL blood) (Baxter Healthcare Corporation, Deerfield, 
IL) as an anticoagulant. The clear yellowish HP layer was separated using lymphocyte 
separation medium (LSM) (Cellgro MediaTech, Herndon, VA) by differential gradient 
centrifugation of blood diluted 1:1 with sterile PBS (400 g, 30 minutes, RT) (Thermo 
Fisher Scientific Inc., Waltham, MA) (Model # 5682, Rotor IEC 216), filtered sterilized 
(0.22 µm) (Corning) and heat inactivated for 30 minutes in a water bath pre-warmed to 
56°C, aliquotted and stored at -20°C. Alternatively, plasma was heat inactivated but left 
unfiltered in order to examine the effects of sterile filtering on the plasma proteins. A 
stock solution of pooled HP from three donors was used for experiments for either 
filtered HP or for control unfiltered HP.  
  On the other hand, for preparation of HS, peripheral human blood was drawn in 
the absence of heparin, to allow for fibrin clot formation.  The non-heparinized blood was 
centrifuged (3000 rpm, 10 minutes, RT) after clots were compressed manually with a 
sterile pipette tip, as needed and maintained at RT for 90 minutes in the TC hood. 
Resultant HS was collected and cleared by further centrifugations at 3000 rpm for 15 
minutes. Again, as necessary, residual precipitates were pressed down and the HS was 
filter sterilized (0.22 µm) and heat inactivated for 30 minutes in a water bath pre-warmed 
to 56°C, aliquotted and stored at -20°C. Alternatively, serum was heat inactivated but left 




experiments for either filtered HS or for control unfiltered HS.  
 
Adsorption and elution of HS or HP proteins from biomaterial surfaces 
The SAM surfaces were pre-incubated with 3 mLs/ dish of solutions of 10% 
filtered heat-inactivated HS or with 1% filtered heat-inactivated HP in PBS at RT for 1 
hr. After this, the HS or HP solutions were removed and the dishes were washed three 
times for 5 minutes each with PBS at RT to remove residual non-adsorbed HS or HP 
proteins. To remove adsorbed proteins the SAM-coated dishes were then incubated in 1 
mL/ dish of 10% SDS/2.3% DTE eluting solution in DI water on a shaker at RT for 24 
hours. Samples of pre-adsorbing HS or HP solutions prior to and after incubation and of 
protein eluates from each SAM chemistry were collected, stored in low retention, 1.7 mL 
PS vials (VWR) at -20ºC at Georgia Tech and shipped overnight on dry ice to McMaster 
University for further analysis. 
 
Polyacrylamide gel electrophoresis and immunoblot analysis of eluates from different 
biomaterial surfaces 
 Polyacrylamide gel electrophoresis and immunoblot analyses were performed to 
characterize the profiles of HS or HP proteins in eluates from different SAM chemistries 
or from control PS surfaces, based on methods described elsewhere (Mulzer 1989; 
Cornelius 1994; Babensee 1998b). Briefly, solutions composed of SDS - proteins from 
serum, plasma or eluate samples (protein concentration 0.4-0.5 mg/ mL; 1 to 150 μL, 
depending on the protein concentration) were reduced with β-mercaptoethanol (Bio-Rad) 




polyacrylamide separating gels and a 4% (w/ v) stacking gel, prepared based on 
previously described protocols. After proteins were separated based on size by SDS-
PAGE (200 V, 45-50 minutes), the proteins were electrophoretically transferred onto an 
Immobilon PVDF membrane (Millipore, Bedford, MA, USA). The transferred proteins 
were blocked for 1 hour with 0.3% Tween 20 (Bio-Rad) in TBS and then rinsed with 
water. Unbound sections of the membrane were stained overnight using Protogold 
solution (Bio-cell Research Laboratories, Cardiff, UK, distributed by Cedarlane 
Laboraties, Hornby, ON, Canada) to identify positions of protein bands.  
 Immunoblot analysis was also performed based on previously established 
protocols (Mulzer 1989; Cornelius 1994; Babensee 1998b).  Alternatively, after proteins 
were separated based on size by SDS-PAGE (200 V, 45-50 minutes) and transferred, the 
membrane was cut into 3 mm strips and blocked with a 5% (w/ v) solution of blocking 
buffer [nonfat dry milk in TBS] for 1 hour. The strips were then treated with 1:1000 
dilutions of desired primary antibodies generated in goat (Table 9) in solutions of 1% (w/ 
v) nonfat dry milk and 0.05% (v/ v) Tween 20 in TBS for 1 hour, then rinsed three times 
for five minutes each with 0.1% (w/v ) nonfat dry milk in TBS. Bound antibodies were 
detected using 1:1000 dilutions of secondary antibodies (Table 10) conjugated with 
alkaline-phosphatase (AP) in 1% (w/ v) nonfat dry milk and 0.05% (v/ v) Tween 20 in 
TBS and 5-bromo-4chloro-3-indonyl phosphate (BCIP) and nitro-blue tetrazolium (NBT) 
(both from Bio-Rad). This experiment was run in parallel with pre-stained molecular 





Table 9: Proteins probed for on immunoblots along with corresponding hosts and 
commercial sources of antibodies 
 
Antibody Host Source 
Factor XI  Goat Cedarlane Laboratories, Hornby, ON, Canada  
Factor XII  Goat Cedarlane Laboratories, Hornby, ON, Canada 
Prekallikrein Sheep Cedarlane Laboratories, Hornby, ON, Canada 
HMWK Goat Cedarlane Laboratories, Hornby, ON, Canada 
Fibrinogen Goat Cedarlane Laboratories, Hornby, ON, Canada 
Plasminogen Goat Sigma, St. Louis, MO, USA 
ATIII  Sheep Cedarlane Laboratories, Hornby, ON, Canada 
Complement Factor C3 Goat Calbiochem, Behring Diagnostic, La Jolla, CA, 
USA 
Transferrin Goat Sigma, St. Louis, MO , USA 
Alpha-1-antitrypsin Goat Cedarlane Laboratories, Hornby, Ontario, 
Canada 
Fibronectin Rabbit Cedarlane Laboratories, Hornby, Ontario, 
Canada 
Albumin Goat Cedarlane Laboratories, Hornby, Ontario, 
Canada 
IgG Goat Sigma, St. Louis, MO, USA 
Beta-lipoprotein Goat Sigma, St. Louis, MO, USA 
Alpha-2-macroglobulin Goat Sigma, St. Louis, MO, USA 
Vitronectin  Sheep Cedarlane Laboratories, Hornby, Ontario, 
Canada 
Complement Factor B Goat Calbiochem, Behring Diagnostic, La Jolla, CA 
Complement Factor H Goat Calbiochem, Behring Diagnostic, La Jolla, CA 
Complement Factor I Goat Calbiochem, Behring Diagnostic, La Jolla, CA 
Apolipoprotein A1 Goat ESBE, Markham, ON, Canada 
Prothrombin Sheep Cedarlane Laboratories, Hornby, Ontario, 
Canada 





Table 10: Alkaline-phosphate conjugated secondary antibodies used in 
immunoblotting and corresponding commercial sources 
 
Secondary Antibody Source 
Rabbit Anti Goat IgG Alkaline Phosphatase Conjugate  Sigma Chemical Co., St. 
Louis, USA 
Rabbit Anti Sheep IgG Alkaline Phosphatase Conjugate  Bethyl Laboratories Inc.,  
Montegomery, TX, USA 
Goat Anti Rabbit IgG Alkaline Phosphatase Conjugate  Bio-Rad Laboratories, 




 Statistical analysis was performed using general linear model analysis of variance 
(Young) with Minitab software (Version 13.20, Minitab Inc., State College, PA) using 
pairwise comparisons between SAMs and a Tukey post-test. A p value of less than or 
equal to 0.05 was considered as significant. 
 
RESULTS: 
Gold-stained gels of proteins present in filtered or unfiltered HS or HP 
 Differential presence of proteins bands were observed between gold-stained gels 
of filtered or unfiltered HS and filtered or unfiltered HP solutions used for pre-incubation 
on control PS surfaces or on different SAM chemistries (Figure 7-1). In general, more 
protein was detected in unfiltered HS (Figure 7-1b) or unfiltered HP (Figure 7-1d) 
compared to filtered HS (Figure 7-1a) or filtered HP (Figure 7-1c), respectively, given 





    
 
Figure 7-1:  Gold stained gels of proteins present in filtered or unfiltered HS or 
filtered or unfiltered HP. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
filtered (a) or unfiltered (b) HS or filtered (c) unfiltered (d) HP proteins. These proteins 
were then transferred to a PVDF membrane and gels were stained with gold. 
 
Gold-stained gels of proteins eluted from control PS surfaces following pre-adsorption 
with either filtered or unfiltered HS or HP 
 Differential presence of proteins bands were observed between gold-stained gels 
of eluates from control PS surfaces that were pre-adsorbed with either filtered or 




































Figure 7-2:  Gold stained gels of proteins eluted from control PS surfaces following 
exposure to filtered or unfiltered HS or filtered or unfiltered HP. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
filtered (a) or unfiltered (b) HS or filtered (c) unfiltered (d) HP proteins present in eluates 
from control PS surfaces. These proteins were then transferred to a PVDF membrane and 
gels were stained with gold. 
 
Gold-stained gels for protein eluates from different SAM chemistries 
 The proteins associated with control PS surfaces or with different SAM 
chemistries were detected using gold-stained gels (Figure 7-3). Proteins bands of 
different molecular weights were observed in eluates from all biomaterials examined, 
following pre-incubation with either filtered HS (Figure 7-3a) or filtered HP (Figure 7-





























Figure 7-3: Gold stained gels of proteins eluted from control PS surfaces or from 
different SAM chemistries following exposure to either filtered HS or filtered HP.  
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
proteins eluted from control PS or from different SAM chemistries following exposure to 
either filtered HS (a) or to filtered HP (b). [PS, CH3 SAM, OH SAM, COOH SAM or 
NH2 SAM] (bandwise from left to right). These proteins were then transferred to a PVDF 
membrane and gels were stained with gold. 
 
Amounts of adsorbed, eluted and bound fibrinogen on different SAM chemistries 
To examine the possibility that the differential presence of proteins associated 
with different SAM chemistries was due to differential elutability of proteins, the 
amounts of adsorbed, eluted or bound radiolabeled fibrinogen associated with the 
different surfaces were assessed.  Significantly higher protein was adsorbed to COOH or 
NH2 SAM surfaces as compared to protein adsorbed to CH3 or OH SAM surfaces. Also, 
significantly higher bound protein remained on COOH or NH2 SAM surfaces after 
elution as compared to CH3 or OH SAM surfaces (Figure 7-4a). The percentage of 




from COOH SAM was 67± 8%, and from NH2 SAM was 77± 8%, (Figure 7-4b). 
Overall, higher elution of fibrinogen was achieved with OH or CH3 SAM surfaces than 
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Figure 7-4: Higher amounts of adsorbed, eluted or bound fibrinogen were 
associated with COOH or NH2 SAM endgroups compared to OH or CH3 SAM 
endgroups. However, higher elution of adsorbed fibrinogen could be achieved on 
CH3 or OH SAM endgroups. 
Amounts of adsorbed, eluted or bound fibrinogen on different SAM chemistries are 
shown in (a) and percentages of eluted proteins from different chemistries in (b). Data 
presented as mean ± S.D, n=12 wells revealed statistical significance of findings; „*‟ 
indicates lower levels of adsorbed fibrinogen, „#‟ indicates lower levels of eluted 
fibrinogen, „^‟ indicates lower levels of bound fibrinogen post-elution compared to other 
SAM endgroups, p≤0.05. 
 
Immunoblot analysis of proteins present in pre-incubating unfiltered or filtered HS or HP  
As expected, several HS or HP proteins were detected in serum or plasma samples 
used for incubation with control PS or SAM surfaces. For filtered HS (Figure 7-5a, Table 
11), these included strong as well as faint bands in certain cases corresponding to 




HMWK, plasminogen, antithrombin, C3, transferrin, α1-anti-trypsin, fibronectin, 
albumin, IgG, α2-macroglobulin, vitronectin, Factor B or Factor H, Factor I, 
apolipoprotein A1 or prothrombin. Certain proteins including β-lipoprotein or 
hemoglobin were non-detectable (n.d) (Figure 7-5a, Table 11). Fibrinogen although 
detected ~ 67 kDa, was present as very faint bands. Bands of fibrinogen at ~58, ~47 kDa 
were n.d. 
As expected a differential profile of proteins were present in filtered HP solutions 
used for pre-adsorption. To summarize, the protein profiles in filtered HP included strong 
as well as/or faint bands in certain cases corresponding to presence of intact or degraded 
fragments of fibrinogen, plasminogen, antithrombin, C3, transferrin, albumin, IgG, α2-
macroglobulin, vitronectin, Factor B, Factor H, Factor I or apolipoprotein A1. Certain 
proteins including fibronectin, α1-anti-trypsin or β-lipoprotein were n.d (Figure 7-5b, 
Table 12). On the other hand, although the profiles of plasma proteins that were 
detectable in filtered HP were similar to those in unfiltered HP, certain differences did 
exist. To summarize, the protein profiles in unfiltered HP (Table 13) included strong as 
well as faint bands in certain cases corresponding to presence of intact or degraded 
fragments of Factor XI, Factor XII, pre-kallikrein, HMWK, fibrinogen, plasminogen, 
antithrombin, transferrin, α1-anti-trypsin, albumin, IgG, C3, vitronectin, Factor B or 
Factor H, Factor I, apolipoprotein A1 or α2-macroglobulin. Certain proteins including 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7-5: Presence of bands corresponding to several major HS or HP proteins in 
either filtered HS or filtered HP as expected, from immunoblotting experiments. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
proteins in either filtered HS (a) or filtered HP (b). Prestained molecular weight 
standards, shown on the right side, were used to estimate the molecular weight of the 
bands. Serum or plasma concentration, intact molecular weights and intensities of major 





Immunoblot analysis of proteins present in eluates from control PS surfaces pre-
incubated with either filtered or unfiltered HS or HP 
 Certain HS or HP proteins that were detected in pre-adsorbing filtered plasma or 
serum (Figure 7-5) were also detected in eluates from control PS surfaces (Figure 7-6). 
For instance, bands corresponding to the presence of Factor XI, Factor XII, fibrinogen 
(again only at ~67 kDa and very faint), plasminogen, C3, antithrombin, transferrin, α1-
anti-trypsin, albumin, IgG, α2-macroglobulin, vitronectin, Factor B, Factor H, Factor I, 
apolipoprotein A1 or prothrombin were present in eluates from control PS surfaces 
(Figure 7-6a, Table 11) that were pre-incubated in HS. Presence of proteins such as pre-
kallikrein, HMWK, hemoglobin or β-lipoprotein was n.d (Figure 7-6a, Table 11). 
 Pre-adsorption of control PS surfaces with filtered HP led to the following profile 
of adsorbed proteins including, fibrinogen, C3, transferrin, albumin, IgG, vitronectin, 
apolipoprotein A1, antithrombin or prothrombin (Figure 7-6b). In contrast, certain other 
proteins such as plasminogen, α2-macroglobulin, Factor B or Factor H that were present 
with unfiltered HP eluates (Table 13) were not present in filtered HP eluates (Figure 7-









































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7-6: Immunoblot of HS or HP proteins present in eluates from control PS 
surfaces preabsorbed with either filtered HS or filtered HP proteins. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
proteins present in eluates from control PS surfaces that were preadsorbed with either 
filtered HS (a) or filtered HP (b). Prestained molecular weight standards, shown on the 
right side, were used to estimate the molecular weight of the bands. Serum or plasma 
concentration, intact molecular weights and intensities of major bands are listed in Table 




Comparisons of Immunoblot analyses of proteins present in eluates from different SAM 
surfaces pre-incubated with either filtered or unfiltered HS or HP 
Interestingly, differential profiles of adsorbed proteins were observed in eluates 
from different SAM chemistries; CH3 (Figure 7-7), OH (Figure 7-8), COOH (Figure 7-9) 
or NH2 (Figure 7-10) as summarized below and shown in Tables 11 or 12 following 
exposure to 10% filtered HS or to 1% filtered HP. With filtered HS, bands at ~60 kDA 
(Factor XI), ~80 kDA (Factor XII), ~55 kDa (pre-kallikrein), fibrinogen, ~95, 96 kDA 
(plasminogen), ~57 kDa (α1-anti-trypsin) or ~93 kDa (prothrombin) were detected in 
eluates from OH, COOH or NH2 SAM or in PS eluates, but not in CH3 SAM eluates. 
Also, multiple protein fragments corresponding to the presence of hemoglobin were 
present in eluates from OH, COOH or NH2 SAM, but could not be detected on CH3 SAM 
or in PS eluates. Finally, bands corresponding to the presence of antithrombin, C3, 
transferrin, albumin, IgG, α2-macroglobulin, vitronectin, Factor B, Factor H, Factor I, 
apolipoprotein A1 were detected in eluates from all SAM chemistries (Figures 7-7a to 7-
10a, Table 11), similar to control PS (Figure 7-6a), while HMWK and β-lipoprotein were 
n.d on any surface. 
With pre-adsorbing filtered HP as well, subtle differences in intensities of bands 
for plasma proteins were observed based on chemistry. Lower band intensities were 
observed for pro-inflammatory fibrinogen present as three distinct bands at ~ 67, ~ 58 
and ~ 47 kDa (absent versus very faint) in the eluates from CH3 SAM surfaces (Figure 7-
7b) compared with eluates from other SAM surfaces or control PS surfaces (Figure 7-6b 
to 7-10b, Table 12). In addition, lower band intensities corresponding to presence of C3 




SAM surfaces (Figure 7-7b) compared with eluates from COOH or NH2 SAM surfaces or 
control PS (Figure 7-6b, 7-9b to 7-10b, Table 12). It is likely that the low molecular 
weight fragments of C3 were generated during heat-inactivation of plasma. Bands 
corresponding to the presence of adhesive protein vitronectin at ~ 75, ~ 65 kDa (very 
faint versus faint) were also weaker in eluates from CH3 SAM (Figure 7-7b, Table 12) as 
compared to COOH or NH2 SAM (Figure 7-9b to 7-10b) or compared to control PS (v. 
faint versus strong) (Figure 7-6b). Finally, lower band intensity of anti-inflammatory 
protein albumin at ~ 66kDa (faint versus strong) was observed for eluates from CH3 
SAM (Figure 7-7b, Table 12) or OH SAM (Figure 7-8b) as compared to other endgroups 
or control PS (Figure 706b). With eluates from OH SAM, no bands corresponding to the 
presence of C3 or vitronectin were detected and faint bands for albumin (Figure 7-8b, 
Table 12). Strong bands corresponding to the presence of apolipoprotein A1 were 
detected in eluates from all SAM endgroups (Figure 7-7b to 7-10b, Table 12).  
Finally, with unfiltered HP, faint bands at ~95, 96 kDa corresponding to presence 
of plasminogen, faint bands at ~110 kDa corresponding to antithrombin as well as faint 
bands at ~150 kDa corresponding to Factor H were detected only in eluates from COOH 
SAM, similar to on control PS (Table 13). In addition, faint bands at ~55 kDA (IgG) or 
~93 kDA (Factor B) were detected in eluates on CH3 or COOH SAM, similar to on 
control PS (Table 13), but not on the other SAMs. Also, faint bands at ~80 kDA 
(transferrin) or bands for prothrombin were detected in eluates of OH or COOH SAM, or 
on OH, COOH, NH2 SAM, respectively (Table 13). Finally, bands corresponding to the 
presence of fibrinogen, C3, albumin, vitronectin, apolipoprotein A1 were detected in 


































































































































































































































































































































































































































































































































































































































































































































































































Figure 7-7: Immunoblot of HS or HP proteins present in eluates from CH3 SAM 
surfaces preabsorbed with either filtered HS or filtered HP proteins. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
proteins present in eluates from CH3 SAM surfaces that were preadsorbed with either 
filtered HS (a) or filtered HP (b). Prestained molecular weight standards, shown on the 
right side, were used to estimate the molecular weight of the bands. Serum or plasma 
concentration, intact molecular weights and intensities of major bands are listed in Table 


































































































































































































































































































































































































































































































































































































































































































































































Figure 7-8 Immunoblot of HS or HP proteins present in eluates from OH SAM 
surfaces preabsorbed with either filtered HS or filtered HP proteins. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
proteins present in eluates from OH SAM surfaces that were preadsorbed with either 
filtered HS (a) or filtered HP (b). Prestained molecular weight standards, shown on the 
right side, were used to estimate the molecular weight of the bands. Serum or plasma 
concentration, intact molecular weights and intensities of major bands are listed in Table 










































































































































































































































































































































































































































































































































































































































































































































































































Figure 7-9: Immunoblot of HS or HP proteins present in eluates from COOH SAM 
surfaces preabsorbed with either filtered HS or filtered HP proteins. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
proteins present in eluates from COOH SAM surfaces that were preadsorbed with either 
filtered HS (a) or filtered HP (b). Prestained molecular weight standards, shown on the 
right side, were used to estimate the molecular weight of the bands. Serum or plasma 
concentration, intact molecular weights and intensities of major bands are listed in Table 









































































































































































































































































































































































































































































































































































































































































































































Figure 7-10: Immunoblot of HS or HP proteins present in eluates from NH2 SAM 
surfaces preabsorbed with either filtered HS or filtered HP proteins. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
proteins present in eluates from NH2 SAM surfaces that were preadsorbed with either 
filtered HS (a) or filtered HP (b). Prestained molecular weight standards, shown on the 
right side, were used to estimate the molecular weight of the bands. Serum or plasma 
concentration, intact molecular weights and intensities of major bands are listed in Table 




Table 11: Serum concentration, intact molecular weights and intensities of major 







Table 12: Plasma concentration, intact molecular weights and intensities of major 








Table 13: Plasma concentration, intact molecular weights and intensities of major 







 Gold-stained gels, immunoblot and PAGE analysis of protein eluates from control 
PS surfaces or from different SAM surfaces were performed to characterize the profiles 
of HS or HP proteins adsorbed to the different biomaterial surfaces. To summarize the 
results from the gold-stained gels, differential presence of protein bands were detected in 
pre-adsorbing solutions of filtered or unfiltered HS (Figure 7-1a or 7-1b) or in filtered or 
unfiltered HS eluates from all biomaterial surfaces (Figures 7-2a, b or 7-3a), compared to 
filtered or unfiltered HP solutions (Figure 7-1c or 7-1d) or corresponding filtered HP 
eluates (Figures 7-2c,d or 7-3b), respectively. From this study, it is evident that the types 
of incubating medias used strongly influence the profiles of proteins adsorbed to different 
biomaterial surfaces. It is also worth noting that the results, or interpretation of results, 
may be skewed depending on the media used. In addition, the effects of filtration should 
be taken into account, since it has been well-established that filtration via a 0.22 μm pore 
filter results in the removal of certain serum/plasma proteins. Lastly, the concentrations 
of incubating medias may also influence the results; higher concentration of proteins in 
10% HS may account for higher presence of proteins as compared to results shown for 
1% HP (Figure 7-3). With lower media concentrations, the possibility that highly 
abundant plasma/serum proteins are more easily detected than less abundant 
plasma/serum proteins cannot be excluded and may partly be responsible for faint/n.d 
presence of certain proteins especially with 1% HP. However, it should be emphasized 
that proteins adsorbed to biomaterial surfaces from 10% filtered heat inactivated HS or 
1% filtered heat inactivated HP are identical to serum/plasma used in DC media and 




In terms of protein adsorption amounts, higher protein was adsorbed to COOH or 
NH2 SAM endgroups compared to CH3 or OH SAM (Figure 7-4a). Also, higher protein 
remained bound to COOH or NH2 SAM endgroups after elution with SDS/DTE 
compared to CH3 or OH SAM (Figure 7-4a). While elutability of proteins from CH3 or 
OH SAM was comparable (86 ± 6% or 91± 3%), the percentage of protein that could be 
successfully eluted from COOH or NH2 SAM surfaces was lower and about 67± 8% or 
77± 8% respectively (Figure 7-4b). These results implied that the lower presence of 
various protein bands in CH3 SAM eluates compared to other SAM endgroups upon 
contact with filtered or unfiltered HS or HP solutions (Figure 7-7, Tables 11-13) was not 
due to lower protein elutability from these surfaces.  
The proteins characterized by immunoblotting in this study represent a subset of 
all the proteins in fact present in HS or HP. Since it is not feasible to test all HS or HP 
proteins, those proteins that are commonly associated with biomaterials were tested here.  
Immunoblot analyses for proteins present in filtered HS or in filtered or unfiltered HP 
have already been completed and presented here, while analyses for unfiltered HS are 
ongoing and will be included in the manuscript version of this chapter to be submitted for 
publication. Proteins have been eluted using SDS in several other studies (Babensee 
1998b), since SDS is not expected to disrupt material surfaces. The caveat to these results 
is that the proteins that were analyzed were SDS-elutable proteins and there may be 
proteins on the surface with which the cell can interact which are not SDS elutable and 
were hence not detected herein. The majority of proteins expected to be present in filtered 
pre-adsorbing HS or HP solutions were detected in Figures 7-5a or 7-5b. Specifically, in 




pre-kallikrein, HMWK, plasminogen, antithrombin, C3, transferrin, α1-anti-trypsin, 
fibronectin, albumin, IgG, α2-macroglobulin, vitronectin, Factor B or Factor H, Factor I, 
apolipoprotein A1 or prothrombin (Figure 7-5a, Table 11), although other proteins such 
as β-lipoprotein or hemoglobin were not present. In contrast, Factor XI, Factor XII, pre-
kallikrein, HMWK or α1-anti-trypsin were not detectable in filtered HP solutions (Figure 
7-5b, Table 12), but could be detected in unfiltered HP (Table 13). Fibronectin was n.d in 
both plasma preparations (Tables 12, 13). In addition, in pre-adsorbing filtered HS, 
multiple bands were detected for antithrombin III, possibly implying the formation of 
antithrombin III-complex (~93 kDa) (Figure 7-5a). For prothrombin also, multiple bands 
were present, not as intact prothrombin (e.g. at ~75 kDa), but as thrombin (~32 kDa) 
(Figure 7-5a). 
To summarize the immunoblot results for filtered HS eluates from control PS 
surfaces or from different SAM chemistries, several HS proteins that were adsorbed to 
control PS were also found associated with all SAM chemistries (Figures 7-6a to 7-10a, 
Table 11). This list comprised proteins such as antithrombin, C3, transferrin, albumin, 
IgG, α2-macroglobulin, vitronectin, Factor B, Factor H, Factor I or apolipoprotein A1. 
Additionally, certain clotting factors or other proteins that were present in control PS 
eluates were detected only in certain SAM eluates; Factor XI, Factor XII, pre-kallikrein, 
plasminogen, α1-anti-trypsin or prothrombin were present in OH, COOH or NH2 SAM 
eluates or in PS eluates, but not in CH3 SAM eluates. Furthermore, although vitronectin 
bands were detected at ~55 kDa and ~65 kDa in filtered HS eluates (Figures 7-6a to 7-
10a),  vitronectin was detected at ~65 kDa and ~75 kDa in plasma eluates, implying that 




suggest that the profiles of proteins on certain SAM endgroups more closely resembled 
those present on hydrophilic control PS surfaces; notably profiles of proteins present on 
hydrophobic CH3 SAM surfaces were least like those on PS surfaces or the other SAM 
surfaces (Figures 7-6a to 10a, Table 11).  
Focusing next on the profile of adsorbed proteins on control PS surfaces that were 
pre-incubated with filtered HP, fibrinogen, C3, transferrin, albumin, Factor H, IgG, 
vitronectin, apolipoprotein A1 or prothrombin (Figure 7-6b) were present similar to 
results observed for unfiltered HP (Table 13). However, plasminogen, α2-macroglobulin, 
Factor B or Factor H were no longer detected adsorbed to control PS, following filtration 
of pre-adsorbed HP. On the other hand, several unfiltered HP proteins that were adsorbed 
to control PS were also found associated with all SAM chemistries (Table 13). This list 
comprised proteins such as fibrinogen, C3, albumin, vitronectin, apolipoprotein A1. 
Additionally, certain proteins that were present in control PS eluates were detected only 
in certain SAM eluates; plasminogen or Factor H were only in COOH SAM eluates, 
Factor B or IgG was in both CH3 and COOH SAM eluates, while transferrin or 
prothrombin were present in OH or COOH SAM eluates or in OH, COOH or NH2 SAM 
eluates, respectively. Taken together, these results suggest that for unfiltered HP, proteins 
present on anionic hydrophilic COOH SAM surfaces closely resembled those present on 
hydrophilic control PS surfaces, notably (Table 13). 
  The SAM chemistries used in this study have been previously characterized by us 
(CHAPTER 6) and others (Mrksich 1996; Kalltorp 1999; Tegoulia 2000; Shen 2001; 
Capadona 2003; Schwendel 2003), (Maoz 1988; Ulman 1991; Whitesides 1991). The 




carboxyl (-COOH) or amine (-NH2) and were shown to be hydrophobic, neutral 
hydrophilic, anionic hydrophilic or cationic hydrophilic respectively. The SAMs are 
composed of alkanethiols [e.g., CH3(CH2)nSH] that are covalently attached to Au/Ti-
coated substrates and hydrophobic chains composed of about 10-12 C atoms tightly 
packed together to exclude water. Profiles, conformations and amounts of adsorbed 
proteins have been shown to vary as a function of surface chemistry. Specifically, more 
pro-inflammatory fibrinogen was associated with OH SAM as compared to CH3 SAM 
(Tegoulia 2000), though this result was controversial (Shen 2001; Dadsetan 2004; 
Barbosa 2005a). More recently, the adsorption of human fibrinogen was demonstrated to 
decrease with increased presence of OH in the monolayer (Rodrigues 2006). In this 
study, weaker band intensities corresponding to fibrinogen were detected on CH3 SAM, 
among filtered HP eluates (Table 12) or fibrinogen bands were absent on CH3 SAM with 
filtered HS (Table 11), as well as lower amounts were present on CH3 SAM from 
radiolabeling experiments (Figure 7-4a). Furthermore, higher presence of pro-
inflammatory C3 (Hirata 2003) was measured on OH SAM than on CH3 SAM. Although 
lower band intensities corresponding to C3 were detected in CH3 SAM eluates in 
agreement with this finding, non-detectable levels were present in OH SAM eluates, 
following pre-adsorption with filtered HP (Table 12), possibly due to the high affiliation 
of C3b for OH SAM (Ratner 1996). Also, highest amounts of human IgG were detected 
on CH3 SAM compared to OH, COOH or NH2 SAM (Silin 1997). Interestingly, although 
bands indicating IgG could be detected on control PS, CH3 or COOH SAM eluates with 
unfiltered HP (Table 13), the presence of IgG could only be detected on control PS 




filtered HP (Table 12). Also, adsorption of anti-inflammatory protein albumin was higher 
on CH3 SAM compared to either OH or COOH SAM (Martins 2003). Finally, bands 
corresponding to the presence of apolipoprotein A1 were detected in eluates from 
different SAM treatments. The significance of this finding may be further examined with 
reference to the profiles of lipid or carbohydrate post-translational modifications present 
on apolipoprotein A1 (Dayal 2002; Zannis 2006) that may act as ligands for DC C-type 
lectin receptors (CLRs) or scavenger receptors (SRs), with different chemistries.  
 Extending this discussion of protein profiles to resultant responses of 
immune/inflammatory cells to different SAM chemistries, platelet adhesion and 
activation was reduced with greater hydrophilicity (increased –OH groups) (Rodrigues 
2006). Furthermore, pre-incubated fibrinogen resulted in platelet stimulation, while pre-
adsorption with albumin elicited anti-inflammatory effects on –OH monolayers but not 
on –CH3 monolayers (Rodrigues 2006). In further support of this observation, others have 
shown that OH SAMs permit increased leukocyte binding. This result agrees with the 
capacities for OH SAM to trigger high complement activation as measured by binding of 
C3b to –OH terminal monolayers. This binding was found to be proportional to the 
numbers of acidic sites on the endgroup. On the other hand, –CH3 endgroups supported 
lowest leukocyte adhesion (Sperling 2005). The opposite was true for effects of OH SAM 
on platelet adhesion (Sperling 2005).  
Different SAM chemistries have demonstrated differential recruitment of 
immune/inflammatory cells including monocytes, polymorphonuclear (PMNs) cells 
(Barbosa 2005a) and activated Mac-1 positive leukocytes in vivo to implant sites in mice 




maximum PMN recruitment, these surfaces were associated with least presence of 
adherent neutrophils or leukocytes, even though platelets were still observed to adhere 
(Sperling 2005). Additionally, the CH3 SAM endgroups were associated with thicker 
fibrous capsules (Barbosa 2006), raising the possibility that these surfaces may support 
highest inflammatory responses among the SAM endgroups tested. Others have shown 
that differential monolayer chemistries direct different conformations of adsorbed 
fibronectin and therefore distinct cell integrin-mediated surface adhesion interactions 
(Keselowsky 2003). Overall, studying the ability of biomaterials to support DC 
maturation in vitro represents a significant initial step towards ultimately examining the 
potential of the biomaterials to stimulate DC-regulated adjuvant effects under in vivo 
conditions.  
 Recent studies have suggested a vital role for glycans in mediating multiple 
biological processes such as in development (Ioffe 1994; Perrimon 2000), coagulation 
(Jin 1997) and in controlling bacterial or viral diseases (Fu 2003). Since glycan post-
translational modifications of proteins exist on cell surfaces, in intracellular cytosolic 
compartments, in the extracellular space between cells and tissues and in serum or plasma 
proteins, it is becoming increasingly evident that they direct multiple phenomena. 
Approaches to target diseases such as cancer (Smorenburg 2001; Liu 2002b; 
Wahrenbrock 2003) and cardiovascular disease (Shriver 2002), include the use of glycan-
directed strategies. However, their importance in mediating fundamental 
immune/inflammatory responses in the context of biomaterials remains to be elucidated. 
Glycosylations may be present associated with adsorbed proteins on biomaterial surfaces 




differentiation and other key cell responses. Future directions may include concentrating 
on a select group of relevant glycosylated serum or plasma proteins that are generally 
adsorbed onto biomaterials, obviously discernible and with established degradation 
profiles on gels, to scrutinize the profiles and protein sources of detected carbohydrates 
that are eluted from different SAM endgroups, thereby adding another dimension to these 
studies. Characterization of carbohydrates present associated proteins in SAM eluates 
would be performed using two-dimensional gel electrophoresis and lectin blotting, using 
a panel of lectins with specificities similar to those described in Table 5 in CHAPTER 6. 
The ultimate goal would be towards the design of optimal norms for synthesizing 
biomaterials that have an extensive spectrum of adjuvancies for wide-ranging 







CONCLUSIONS AND FUTURE WORK 
 
The host response elicited against implanted combination products may comprise 
a non-specific inflammatory response against the biomaterial component as a well as a 
specific adaptive immune response against the biological component, which may be 
enhanced by the biomaterial adjuvant effect. Since adjuvants function by supporting DC 
maturation in vivo, this hypothesis was tested by examining the effects of different 
biomaterials in sustaining DC maturation in vitro. With this objective, attempts have been 
made in this thesis research to compare the morphologies, phenotypes and functional 
characteristics of DCs following contact with different biomaterials. Since DCs 
orchestrate the adaptive immune response or may mediate immune tolerance, DC 
responses to biomaterials may predict the nature of the host adaptive response to 
biomaterial implants. The adaptive immune response may be synergistic with the host 
inflammatory response and therefore be important in determining the tendency of the 
biomaterial to stimulate adaptive immunity against associated biological components and 
hence cause graft rejection. 
The in vitro assays conducted in this thesis research were designed to evaluate DC 
responses to different biomaterial surface chemistries, as an in vitro measure of their 
adjuvant potentials in vivo. These assays examined several key parameters of DC 
responses and underlying mechanisms, as well as characterized likely DC ligands in the 
context of biomaterial responses. The key areas that may be included in future studies 




While experiments conducted in this thesis work have included characterizations 
of DC cultures and of the other cell types that were present in cultures derived from 
human PBMCs such as autologous lymphocytes (CHAPTER 4), the importance of DC-
lymphocyte interactions in maintaining the differentiated DC status and in influencing 
DC immune responses and the receptors mediating these interactions should be further 
investigated. Furthermore, the cytokines and chemokines secreted both by DCs and 
lymphocytes should be assessed. A more complete characterization of the proportions of 
different DC subsets (lymphoid, myeloid, pre-DC1s, pre-DC2s) (Liu 2001) isolated using 
PBMCs as a starting population should be identified. The types of DC subsets collected 
may influence the ensuing Th1/Th2 cytokine balances and hence this information may be 
helpful in optimizing DC isolation protocols to drive the Th cell responses based on 
desired end applications. In addition, more thorough analyses of the mechanisms 
underlying differential DC responses to biomaterials should be conducted. The temporal 
variations of DC maturation responses should be assayed by examining other timepoints 
besides 24 hours such as 6 and 12 hours. The 6-hour timepoint may be especially relevant 
for studies characterizing the expression of PRRs such as TLRs or CLRs, which are 
upregulated on iDCs and may be downregulated by the 24-hour timepoint. Furthermore, 
blocking studies should be performed to identify the roles of specific PRRs molecules, 
both at the protein level using function blocking antibodies (Akashi 2000), as well as 
using RNA interference approaches involving short hairpin RNA (Arrighi 2004; Cekaite 
2007). More emphasis may also be placed on exploring the key signaling pathways 
triggered by activation of different PRRs or combinations of multiple PRRs. For instance, 




and MAPK/ IKK pathways or Trif-mediated activation of interferon regulatory factors 
(IRF) pathways (Kawai 2006) in response to biomaterial associated antigens, preferential 
signaling via these pathways for certain TLRs and the balance between NF-κB 
(maturation, differentiation, survival) and AP-1 pathways (apoptotic death) (Kriehuber 
2005a) in the presence of different biomaterials. Finally the link between activation of 
certain TLRs/CLRs by antigens related to biomaterials and the ensuring regulation of 
Th1/Th2 cytokine balances should be probed (Pulendran 2005). The endotoxin levels 
associated either with the biomaterials or with specially processed FBS used in DC media 
have been vigilantly monitored throughout this work. Although the endotoxin levels 
associated with SAM surfaces were negligible (CHAPTER 5), high endotoxin was 
present in de-glycosylated FBS (Figures A1-1 to A1-3 and Figure A2-1, APPENDIX), 
probably as result of the extensive processing steps. At present, the current strategies 
available to purge proteins of endotoxin are not applicable for protein concentrations as 
high as that present in FBS and hence cannot be used. Future studies may however, focus 
on overcoming this issue towards examining the role of carbohydrates in supporting 
biomaterial-centered DC maturation.   
Among the model SAM chemistries utilized in this thesis research, we concluded 
that CH3 SAM surfaces supported lowest DC maturation, since cells cultured on these 
surfaces were rounded,  similar to iDCs and were undergoing high apoptosis, which may 
partly explain the DC immunosuppression observed, since phagocytosis of apoptotic DCs 
is a potent inducer of anti-inflammatory effects on DCs (Skoberne 2005b; Wallet 2005b; 
Chen 2006c) (CHAPTER 5). Although others have concluded from in vitro (Lindbald 




2003; Schwendel 2003; Barbosa 2005a) that CH3 SAM surfaces caused an acute 
inflammatory response as exemplified by increased recruitment of inflammatory cells to 
CH3 SAM surfaces, higher presence of Mac-1
+
 cells and thicker fibrous capsule, some 
inconsistencies do still exist since both this group and others (Schwendel 2003) observed 
that cells still adhered least to CH3 SAM surfaces. Since Mac-1 (CD11b/CD18) is an 
integrin receptor and these cells show least adhesion to the CH3 SAM surface, it may 
indicate that Mac-1 receptor may play another role on this surface. Several groups 
(Coxon 1996; Whitlock 2000; Verbovetski 2002; Morelli 2003; Skoberne 2005b) have 
shown that Mac-1 receptor (also CR3), plays a role in internalizing apoptotic cells and 
causing DC tolerance. In human DCs, opsonization by Mac-1 ligand iC3b, resulted in 
tolerized DCs having downregulated MHC II and CD86 and upregulated CCR7 
expression (Verbovetski 2002). In the splenic marginal zone, DCs were found to undergo 
apoptosis resulting in DC tolerance that was mediated by CR3 (CD1b/Cd18) receptor 
(Morelli 2003). Furthermore, αM-ß2-mediated leukocyte apoptosis and apoptosis of 
neutrophils should be blocked using CD11b/CD18 antibodies (Coxon 1996). These 
results could be interpreted in a different manner, taking into account this recent 
literature. The CH3 SAM surfaces that have high Mac-1+/CR3+ cells may cause 
increased cellular apoptosis and render cells anti-inflammatory. This leads to several 
interesting questions and future directions, including if CH3 SAM implant surfaces would 
recruit more cells, allow lower cell adhesion, support higher apoptosis and hence mediate 
immune tolerance, thereby reflecting our in vitro results (CHAPTER 5) in vivo. The 
effect of apoptosis in mediating immunosuppression in vivo should be tested by 




renders recruited cells less apoptotic, in connection with the literature implicating Mac-1 
in inducing DC apoptosis. These and other unanswered questions may be investigated 
using model SAM surfaces in vivo, once issues concerning the stability of these 
monolayers in vivo  have been resolved, although the use of short term implants have 
been shown to be successful. 
Another significant factor in determining biomaterial biocompatibility is the 
nature of the host protein biofilm that forms very rapidly on the biomaterial surfaces and 
with which host immune cells interact. This interaction may be bi-directional and may 
influence immune cell responses as well as induce cellular protease-directed biofilm 
remodeling (Hubbell 1995). Hence, the characterization of the biofilm may be important 
towards the elucidation biomaterial surface properties that render biomaterials activating 
or passivating and may be of interest in future studies, as an extension of the work 
performed in (CHAPTER 6). 
As an initial approach to characterize the adsorbed protein layer and associated 
post-translational modifications such as carbohydrates or lipids, mass spectrometry (MS) 
should be performed on SAM surfaces that have been pre-incubated with human serum 
or plasma. Firstly, MS should be performed directly on SAM surfaces pre-coated with 
serum/plasma (37°C, 1hr). Secondly, proteins should be eluted from SAM surfaces prior 
to MS [trypsin/ SDS and MS analysis should be performed by matrix-assisted laser 
desorption ionization (MALDI)/ electrospray ionization (ESI)-time of flight (TOF) 
(Chalabi 2006; Comelli 2006). Finally, enzyme-based cleavage of lipids or carbohydrates 
associated with adsorbed proteins should be performed and MS analysis should be 




surfaces. There are however, several technical issues associated with performing MS that 
need to be overcome, prior to these analyses. These include successfully removing 
proteins off the surface and into the analyzer, which may be compounded if multiple 
serum or plasma proteins were adsorbed. Furthermore, lipase/glycosidase cleavages 
would occur at random positions and methods to confirm that cleavages have occurred 
and the positions they have occurred in would first need to be identified. Also, 
importantly, the cleavage of only the presented sugars that the cells interact with on the 
surface should not be controlled. Finally, several proteins in serum are glycosylated, with 
multiple types of glycosylations and sugar linkages, making data interpretation difficult. 
Although several groups have performed MS to characterize proteins, those experiments 
were performed on samples in solution and considerable expertise may be required to 
transition to characterizing adsorbed biofilms on biomaterial surfaces. 
As another approach to characterizing the biofilm layer, immunoblot analysis of 
protein eluates from different SAM chemistries have already been examined in this thesis 
work, as part of collaboration with Dr. Brash and his laboratory at McMaster University, 
Canada (CHAPTER 7). Furthermore, in order to elucidate the profiles of carbohydrates 
associated with proteins eluted from different SAM chemistries, as well as the protein 
sources of these glycosylations, a protocol to perform lectin blotting using NPA, UEA-1, 
UEA-2, SNA-1 or HHA lectins that are specific for different carbohydrate moieties has 
been optimized and has been tested on purified single proteins including anti-thrombin 
III, fibrinogen, albumin, vitronectin, plasminogen (Figure A3-1b, APPENDIX). In 
addition, lectin blotting using NPA, UEA-1, UEA-2, SNA-1 or HHA lectins was 




electrophoresis (PAGE) (Figure A3-1a, APPENDIX). However since several lectins bind 
the same protein and vice-versa, clear trends were not distinguishable. Finally, to 
circumvent the technical difficulty of handling all proteins in serum or plasma 
simultaneously, future directions include focusing in on a panel of up to five glycosylated 
serum or plasma proteins that are commonly adsorbed onto biomaterials, clearly 
distinguishable and with known fragmentation profiles on gels, to investigate the profiles 
and protein sources of detected carbohydrates that are eluted from different SAM 
endgroups. Specifically, this panel of proteins on interest could include IgG, fibronectin, 
vitronectin, fibrinogen, complement-3 and IgA. While IgG has been characterized as 
having N-linked glycans with fucose  (Jefferis 1990) and  galactose moieties on mannose 
α(1-3) or α(1-6) (Takahashi 1987), fibronectin possesses N-glycosylations at one site 
each on its ß and γ chains, IgA contains terminal sialic acid, galactose and GalNAc (Xu 
2005), complement-3 has glucosylated N-linked glycans (Crispin 2004), fibrinogen 
possesses N-linked glycans  (Henschen-Edman 2001) and  vitronectin has N-linked 
glycans and sialylations (Uchibori-Iwaki 2000). N-glycosylations are typically present on 
asparagine and typically include N-acetylneuraminic acid (NeuNAc), galactose, GlcNAc 
and mannose. Alternatively, O-glycosylations occur on serine or threonine and comprise 
NeuNAc, galactose, GlcNAc and GalNAc (Voet 2004). Besides this set of proteins, 
additionally, other glycosylated serum/plasma proteins such as apolipoprotein A1 (Dayal 
2002; Zannis 2006) may be examined. Alternatively, proteins having known specific 
glycosylations such as α1-antitrypsin that contains di and tri-antennary N-glycans with 
alpha-neuraminic acid (Kolarich 2006), transferrin (Bryrne 2006), haptoglobin (He 2006) 




inherently or following the induction of mutations (Isordia-Salas 2003), α2-macroglobulin 
that has oligomannose glycans (Arnold 2006), that have been probed for using 
immunoblot analyses as described in CHAPTER 7, may be investigated.  
Following the characterization of the profiles of proteins and their post-
translational modifications presented in adsorbed biofilms on different biomaterials either 
by MS or SDS-PAGE and lectin blotting, the next step should be directed towards 
describing the roles of these modifications in directing DC-mediated host responses to 
biomaterials. These strategies may include using conjugates composed of carbohydrate 
ligand - BSA such as mannose-BSA for instance, that would specifically block 
carbohydrate-binding abilities of DC receptors, or lectin-BSA conjugates to specifically 
block certain glycosylations presented by adsorbed proteins on biomaterials, or, finally, 
receptor blocking using mannan, β-glucans (Rogers 2005), ManLAM (Geitjenbeek 2005) 
or other ligands mentioned in the literature. Caveats to these suggestions are the host 
immune responses generated against BSA or the lectin itself. Also, any one carbohydrate-
BSA or lectin-BSA conjugate used alone may not successfully block the functionality of 
type I CLRs (such as MMR) that have multiple carbohydrate recognition domains to bind 
distinct glycosylated ligands. In such cases, approaches involving combinations of these 
should be utilized.  
Another potential future direction would be towards the development of 
sophisticated, high-throughput biomaterial screening systems, utilizing techniques such 
as DNA microarrays (Ahn 2002; Edwards 2003), proteomics (Richards 2002), genomics 
(Hashimoto 1999) as readouts of DC responses, on combination libraries of different 




in Dr. Jorge Lahann‟s laboratory at the University of Michigan, at Ann Arbor (Chen 
2006a) may be utilized as one such example high-throughput systems to examine if 
different proteins and/or carbohydrates ligands of DC PRRs immobilized on 
polydimethylsiloxane (PDMS) substrates either alone or as combinations, support 
differential DC maturation. Multi-well surfaces in which each well is modified with any 
one known carbohydrate DC ligand (mannose, fucose, NeuNAc, GalNAc, galactose, 
GlcNAc) (Figdor 2002) or if available, with one known lipid ligand of scavenger 
receptors (SR) [acetylated low density lipoprotein (acLDL) (Chen 2006d), oxidized LDL 
(Yoshida 2006c), high density lipoprotein (Tserentsoodol 2006), apolipoprotein A-1 
(Cavelier 2006)] or other SR ligands including advanced glycation end products (Nagai 
2007), gp96 (Berwin 2003), careticulin (Berwin 2003), bacteria, heat shock proteins 
(HSPs) (Facciponte 2005), phosphotidylserine (Greenberg 2006) should be used to 
observe effects on DC maturation. As a next step towards gradually building up the 
complexity of the system to resemble adsorbed biofilms and based on the results obtained 
from pre-immobilized carbohydrate or lipid-modified surfaces alone, surfaces may then 
be modified with both lipids and carbohydrates, either as random amalgamations or as 
combinations that mimic PAMPs as LPS that has a complex chemistry composed of both 
lipid and sugar components. Dendritic cells would be cultured on these surfaces and both 
DC maturation as well as expressions of TLRs such as TLR2, TLR4, TLR5 (that bind 
carbohydrate and/or lipid ligands), CLRs such as Dectin-1, MMR, DC-SIGN and ASGPR 
and SRs of interest that bind these ligands should be examined at different timepoints, to 
identify the PRRs on DCs that mediate biofilm recognition. A similar system comprising 




proteins has also been developed (personal communication with Dr. Dan Ratner). Other 
sophisticated tools such as those involving the incorporation of sugar labeling groups to 
visualize and follow glycoconjugates within cells (Hsu 2007) or in vivo (Sawa 2006) or 
even lectin microarrays (Kuno 2005) could be employed. Next, ELISA-based 
quantization of binding and immunohistochemical staining by biochemical cross-linking 
of bound receptors, previously achieved on SAMs (Keselowsky 2003) should be 
performed. This assay involves the removal of other cellular components while leaving 
behind cell receptors still attached to ligand. However, there are still some issues that 
need to be overcome prior to conducting this assay. The exact structure of the receptors 
of interest would need to be known, since specific biochemical linking steps need to be 
performed.  The advantages of using this adaptation of the CVD system compared to 
using SAM surfaces presenting different chemistries are that this would be a more 
controlled system where cell responses should be attributed to the presence of specific 
adsorbed sugar/lipid ligand of PRRs. This system may be an initial method of addressing 
the roles of relevant carbohydrate or lipid modifications of serum/ plasma proteins, 
systematically. However a significant level of characterization would first need to be 
performed on these surfaces, prior to their usage. Endotoxin levels of these surfaces 
would also need to be carefully monitored. 
This thesis starts to address the roles of biomaterials as adjuvants in the context of 
combination products used in vivo, by examining the effects of biomaterials in supporting 
DC maturation in vitro. This work along with future studies that systematically examine 
the physical and chemical properties of biomaterials and their associated adsorbed 















ROLES OF CARBOHYDRATE LIGANDS IN SUPPORTING DENDRITIC CELL 
MATURATION IN THE CONTEXT OF SELF-ASSEMBLED MONOLAYERS 
 
INTRODUCTION:  
Controlling the non-specific host responses associated with implanted tissue-
engineered (TE) devices is critical for their success (Anderson 1988; Langer 1993; Tang 
1995; Ratner 1996; Babensee 1998a; Babensee 2000; Rihova 2000; Stock 2001; Wettero 
2002). More recently, it was also observed that the specific immune response generated 
against the biological constituent of combination products could be enhanced by the 
biomaterial component, thereby causing the biomaterial to act as an adjuvant (Babensee 
1998a). Adjuvants function by stimulating antigen (Ag) presenting cells (APCs) such as 
dendritic cells (DCs) and causing DC maturation as exemplified by the upregulation of 
co-stimulatory and major histocompatibility II (MHC II) molecules that facilitate 
activation and presentation of peptide Ag to adaptive immune cells, as well as the 
secretion of pro-inflammatory cytokines (Sallusto 1994; Zhao 1996; Cella 1997a; 
Winzler 1997; Banchereau 1998a; Singh 1999; Banchereau 2000; Sun 2003). The 
biomaterial adjuvant effect was demonstrated in vivo, when delivery of poly (lactic-co-
glycolic acid) (PLGA) along with ovalbumin (OVA) resulted in the production of higher 
levels of antibodies that were specific against OVA (Bennewitz 2005). Furthermore, 
treatment of immature DCs (iDCs) with PLGA resulted in DC maturation (Yoshida 
2006a). In contrast, iDCs matured to a lesser extent when treated with agarose (Yoshida 
2006a), demonstrating that while certain biomaterials may have potent adjuvant effects in 
vitro, others may facilitate modest immune responses against the biological component 
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(Ertl 1996; Walker 1998; Yoshida 2004; Babensee 2005; Bennewitz 2005; Yoshida 
2006a; Yoshida 2006b). 
 The differential ability of biomaterials to stimulate immune and inflammatory 
responses is a critical parameter in the design of suitable biomaterials for diverse 
applications. For instance, lower adjuvant potency is ideal for biomaterial scaffolds used 
in TE applications, while the opposite is required for materials that are used to deliver 
protein vaccines, where an augmented immune response is desired to ensure vaccine 
efficacy. It is well known that biomaterial surface properties such as chemistry, 
hydrophobicity/hydrophilicity and charge, as well as bulk properties such as porosity, 
hardness, among others, are important criteria in determining host-biomaterial 
associations including the amounts, profiles and conformations of non-specifically 
adsorbed host proteins, cell adhesion, survival, differentiation, proliferation, secretion of 
growth factors and cytokines and in directing cell-cell communications (Anderson 1988; 
Langer 1993; Tang 1995; Ratner 1996; Babensee 1998a; Babensee 2000; Rihova 2000; 
Stock 2001; Wettero 2002). The types of adsorbed proteins (regulated by surface 
properties) could be important; for instance, while adsorbed albumin (Martins 2003) has 
been linked to having a passivating effect, adsorbed proteins such as complement-3 (C-3) 
(Hirata 2003) or fibrinogen (Fn) (Silver 1995) are associated with pro-inflammatory 
effects. For the purposes of this study, well-characterized, robust self-assembled 
monolayers (SAM) (Mrksich 1996; Lindbald 1997; Harder 1998; Sigal 1998; Kalltorp 
1999; Luk 2000; McClary 2000; Tegoulia 2000; Shen 2001; Barbosa 2003; Capadona 
2003; Keselowsky 2003; Michael 2003; Schwendel 2003; Dadsetan 2004) having (-CH3), 
(-OH), (-COOH) or (-NH2) endgroups were used model biomaterial surfaces to study the 
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interactions between surface chemistry and immune cells, specifically DCs. The broad 
hypothesis underlying this work is that DCs may interact differentially with adsorbed 
host proteins on different surface chemistries, specifically with the glycosylations that are 
associated with adsorbed host proteins and mature differentially, hence triggering distinct 
adaptive immune responses. Although glycosylations may play major roles in mediating 
host responses to biomaterials, these have hitherto been largely unstudied. However, with 
the arrival of the glycomics era and associated novel strategies to probe carbohydrate 
structure and function (Shriver 2004; Turnbull 2007), the roles of these biomolecules in 
maintaining key biological processes are gaining in prominence. 
 Immature DCs recognize conserved protein-carbohydrate-lipid-based pathogen 
associated molecular patterns (PAMPs) using pattern recognition receptors (PRRs) such 
as Toll-like receptors (TLRs) (Aderem 2000; Akira 2001; Medzhitov 2001) or 
carbohydrate-binding C-type lectin receptors (CLRs). This recognition event may trigger 
the iDCs to transition into mature DCs (mDCs) that present processed internalized 
antigen via MHC complexes to T or B lymphocytes or result in DC tolerance, thereby 
linking innate and adaptive immune immunity (Matzinger 1994; Cella 1997a; 
Banchereau 1998a; Gallucci 1999; Banchereau 2000; Heath 2001; Medzhitov 2001; 
Engering 2002; Figdor 2002; Janeway 2002; Sun 2003; van Kooyk 2003). The CLRs 
include mannose receptor (MR) that binds terminal mannose, fucose, sialylated groups or 
GlcNAc (Sallusto 1995), DC-specific ICAM-3 grabbing non-integrin (where ICAM-3 is 
intercellular adhesion molecule 3) (DC-SIGN) that binds mannose-enriched internal 
residues (Geitjenbeek 2000), Dectin-1 (Brown 2000; Brown 2001a; Brown 2006) that 
binds β-glucans, asialoglycoprotein receptor (ASGPR) (Valladeau 2001) and macrophage 
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galactose N-acetyl-galactosamine (GalNAc) specific lectin 1 (MGL) that bind α- and/or ß 
-galactose or GalNAc. The carbohydrates internalized via CLR binding events have been 
shown to reach different intracellular compartments, may be differentially presented on 
MHC complexes, stimulate the secretion of pro- or anti-inflammatory mediators in 
combination with TLRs (Gantner 2003; Rogers 2005; Dillon 2006) or individually, upon 
ligand binding (Gantner 2003; Rogers 2005) and induce CLR-mediated augmentation of 
TLR-2-induced activation of transcription factors such nuclear factor-кB (NF- кB) 
(Brown 2006) that mediates critical cellular events such as DC maturation.  
Carbohydrate moieties that are similar to those present in PAMPs and that are 
ligands for DC CLRs may play a role in supporting DC maturation in the context of 
biomaterials. It was previously observed that differential profiles of carbohydrate ligands 
of DC CLRs were present on different SAM chemistries (CHAPTER 6). In this study, a 
first step has been taken towards examining the roles of these carbohydrates in causing 
DC maturation, by comparing DCs that were cultured in DC media with fetal bovine 
serum (FBS) that was selectively de-glycosylated of these carbohydrate ligands, versus 
DCs that were cultured in DC media with non-processed FBS. While several groups have 
previously focused on the inflammatory roles of adsorbed proteins, this study is 
significant as it focuses on the effects of glycosylated ligands of DCs presented by 
biomaterials surfaces in stimulating DC-mediated immune responses. 
 
METHODS:  
Self-Assembled Monolayer Preparation  
 Self-assembled monolayer surfaces were assembled on 16-well glass chamber 
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slides (LAB-TEK, Nalge Nunc International, Rochester, NY) for carbohydrate or protein 
measurement assays or on 35 mm X 10 mm sterile, tissue culture (TC)- treated, non-
pyrogenic polystyrene (Phillips) dishes (Corning, Corning, NY) used for DC culture 
(Keselowsky 2003) as described in CHAPTERS 4 and 5. Clean chamber slides or dishes 
were coated sequentially with 50 Å Ti followed by 150 Å Au films using an electron 
beam evaporator (CVC Products/ Veeco, Rochester, NY) as described in (Keselowsky 
2003) and stored under vacuum at room temperature (RT) until two weeks until used.  
The following alkanethiols were used as received from commercial sources (1 mM in 
absolute ethanol): 1-dodecanethiol (SH-(CH2)11-CH3) (CH3 SAM), 11-mercapto-
undecanol (HS-(CH2)11OH) (OH SAM), 11-mercaptoundecanoic acid (HS-(CH2)10-
COOH) (COOH SAM), (Aldrich Chemical, Milwaukee, WI) and 11-amino-1-
undecanethiol, hydrochloride (C11H26ClNS) (NH2 SAM) (Dojindo Laboratories, 
Gaithersburg, MD). The SAMs were allowed to assemble by 12 hr incubation at RT by 
immersing the Ti/Au-coated slides or dishes in alkanethiol solutions, following which the 
chamber slides were washed with 95% ethanol (Sigma, St. Louis, MO) dried with N2 gas 
(Airgas South, Chamblee, GA) for ten minutes in a fume hood, equilibrated with 
Phosphate Buffered Saline (PBS) (Gibco, Grand Island, NY) for 5 minutes at RT and 
used fresh. The SAM-immersed dishes used for DC culture were opened under sterile 
conditions in the TC hood, washed once with absolute ethanol (Sigma), followed by five 
washes with sterile-filtered (0.22 µm) (Corning, Corning, NY) PBS and used 
immediately for cell culture assays. Based on previous characterizations CH3 SAMs were 
most hydrophobic and OH SAMs were most hydrophilic. Also, x-ray photon 
spectroscopy (XPS) analysis of surface elements showed close agreement with calculated 
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theoretical values (CHAPTER 6). 
 
Selective de-glycosylation of Fetal Bovine Serum (FBS) 
 Fetal bovine serum (Invitrogen, Carlsbad, CA) (50 mLs) was thawed and treated 
with 1 µl of N- or O-glycosidases (PNGase F, Sialidase, ß-galactosidase, 
glucosaminidase and O-glycosidase) sequentially, in no specific order, as per 
manufacturer‟s instructions (QA bio, San Mateo, CA) in the absence of denaturing 
proteins and incubated for 24 hours at 4°C. Next, to separate the cleaved N- or O-linked 
carbohydrates from the protein mixture, FBS was flowed sequentially through lectin gel 
columns (gravity separation) that were specific for carbohydrate ligands of DC CLRs, 
similar to those used in Enzyme Linked Lectin Assays (ELLA) (CHAPTER 6) and 
cleaved moieties were separated by affinity chromatography at RT as per manufacturer‟s 
instructions. The effluent de-glycosylated FBS was collected. Carbohydrates retained via 
binding to lectin gel probes were eluted and the eluates were collected separately. Lectin 
columns used included Narcissus pseudonarcissus (NPA) (probe for mannose), 
Sambucus nigra (SNA-1) (sialylated groups), Ulex europeaus I (UEA-1) (fucose), Ulex 
europeaus II (UEA-2) (GlcNAc), or Peanut agglutinin (PNA) (α-galactose) (all from EY 
Laboratories, Inc., San Mateo, CA).  To elute the bound carbohydrates from the columns, 
the following eluates were used:  0.2 M mannose in Tris Buffered Saline (TBS) (for 
NPA), 0.1 M lactose in PBS (for SNA-1), 0.1 M fucose in PBS (for UEA-1), 0.1 M 
GluNAc in PBS (for UEA-2), 0.2 M galactose (for PNA) in PBS or 0.05 M GalNAc in 
TB (all from EY laboratories lectin gel kit), respectively. Lectin columns were 
regenerated with 1.4 M NaCl (Sigma) and conditioned with PBS or TBS (only for NPA 
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or PNA) prior to flowing FBS through. To measure the total protein recovered in 
processed FBS (hereafter referred to as proc-FBS) a BCA assay (Sigma) was performed 
on non-processed FBS (hereafter referred to as FBS) or proc-FBS samples following 
manufacturer‟s instructions. A glycoprotein carbohydrate estimation assay (Pierce, 
Rockford, IL) was used to measure % carbohydrate content of FBS or proc-FBS after 
selective de-glycosylation, following manufacturer‟s instructions. About 75% of the total 
protein in FBS was recovered in proc-FBS and the % carbohydrate content decreased 
from about 10% in FBS to below detection (detection limit: 0.1% carbohydrate content; 
i.e., absorbance readings below blank sample) in proc-FBS. 
 
Chromogenic Endotoxin Assay 
 Endotoxin content of FBS or sterile-filtered (0.22 µm) proc-FBS was measured 
using a chromogenic Limulus Amebocyte Lysate (LAL) assay (QCL-1000 Chromogenic 
LAL Endpoint Assay, Cambrex, Walkersville, MD) as previously described in 
CHAPTER 5. Standards or samples (triplicate) in endotoxin-free water were added to TC 
- treated 96-well PS plates (Corning). Next, LAL was added and incubated for 10 minutes 
at 37°C after which, the chromogenic substrate (Ac-lle-Glu-Ala-Arg-pNA) was added to 
each well and incubated for 6 minutes. Finally, glacial acetic acid in endotoxin free water 
(25% v/ v) (J.T.Baker, Phillipsburg, NJ) was added as a stop solution and the absorbance 
associated with color development in the substrate corresponding to the endotoxin 
present in the sample was measured at 405 nm. Endotoxin content in the samples was 
read off standards generated from endotoxin standards. For FBS, endotoxin amounts 
were below detection (detection limit: 0.1 endotoxin units (EU)/ ml; i.e., absorbance 
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readings below blank sample) and well below the approved FDA endotoxin limit for 
implantable devices; 0.5 EU/ ml. However, for proc-FBS, endotoxin levels detected were 
above 10 ng/ ml or 100 EU/ ml. 
 
Enzyme Linked Lectin Assay (ELLA) for detection of carbohydrates associated with 
adsorbed proteins on SAM   
 To further characterize the processed FBS and to measure remaining 
carbohydrates from processed FBS associated with adsorbed proteins on biomaterial 
surfaces that may act as ligands for DC CLRs, ELLAs were performed on SAM using a 
previously described method with some modifications (Leriche 2000), as described in 
CHAPTER 6. Briefly, the SAM were incubated with 60 l/ well of 10% (v/ v) FBS or 
proc-FBS in PBS or with PBS alone (1 hr, 37C). After aspirating out FBS, proc-FBS or 
PBS samples from wells, wells were blocked with 0.5 mg/ mL of Bovine Serum Albumin 
(BSA) (Sigma) in PBS (block buffer; 1 hr, 37C), washed three times for five minutes 
each with block buffer at RT and incubated with biotinylated lectin [Narcissus 
pseudonarcissus (NPA; 12.5 g/ mL), Sambucus nigra (SNA-1; 12.5 g/ mL), 
Hippeastrum hybrid  (HHA; 50 g/ mL), Peanut agglutinin (PNA; 12.5 g/ mL), or 
Bauhinia purpurea (BPA; 25 g/ mL) for which differential trends were previously 
observed in CHAPTER 6 depending on the SAM endgroup] with the carbohydrate 
detection specificities indicated in Table 5 from CHAPTER 6 (all from EY Laboratories, 
Inc., San Mateo, CA)] (94) in block buffer (2 hrs, 37C). For BPA lectin, wells were 
blocked with 1.0 mg/ mL of BSA in PBS. Following incubation with the biotinylated 
lectin, wells were washed and incubated with 10 µg/ mL avidin/alkaline phosphate 
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(AV/AP) (EY laboratories Inc.) in block buffer (1 hr, 37C) for detection of bound lectin. 
The concentration of AV/AP used was 1.25 µg/ mL for SNA-1 or 20 µg/ mL for BPA 
lectin. Finally, wells were washed and incubated with 1.0 mg/ mL p-
nitrophenylphosphate (pNPP) (Sigma) substrate for detecting AV/AP (1 hr, 37C). The 
solutions were transferred to wells of a clear flat-bottomed TC-treated 96-well plates to 
avoid interference with the reading by the SAM, reaction stopped with 40 l of 0.4 M 
NaOH (Sigma) and absorbance read at 405 nm using a SpectraMax Plus 384 plate reader 
(Molecular Devices, Sunnyvale, CA). Positive control glycoprotein standard dilutions in 
PBS (1:1) were run in parallel on TC-treated PS 96-well plates (control) for each lectin; 
α-2-macroglobulin (from 100 – 12.5 µg/ mL) or (1000 – 3 µg/ mL) for NPA (van Leuven 
1993) or HHA (Balzarini 2005) respectively, glycophorin A (100 – 3 µg/ mL) for SNA-1 
(Shibuya 1987), asialofetuin (5 – 0.6 µg/ mL) or (31.25 – 1.9 µg/ mL) for PNA (Balu 
2001) or BPA (Sueyoshi 1988) (all from Sigma), and based on lectin probe specificity 
data from (van Damme 1998). An identical set of samples (FBS or proc-FBS) as those 
run on SAM were also run on control PS for each experiment.  
 
Human Peripheral Blood Mononuclear Cell-derived Dendritic Cell Culture  
 To investigate the roles of carbohydrate ligands of DC CLRs associated with FBS 
proteins in supporting DC maturation, proc-FBS that was selectively de-glycosylated of 
DC CLR ligands was used in DC media on different SAM chemistries. Dendritic cells 
were derived in vitro from human peripheral blood mononuclear cells (PBMCs) using a 
previously described method (Romani 1996) as reported elsewhere (Yoshida 2004) and 
in CHAPTER 5. Briefly, peripheral human blood was collected from consenting donors 
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using heparin (333 U/ mL blood) (Baxter Healthcare Corporation, Deerfield, IL) as an 
anticoagulant.  This procedure was performed by phlebotomists at the Georgia Tech 
Student Health Center in accordance with the Georgia Institute of Technology‟s Institute 
Review Board (IRB)-approved protocol # H05012. All subjects enrolled in this research 
responded to an Informed Consent which was approved by the IRB of Georgia Institute 
of Technology.  Briefly, the PBMC layer was separated using lymphocyte separation 
medium (LSM) (Cellgro MediaTech, Herndon, VA) from whole blood using 
centrifugation. The PBMCs were resuspended at 5x10
6 
cells/ mL in media{RPMI-1640 
containing 25 mM HEPES [4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid) and L-
glutamine] (Gibco), 100 U/ mL penicillin/streptomycin (Cellgro MediaTech, Herndon, 
VA)} and 10% (v/ v) FBS or proc-FBS and 10 mL of either of these cell suspensions 
were plated onto a TC plates and incubated for adherence (2 hrs) at 37°C with 95% 
relative humidity and 5% CO2 to select for adherent monocytes. Adherent cells that 
remained following three washes with pre-warmed media were cultured in fresh media 
supplemented with granulocyte macrophage colony-stimulating factor (GM-CSF) (1000 
U/ mL) and interleukin-4 (IL-4) (800 U/ mL) (both from Peprotech, Rocky Hill, NJ) (DC 
media) for 5 days.  On the fifth day of culture, DCs were collected and  plated at 1.5x10
6 
cells/ well in 3 mL/ well in DC media with FBS or proc-FBS, supplemented with the 
cytokines and left as untreated iDCs, or as lipopolysaccharide LPS-treated mDCs or 
treated with different SAM endgroups. On day 6 of culture, the loosely adherent cell 
fractions containing DCs were harvested for DCs cultured in DC media with FBS or 
proc-FBS for the various treatment groups, for further analysis. 
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Dendritic cell morphology 
 Dendritic cell morphology was examined throughout the culture duration by 
phase contrast microscopy. Dendritic cells cultured in DC media with FBS or proc-FBS 
were processed for Cytospin preparations as described earlier (Yoshida 2004) (Cytospin 
Cytocentrifuge, Thermo Shandon, Pittsburg, PA) and stained with Differential 
Hematology Stain (Astral Diagnostics, West Deptford, NJ). Giemsa-stained cytospin 
images were obtained on day 6, following 24 hour SAM treatment, for loosely adherent 
cell populations containing DCs for iDCs, mDCs or DCs treated with different SAM 
endgroups in DC media with FBS or proc-FBS. Three images were taken at three 
different regions for each cytospin and a representative image was chosen. 
 
Flow cytometry for determination of maturation marker expression 
 To examine the effects of DC culture in DC media with proc-FBS, the levels of 
DC surface marker expression were measured on day 6 using a flow cytometric technique 
as described previously (Yoshida 2004).  Loosely adherent cell fractions containing DCs 
that were cultured in DC media with FBS or proc-FBS were collected and resuspended in 
Hank‟s HEPES buffer (120 mM NaCl, 10 mM KCl, 10 mM MgCl2, 10 mM glucose, 30 
mM HEPES) (all from Sigma) containing 1% Human Serum Albumin (HSA) (EMD 
Biosciences, San Diego, CA) and 1.5 mM CaCl2 (Sigma) and stained with saturating 
concentrations of mouse anti-human monoclonal antibody against CD14 (clone UCHM1; 
IgG2a), CD40 (clone B-B20; IgG1), CD80 (clone BB1; IgM, CD86 (clone BU63; 
IgG1 (all from Southern Biotech, Birmingham, AL), CD83 (clone HB15a; IgG2b) (IO 
Test Immunotech Beckman Coulter, Marseille, France) HLA-DQ (clone TU169; 
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IgG2a), or HLA-DR (clone TU36; IgG2a) (both from Becton Dickinson Pharmingen, 
San Diego, CA), while maintained on ice and in the dark. Samples were strained via cell 
strainers (40 µm nylon pore) (Becton Dickinson, San Jose, CA) into 200 µl of flow 
cytometry buffer and analyzed immediately using BD LSR flow cytometer (Becton 
Dickinson, San Jose, CA) and 5000 events were collected per sample. Autofluorescence 
was used as negative controls.  Analysis was performed using BD LSR flow cytometer 
(Becton Dickinson, San Jose, CA).  Data analysis was performed using BD FACS DIVA 
v. 4.1.2 (Becton Dickinson Biosciences, San Jose, CA) and using WinMDI 2.8 (Scripps 
Research Institute, La Jolla, CA).     
 
Secretion of Tumor Necrosis Factor - α (TNF- α) or (IL-6) per DNA amount 
 The release of pro-inflammatory cytokines, tumor necrosis factor- α (TNF-α) or 
IL-6 normalized to DNA amounts, by DCs during their culture in DC media with FBS or 
proc-FBS on SAM endgroups was assessed in cell culture supernatants. Briefly, 
supernatants were collected by swirling cell culture dishes clockwise, anti-clockwise, 
from left to right and from right to left, ten times in each direction on day 6 of culture. 
This was performed following treatment of DCs for 24 hrs in DC media containing FBS 
or proc-FBS, with the different SAM chemistries. The supernatants were cleared by 
centrifugation at 1100 rpm for 10 minutes and stored at -20°C for analysis, using a 
method as described previously (Yoshida 2004).  Concentrations of TNF-α or IL-6 per 
DNA amount were measured using ELISAs (R&D Systems, Minneapolis, USA) in 
accordance with manufacturer‟s instructions. The DNA amounts were measured by 
pooling both loosely adherent cells and the non-adherent fraction, [removed using 
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trypsin/ 0.05% EDTA (Sigma)] using a PicoGreen DNA kit (Molecular Probes, Oregon, 
USA) following manufacturer‟s instructions. Amounts of pro-inflammatory cytokines 
were normalized against total DNA amounts for each treatment group. 
 
Statistical Analysis 
 Statistical analysis was performed using two-way analysis of variance (Young 
2001), setting variance due to treatments as the fixed factor and variance due to donors as 
the random factor and performing pairwise comparisons between treatments with a 
Tukey post-test using Minitab software (Version 13.20, Minitab Inc., State College, PA).  
To observe the effects of different treatments compared to iDCs, one-sided Student‟s T 
Test was performed (Microsoft Excel v. 2003). The p value of less than or equal to 0.05 
was considered significant. 
 
RESULTS  
Characterization of selectively proc-FBS using ELLAs 
 The ELLA assays were performed following pre-incubation of different SAM 
chemistries with either FBS or proc-FBS to characterize the profiles of carbohydrates 
associated with adsorbed proteins. No significant differences were observed for 
carbohydrate associated with proteins adsorbed to different SAM chemistries with either 





Morphology of DCs cultured in DC media with FBS or proc-FBS 
 For DCs cultured in DC media with FBS, iDCs or DCs on CH3 SAM were 
rounded and presented fewer dendritic extensions as compared to mDCs or DCs on OH, 
COOH or NH2 SAM endgroups (Figure A1-1a-f). In contrast, for DCs cultured in DC 
media with proc-FBS, iDCs, mDCs or DCs treated with all SAM endgroups exhibited 










Figure A1-1: Dendritic cells cultured in DC media with FBS or proc-FBS 
demonstrate variations in cell morphology.  
Immature DCs derived from human PBMCs were cultured in DC media with FBS (a-f) or 
with proc-FBS (g-l) in the presence of GM-CSF and IL-4 until Day 5 and then plated on 
polystyrene surfaces. Cells were cultured in DC media without (a or g), or with LPS (b or 
h), or on CH3 (c or i), OH (d or j), COOH (e or k), NH2 (f or l) SAM endgroups for 24 
hours with FBS or proc-FBS, respectively. Giemsa-stained cytospins taken on Day 6 of 
culture indicated that DCs treated with OH, COOH or NH2 SAM endgroups exhibited 
dendritic processes similar to positive control LPS-treated mDCs and unlike those treated 
with CH3 SAM endgroups which were similar to iDCs when cultured in DC media with 
FBS. However, DCs cultured in DC media with proc-FBS exhibited membrane processes 
for all treatments similar to mDCs. Original magnification: 40x.  Cytospins were 




Maturation marker expression for DCs cultured in DC media with FBS or proc-FBS 
Lipopolysaccharide treatment resulted in an upregulation of CD40, CD83, CD86, 
HLA-DQ or HLA-DR expression on mDCs as compared to iDCs only for DCs that were 
cultured in DC media with FBS (Figure A1-2a) but not for DCs that were cultured in DC 
media with proc-FBS (Figure A1-2b). Dendritic cells cultured in DC media with FBS on 
CH3 SAM exhibited highest expression of anti-inflammatory apoptosis inducing HLA-
DQ receptor as compared to iDCs or to DCs treated with all other SAM endgroups, in 
agreement with previous results (Figure A1-2a and CHAPTER 5). Other modest 
differences were observed for DCs cultured in DC media with FBS on different SAM 
chemistries (Figure A1-2a).  In contrast, DCs treated with different SAM endgroups with 
proc-FBS exhibited no differences in maturation marker expression among SAM 
endgroups (Figure A1-2b).  Furthermore, for DCs cultured in DC media with proc-FBS 
no differences were observed in the levels of expression of markers with different SAM 
treatments as compared to mDCs (Figure A1-2b). On the contrary, for DCs cultured in 
DC media containing FBS, mDCs exhibited higher levels of CD40, CD80 and CD83 as 







































































Figure A1-2: Dendritic cells cultured in DC media with FBS exhibit increases in 
expression of CD40, CD83, CD86, HLA-DQ or HLA-DR when matured using LPS 
while DCs cultured in DC media with proc-FBS do not.  
Immature DCs cultured in DC media with FBS exhibited higher expression of maturation 
markers in response to 24 hour exposure to LPS (a), in contrast to DCs cultured in DC 
media with proc-FBS which did not exhibit significant increases in expression (b). 
Furthermore, any differences in marker expression observed for DCs on different SAM 
chemistries with FBS (a) were absent with proc-FBS (b). This experiment was performed 
six times with six different donors. Data represented as treatment control ratios of gMFI 
values revealed statistical significance of the findings; mean ± S.D, „+‟: indicates increase 
over iDC, „*‟: indicates less than SAM endgroup,‟#‟ indicates less than mDCs, p≤0.05.   
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Secretion of TNF-α or IL-6 by DCs cultured in DC media with FBS or proc-FBS 
 As expected, for DCs cultured in DC media with FBS, LPS-treated mDCs 
secreted significantly higher levels of TNF-than iDCs. Among SAM endgroups, DCs 
treated with CH3 SAM secreted higher levels of pro-inflammatory TNF-compared with 
DCs treated with all other SAM endgroups. Also, DCs treated with OH SAM instigated 
higher TNF-secretion than DCs treated with COOH or NH2 SAM (Figure A1-3a) as 
reported in CHAPTER 5.  On the other hand, for DCs cultured in DC media with proc-
FBS, mDCs or DCs treated with the different SAM endgroups all secreted similar levels 
of TNF-that were significantly higher as compared to TNF- secreted by iDCs and no 
differences in TNF- levels were observed among DCs treated with different SAM 
endgroups (Figure A1-3b). Similar results were observed when amounts of IL-6 secreted 


























































































Figure A1-3: Differential profiles of TNF- α secretion for DCs cultured in DC media 
with FBS or with proc-FBS. 
Supernatants from iDCs, LPS-matured DCs, or DCs treated with different SAM 
endgroups were collected and TNF- α content was measured and shown normalized 
against DNA content for culture in DC media with FBS (a) or proc-FBS (b). Dendritic 
cells cultured in DC media with proc-FBS, with all treatments, secreted high TNF- α 
similar to levels secreted by mDCs cultured in DC media with FBS. Among SAM 
endgroups, contact with CH3 SAM induced highest TNF- α secretion by DCs cultured in 
DC media with FBS (a). No differences were observed in levels of TNF- α secreted by 
DCs treated with different SAM endgroups with proc-FBS (b). This experiment was 
performed three times with three different donors; mean ± S.D, „*‟: greater than iDCs; „#‟ 




 This study focused on investigating the roles of carbohydrate ligands of DC 
PRRs associated with adsorbed proteins on biomaterial surfaces in supporting DC 
maturation. As an initial step towards elucidating their roles, the FBS used in the DC 
media was selectively de-glycosylated of carbohydrates which are known ligands for DC 
CLRs.  This proc-FBS was used in the DC media with which to treat DCs with different 
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SAM endgroups and these DCs were compared morphologically, phenotypically and 
functionally against DCs that were cultured in DC media using non-processed FBS (FBS) 
to assess the role of protein glycosylations. Overall, these results demonstrated that 
culture in DC media with proc-FBS slightly increased background iDC maturation, but 
strikingly lowered LPS maturation effects and for the most part overwhelmed any 
biomaterial effects on maturation marker expression. Based on morphology, DCs 
cultured in DC media with proc-FBS exhibited several dendritic extensions of the plasma 
membrane indicative of maturation, irrespective of whether they were treated with or 
without LPS, or on different SAM endgroups (Figure A1-1b), notably distinctive from 
iDCs or DCs on CH3 SAM which were less mature following culture in DC media with 
FBS (Figure A1-1a). As shown in Figure A1-2a, LPS treatment caused DC maturation as 
exemplified by an upregulation of CD40, CD80, CD86 and HLA-DQ only when DCs 
were cultured in DC media with FBS (Figure A1-2a) but not with proc-FBS (Figure A1-
2b). Finally, culture in DC media with proc-FBS also resulted in significantly higher 
secretion of TNF-Figure A1-3) for iDCs as well as for all treatments as compared to 
culture in DC media with FBS. Taken together, these results imply that although proc-
FBS caused higher basal maturation of iDCs, the removal of glycosylations lowered the 
ability of DCs to mature in response to LPS stimulus and may imply a significant role for 
protein glycosylations as DC maturation stimuli in the context of biomaterials.  
 There are several interpretations as well as caveats for these results. Firstly, in 
proc-FBS, the lowered levels of DC carbohydrate ligands may have counteracted the LPS 
maturation stimulus and lowered expression of DC maturation markers. This may imply 
that serum glycosylations are an important stimulus for DC maturation. Secondly, 
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selective removal of glycosylations in proc-FBS may have exposed other DC ligands or 
removal of glycosylations may be incomplete or proteins that are critical to the host 
response may have been removed, thereby yielding higher basal maturation with iDCs. 
Lastly selective de-glycosylation of FBS may have a more potent effect on DC 
maturation that masks the weaker effects due to the biomaterial. However, elevated levels 
of endotoxin were present in proc-FBS and introduce an important caveat to these results. 
Also, results from ELLA assays did not indicate differences in profiles of presented 
carbohydrates on different SAM chemistries with either FBS or proc-FBS incubating 
solutions, implying that the carbohydrate profiles on the biomaterials after FBS de-
glycosylations were not significantly altered. Other considerations include that no trends 
in carbohydrate profiles were observed even with FBS, different from results in 
CHAPTER 6, where pooled human serum was used instead of FBS. Furthermore, 
although profiles of presented carbohydrates were not modified with de-glycosylation, % 
carbohydrate content decreased. 
 Dendritic cells exhibit impaired abilities to respond to a second LPS challenge 
(high-dose – 10 ng/ ml for human DCs) (Jotwani 2003; Saito 2006) following exposure to 
the first dose of LPS (low dose – 0.2 ng/ ml for human DCs). This LPS-unresponsiveness 
of DCs is also referred to as LPS tolerance or endotoxin desensitization. Results from 








Table 14: Summary of phenotypic and functional characteristics of endotoxin-
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 The objective in performing this comparative analysis of results was to observe if 
the reduced DC maturation observed with proc-FBS in this study was due to the presence 
of endotoxin contaminant and not due to carbohydrate removal alone. The analysis 
suggests that although some of the findings in this study agree with DC responses 
typically induced by endotoxin (i.e. inability to upregulate maturation marker expression 
in response to LPS) (Figure A1-2), other results do not [CD83 expression, TNF-α, IL-6 
secretion (Figure A1-3), allostimulation] and in fact were exactly opposite to well-
documented characteristics of endotoxin-exposed DCs. The DC responses observed here 
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therefore, strongly contrasted with those normally seen due to endotoxin contamination. 
 Taken together, these results suggest that although endotoxin was present, it 
does not fully explain our results and may need to be further investigated. The dosage of 
endotoxin present may be important; here the concentration of endotoxin present was 
higher than that of other studies and may explain the atypical DC responses to endotoxin 
observed here. The other possibility is that the removal of carbohydrates from FBS 
counteracted the endotoxin effect resulting in DCs that were phenotypically similar to 
endotoxin-exposed DCs, but functionally opposite (pro-inflammatory cytokine secretion, 
allostimulation). Therefore, the dual presence of endotoxin as well as de-glycosylated 
FBS may have rescued DCs from the deactivation state that is characteristic of endotoxin 
treatment. Hence DCs may respond to LPS re-challenge more effectively in the absence 
of other glycosylated ligands of DC C-type lectin receptors, as part of a complex 
interplay of factors that are responsible for DC responses. Considering the effects due to 
biomaterials, the dual presence of endotoxin and de-glycosylated FBS overwhelmed the 
weaker effects of biomaterials presenting different endgroup chemistries on DC 
responses.  
 In summary, a novel protocol has been developed for selective partial removal 
of carbohydrate ligands of DC CLRs of interest from FBS. Although serum remained 
glycosylated after processing (as expected since only selective removal of all 
glycosylations in serum was planned) successful removal of carbohydrates did occur as 
indicated by high levels of carbohydrate in eluates (data not shown) as well as the 
decrease in carbohydrate content from 10% for FBS to below assay detection limits for 
proc-FBS. Furthermore, the glycosylations remaining in proc-FBS may include 
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carbohydrates that are not ligands of DC CLRs. Although no differences were observed 
in profiles of presented carbohydrates on different SAM chemistries with proc-FBS 
versus FBS from ELLAs, this may have been due to the fact that no trends were observed 
between biomaterials for FBS itself. The effect of complement activation in causing basal 
iDC maturation is not expected to be a factor since commercially available heat-
inactivated FBS was used. This protocol may be further optimized to enable higher 
protein recovery from columns, to ascertain complete removal of glycosylations of 
interest and to better control the removal of only carbohydrates of interest. In future 
studies, attempts may be made to decontaminate the FBS of high endotoxin contaminant 
levels that were likely acquired during the multiple processing steps, using commercially 
available strategies that are inapplicable at present due to the high protein concentration 
in FBS, but may become available once concentration issue are overcome. Other 
strategies to probe the effects of carbohydrates or glycoproteins on DC maturation may 
include high-throughput carbohydrate, glycoprotein (Feizi 2004; Palma 2006) or lectin 
microarrays (Kuno 2005). These as well as other future directions towards linking the 
roles of carbohydrates in regulating DC responses using novel analytical tools from the 
glycomics era have been outlined in CHAPTER 8. 
In conclusion, this study represents an ongoing effort to examine the roles of 
carbohydrate ligands of DC PRRs towards supporting DC maturation. Due to the 
indefinite nature of certain results, this work would need to be re-examined prior to 
drawing any definite conclusions and has therefore been relegated to the appendix 
section. 
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                                                       APPENDIX 2 
A.2   Maturation marker expression for DCs cultured using regular FBS or de- 
         glycosylated FBS on different SAM chemistries 
 The expression levels of the various markers of DC phenotype including CD80 
and CD86 co-stimulatory molecules, HLA-DQ and HLA-DR MHC II molecules, CD83, 
a dendritic cell marker and CD40 were assessed by using flow cytometry. A 
representative set of histograms are presented here. Generally, iDCs expressed lower 
levels of these markers and maturation induced by LPS treatment resulted in upregulated 
expression on mDCs as seen with CD40, CD80 and CD83. Differential levels of 
expression of maturation markers were observed for different SAM chemistries as 
reported in CHAPTER 5, implying differential DC responses to different SAM 




Figure A2-1a: Dendritic cells treated with various SAM chemistries differentially 
modulate their expression of co-stimulatory and MHC class II molecules when 
cultured with regular FBS.   
Immature DCs expressed lower levels of CD40, CD80 and CD83 as compared to mature 
DCs that were treated with LPS. Dendritic cells treated with –CH3, -OH, -COOH, or –
NH2 SAM chemistries exhibited differential levels of different maturation markers. Black 
unfilled histograms represent autofluorescence and red filled histograms represent 
fluorescence due to marker.  This experiment was repeated six times with similar results, 
and representative results are shown. 
 
Next the expression levels of the various maturation markers were assessed for 
DCs that were cultured on the different SAM chemistries, in the presence of processed 
de-glycosylated FBS, prepared as per methods described in APPENDIX 1. It was 
observed that in the presence of de-glycosylated FBS, no differences were observed for 
different SAM treatments as compared to culture using regular FBS, where a differential 
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the presence of de-glycosylated FBS, similar levels of most maturation markers were 
observed even for iDCs and LPS-treated mDCs (Figure A2-1b). 
 
 
Figure A2-1b: Dendritic cells treated with various SAM chemistries exhibit similar 
expressions of costimulatory and MHC class II molecules in the presence of de-
glycosylated FBS.   
Immature DCs did not express lower levels of CD40, CD80 and CD83 as compared to 
mature DCs that were treated with LPS, when cells were cultured with processed de-
glycosylated FBS. Dendritic cells treated with –CH3, -OH, -COOH, or –NH2 SAM 
chemistries exhibited similar levels of different maturation markers. Black unfilled 
histograms represent autofluorescence and red filled histograms represent fluorescence 
due to marker.  This experiment was repeated six times with similar results, and 
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    APPENDIX 3 
A.3   Lectin blotting on serum, plasma or single purified protein samples 
This work was performed in collaboration with Dr. John Brash and Rena 
Cornelius from McMaster University in Canada. The overall goal of this study is to 
characterize the carbohydrates modifications of proteins present in eluates from different 
SAM chemistries and to identify the specific proteins that were associated with these 
glycosylations.  As a first step, lectin blotting was performed using NPA, UEA-1, UEA-
2, SNA-1 or HHA lectins either on pre-absorbing plasma or serum samples including 
10% filtered serum, 1% filtered heat-inactivated plasma, 10% unfiltered serum, 1% 
unfiltered heat-inactivated plasma and 1% filtered non-heat-inactivated plasma (Figure 
A3-1a) or on purified single proteins including anti-thrombin III, fibrinogen, albumin, 
vitronectin, plasminogen (Figure A3-1b). Heat inactivation was performed by 
maintaining samples for 30 minutes at 56ºC. Plasma, serum or purified proteins were 
initially run using SDS-PAGE and then the proteins were transferred to polyvinylidene 
fluoride (PVDF) membranes for lectin blotting. For lectin blotting, membranes were first 
blocked using Tween/Tris buffered saline (TBS) (RT, 2.5 hrs) then incubated with the 
lectin (RT, 2 hrs), washed 3 times for 5 minutes each using block buffer, then incubated 
with avidin alkaline phosphatase (RT, 15 minutes), washed and color was developed with 
NBT/BCIP in alkaline phosphatase buffer (RT) on a shaker. Although the protocol for 
performing lectin blotting was successfully optimized, it was observed however that since 
several lectins bind the same protein and vice-versa, clear trends were not distinguishable 
(Figure A3-1a). However, distinct trends were observed when single glycosylated 
proteins were used, in agreement with their known glycosylations. Fibrinogen or 
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vitronectin are controls for N-glycans including sialylated groups (NeuNAc), GlcNAc or 
mannose (Uchibori-Iwaki 2000; Henschen-Edman 2001). On the other hand, albumin is 
composed of trace glycosylations. As expected, positive staining was obtained for most 
N-linked glycans tested on fibrinogen or vitronectin, while in general, negligible to non-
existent carbohydrate levels were detected for albumin (Figure A3-1b). 
Figures A3-1a: Absence of clearly distinguishable trends from lectin blotting 
experiments performed using different preabsorbing serum or plasma samples. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis was performed to separate 
serum or plasma proteins [10% filtered serum (1), 1% filtered heat-inactivated plasma 
(Wallet), 10% unfiltered serum (3), 1% unfiltered heat-inactivated plasma (4) or 1% 
filtered non-heat-inactivated plasma (Wallet)] (bandwise, 1-5 from left to right) (row 1). 
These proteins were then transferred to a PVDF membrane and lectin blotting performed 
with Con A (glucose, mannose), NPA (mannose), HHA (mannose) (all in row 2, from left 
to right), SNA-1 (sialylated groups), UEA-I (fucose) or UEA-II (GalNAc) (all in row 3, 
from left to right). No clear trends could be obtained using different lectin probes. 
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Figures A3-1b: Lectin blotting protocol has been optimized for lectins having 
different specificities on purified single protein samples. 
Sodium dodecyl sulfate - polyacrylamide gel electrophoresis was performed using 
different single purified proteins [fibrinogen (1), antithrombin III (Wallet), vitronectin 
(3), albumin (4), plasminogen (Wallet)] (bandwise, 1-5 from left to right) (both in row 1). 
These proteins were then transferred to a PVDF membrane and lectin blotting performed 
with Con A (glucose, mannose), NPA (mannose), HHA (mannose) (all in row 2, from left 
to right), SNA-1 (sialylated groups), UEA-I (fucose) or UEA-II (GalNAc) (all in row 3, 
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